<!DOCTYPE html>
<html>
<head>

      <meta http-equiv="Content-Type" content="text/html; charset=utf-8">

        <script> var url = encodeURIComponent('https://www.mdpi.com/journal/jcm');</script>

        <script> var body_html = '<body> <div > <div > <div > <a > <h2>25th Anniversary</h2> </a> <a > <h2>Journals</h2> </a> <div > <div > <h2>Information</h2> </div> <div > <div > <div > <a >For Authors</a> <a >For Reviewers</a> <a >For Editors</a> <a >For Librarians</a> <a >For Publishers</a> <a >For Societies</a> </div> <div > <a >Article Processing Charges</a> <a >Open Access Policy</a> <a >Institutional Open Access Program</a> <a >Editorial Process</a> <a >Awards</a> <a >Research and Publication Ethics</a> </div> </div> </div> </div> <a > <h2>Author Services</h2> </a> <div > <div > <h2>Initiatives</h2> </div> <div > <div > <div > <a >Sciforum</a> <a >MDPI Books</a> <a >Preprints</a> <a >Scilit</a> <a >SciProfiles</a> <a >Encyclopedia</a> <a >JAMS</a> <a >Proceedings Series</a> </div> </div> </div> </div> <a > <h2>About</h2> </a> </div> <div > <a >Sign In / Sign Up</a> </div> </div> </div> <div > <h2 >Notice</h2> <a > <i >clear</i> </a> </div> <div > <div > <div > <h2 >Notice</h2> <p> You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader. </p> </div> </div> <div > <div > <a >Continue</a> <a >Cancel</a> </div> </div> <a > <i >clear</i> </a> </div> <div > <p> All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. </p> </div> <div > <p> Feature Papers represent the most advanced research with significant potential for high impact in the field. Feature Papers are submitted upon individual invitation or recommendation by the scientific editors and undergo peer review prior to publication. </p> <p> The Feature Paper can be either an original research article, a substantial novel research study that often involves several techniques or approaches, or a comprehensive review paper with concise and precise updates on the latest progress in the field that systematically reviews the most exciting advances in scientific literature. This type of paper provides an outlook on future directions of research or possible applications. </p> </div> <div > <p> Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to authors, or important in this field. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal. </p> </div> <div > <div >  </div> <section > <header> <div > <div > <div > <ul> <li > <a >25th Anniversary</a> </li> <li > <a >Journals</a> </li> <li > <a >Information</a> <ul > <li> <div > <div > <ul> <li> <a >For Authors</a> </li> <li> <a >For Reviewers</a> </li> <li> <a >For Editors</a> </li> <li> <a >For Librarians</a> </li> <li> <a >For Publishers</a> </li> <li> <a >For Societies</a> </li> </ul> </div> <div > <ul> <li> <a >Article Processing Charges</a> </li> <li> <a >Open Access Policy</a> </li> <li> <a >Institutional Open Access Program</a> </li> <li> <a >Editorial Process</a> </li> <li> <a >Awards</a> </li> <li> <a >Research and Publication Ethics</a> </li> </ul> </div> </div> </li> </ul> </li> <li > <a >Author Services</a> </li> <li > <a >Initiatives</a> <ul > <li> <div > <div > <ul> <li> <a > Sciforum </a> </li> <li> <a > MDPI Books </a> </li> <li> <a > Preprints </a> </li> <li> <a > Scilit </a> </li> <li> <a > SciProfiles </a> </li> <li> <a > Encyclopedia </a> </li> <li> <a > JAMS </a> </li> <li> <a > Proceedings Series </a> </li> </ul> </div> </div> </li> </ul> </li> <li > <a >About</a> </li> </ul> </div> <div > <div> <a >Sign In / Sign Up</a> <a >Submit</a> </div> </div> </div> </div> <div > <div > <div > <div > <a > Covered in: PubMed </a> </div></div> <div > <div > <a > IMPACTFACTOR 4.242 </a> </div> </div> </div> <div > Journals </div> <div > JCM </div> </div> </header> <div > <div > <div > <div > <div > <ul > <li> <a > <div > Targeting Inflammatory Signaling in Prostate Cancer Castration Resistance </div> </a> </li> <li > <a > <div > Immunotherapy Monitoring with Immune Checkpoint Inhibitors Based on [<sup>18</sup>F]FDG PET/CT in Metastatic Melanomas and Lung Cancer </div> </a> </li> </ul> </div> </div> <div > <div > <h2 >Journal Description</h2> </div> <div > <div > <h1> Journal of Clinical Medicine </h1> <div > Journal of Clinical Medicine is an international, <a >peer-reviewed</a>, open access journal of clinical medicine, published semimonthly online by MDPI. The <a >International Bone Research Association</a> (IBRA), <a >Italian Resuscitation Council</a> (IRC), <a >Nuclear Medicine Discovery</a> (Nu.Me.D.), <a >Spanish Society of Hematology and Hemotherapy</a> (SEHH), <a >Japan Association for Clinical Engineers</a> (JACE) and <a >European Independent Foundation in Angiology/ Vascular Medicine</a> (VAS) are all affiliated with JCM, and their members receive a discount on article processing charges. <ul> <li>Open Access— free for readers, with <a >article processing charges (APC)</a> paid by authors or their institutions.</li> <li>High Visibility: indexed within <a >Scopus</a>, <a >SCIE (Web of Science)</a>, <a >PubMed</a>, <a >PMC</a>, <a >Embase</a>, <a >CAPlus / SciFinder</a>, and many <a >other databases</a>.</li> <li>Journal Rank: JCR - Q1 (Medicine, General Internal)</li> <li>Rapid Publication: manuscripts are peer-reviewed and a first decision provided to authors approximately 19.3 days after submission; acceptance to publication is undertaken in 3.6 days (median values for papers published in this journal in the first half of 2021).</li> <li>Recognition of Reviewers: reviewers who provide timely, thorough peer-review reports receive vouchers entitling them to a discount on the APC of their next publication in any MDPI journal, in appreciation of the work done.</li> <li>Companion journals for JCM include: Epidemiologia, <a >Transplantology</a>, <a >Uro</a>, <a >Sinusitis</a>, <a >Rheumato</a>, <a >Biologics</a> and <a >Current Ophthalmology</a>.</li> </ul> </div> <div > Impact Factor: 4.242 (2020) ; 5-Year Impact Factor: 4.567 (2020) </div> <div> <a > <i >subject</i> Imprint Information </a> <a > <i >get_app</i> Journal Flyer </a> <a > Open Access </a> ISSN: 2077-0383 </div> </div> </div> </div> <div > <div > <h2 >Latest Articles</h2> </div> <div > <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: <a >Abstract Page</a> </div> </div> <div >Open AccessArticle</div> Analysis of Indications for Voiding Cystography in Children <div > by <span ><div >Natalia Kopiczko</div>, </span><span ><div >Aleksandra Dzik-Sawczuk</div>, </span><span ><div >Karolina Szwarc</div>, </span><span ><div >Anna Czyż</div> and </span><span ><div >Anna Wasilewska</div></span> </div> <div > J. Clin. Med. <b>2021</b>, 10(24), 5809; https://doi.org/10.3390/jcm10245809 (registering DOI) - 11 Dec 2021 </div> <div > Abstract <div > In this study, we report the experience of our center with the prognosis of vesicoureteral reflux, depending on the indications for voiding cystography, during a 12-year period. Retrospective analysis included 4302 children who were analyzed according to the indication for voiding cystography: (1) [...] Read more. </div> <div > In this study, we report the experience of our center with the prognosis of vesicoureteral reflux, depending on the indications for voiding cystography, during a 12-year period. Retrospective analysis included 4302 children who were analyzed according to the indication for voiding cystography: (1) a febrile urinary tract infection, (2) urinary tract malformations on ultrasonography and (3) lower urinary tract dysfunction. Vesicoureteral reflux was found in 917 patients (21.32%; 24.1% of girls and 17.9% of boys). In group (1), reflux was found in 437/1849 cases (23.63%), group (2) in 324/1388 cases (23.34%) and group (3) in 156/1065 cases (14.65%). A significantly lower prevalence of reflux and its lower degree was found in children from group (3) when compared to other groups (<i>p</i> &lt; 0.01). VURs were confirmed in over 20% of children with urinary tract malformations on ultrasonography or after a febrile urinary tract infection, suggesting the need for voiding cystography in these children. Indications for this examination in children with lower urinary tract dysfunction should be limited. Full article </div> </div> <div > (This article belongs to the Special Issue Pediatric and Adolescent Nephrology Facing the Future: Diagnostic Advances and Prognostic Biomarkers in Everyday Practice) </div> </div> </div> </div> <div > <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page </div> </div> <div >Open AccessReview</div> Advances in Diagnostic Imaging for Cardiac Sarcoidosis <div > by <span ><div >Osamu Manabe</div>, </span><span ><div >Noriko Oyama-Manabe</div>, </span><span ><div >Tadao Aikawa</div>, </span><span ><div >Satonori Tsuneta</div> and </span><span ><div >Nagara Tamaki</div></span> </div> <div > J. Clin. Med. <b>2021</b>, 10(24), 5808; https://doi.org/10.3390/jcm10245808 (registering DOI) - 11 Dec 2021 </div> <div > Abstract <div > Sarcoidosis is a systemic granulomatous disease of unknown etiology, and its clinical presentation depends on the affected organ. Cardiac sarcoidosis (CS) is one of the leading causes of death among patients with sarcoidosis. The clinical manifestations of CS are heterogeneous, and range from [...] Read more. </div> <div > Sarcoidosis is a systemic granulomatous disease of unknown etiology, and its clinical presentation depends on the affected organ. Cardiac sarcoidosis (CS) is one of the leading causes of death among patients with sarcoidosis. The clinical manifestations of CS are heterogeneous, and range from asymptomatic to life-threatening arrhythmias and progressive heart failure due to the extent and location of granulomatous inflammation in the myocardium. Advances in imaging techniques have played a pivotal role in the evaluation of CS because histological diagnoses obtained by myocardial biopsy tend to have lower sensitivity. The diagnosis of CS is challenging, and several approaches, notably those using positron emission tomography and cardiac magnetic resonance imaging (MRI), have been reported. Delayed-enhanced computed tomography (CT) may also be used for diagnosing CS in patients with MRI-incompatible devices and allows acceptable evaluation of myocardial hyperenhancement in such patients. This article reviews the advances in imaging techniques for the evaluation of CS. Full article </div> </div> <div > (This article belongs to the Special Issue New Frontiers in the Diagnosis of Sarcoidosis) </div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page </div> </div> <div >Open AccessArticle</div> Prognostic Implications of a Modified Seattle Heart Failure Model Score following Transcatheter Aortic Valve Replacement <div > by <span ><div >Teruhiko Imamura</div>, </span><span ><div >Nikhil Narang</div>, </span><span ><div >Hiroshi Onoda</div>, </span><span ><div >Shuhei Tanaka</div>, </span><span ><div >Ryuichi Ushijima</div>, </span><span ><div >Mitsuo Sobajima</div>, </span><span ><div >Nobuyuki Fukuda</div>, </span><span ><div >Hiroshi Ueno</div> and </span><span ><div >Koichiro Kinugawa</div></span> </div> <div > J. Clin. Med. <b>2021</b>, 10(24), 5807; https://doi.org/10.3390/jcm10245807 (registering DOI) - 11 Dec 2021 </div> <div > Abstract <div > Background: The Seattle heart failure model (SHFM) score is a well-known risk predictor of mortality in patients with heart failure. We validated this score in patients receiving transcatheter aortic valve replacement (TAVR) and aimed to generate further risk discrimination by adding invasive hemodynamics [...] Read more. </div> <div > Background: The Seattle heart failure model (SHFM) score is a well-known risk predictor of mortality in patients with heart failure. We validated this score in patients receiving transcatheter aortic valve replacement (TAVR) and aimed to generate further risk discrimination by adding invasive hemodynamics parameters. Methods:<b> </b>Patients who underwent TAVR at our institute between 2015 and 2020 were included and followed for 2 years from index discharge. Patients were randomly assigned to the derivation cohort or the validation cohort. In the derivation cohort, the original SHFM score was modified by adding baseline hemodynamics parameters to evaluate the primary outcomes: 2-year incidence of mortality or readmission from heart failure. The model performance of the modified SHFM score was evaluated in the validation cohort. Results:<b> </b>A total of 217 patients (median age: 86 (83, 88) years old, 64 (29%) men) were included. From the derivation cohort (N = 108), a novel modified SHFM score was constructed: 6 × (original SHFM score &lt;88.1%) + 5 × (pulmonary capillary wedge pressure &gt; 14 mmHg) + 4 × (cardiac index &lt; 2.26 L/min/m<sup>2</sup>), which had an improved discrimination compared with the original model (area under the curve: 0.887 versus 0.679, <i>p</i> = 0.014). In the validation cohort (<i>N</i> = 109), the modified SHFM score showed accurate predictive discrimination of the 2-year cumulative incidence of the primary endpoint into three groups (a low score group with 0–5 points, 3%; an intermediate score group with 6–10 points, 12%; and a high score group with 11–15 points, 43%, <i>p</i> &lt; 0.001). Conclusion:<b> </b>A modified SHFM score consisting of the original SHFM score and invasive hemodynamics parameters predicted mortality and morbidity following TAVR. Evaluation of the external validity of this score in other cohorts needs further investigation. Full article </div> </div> <div > (This article belongs to the Special Issue Transcatheter Aortic Valve Replacement in 2021 and Beyond) </div> </div> </div> </div> <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: Supplementary File 1 (ZIP, 102 KiB) </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page </div> </div> <div >Open AccessArticle</div> Physician-Led Thoracic Trauma Management in a Specialist Emergency Care Centre <div > by <span ><div >Jonathan Bates-Powell</div>, </span><span ><div >David Basterfield</div>, </span><span ><div >Karl Jackson</div> and </span><span ><div >Avinash Aujayeb</div></span> </div> <div > J. Clin. Med. <b>2021</b>, 10(24), 5806; https://doi.org/10.3390/jcm10245806 (registering DOI) - 11 Dec 2021 </div> <div > Abstract <div > Introduction: Falls cause 75% of trauma in patients above 65 years of age, and thoracic trauma is the second commonest injury; rib fractures are the most common thoracic injury. These patients have up to 12% mortality, with 31% developing pneumonias. There is wide [...] Read more. </div> <div > Introduction: Falls cause 75% of trauma in patients above 65 years of age, and thoracic trauma is the second commonest injury; rib fractures are the most common thoracic injury. These patients have up to 12% mortality, with 31% developing pneumonias. There is wide variation in care. Northumbria Healthcare has a team of respiratory consultants, physiotherapists, specialist nurses and anesthetists for thoracic-trauma management on a respiratory support unit. Methods: With Caldicott approval, basic demographics and clinical outcomes of patients admitted with thoracic trauma between 20 August 20–21 Aprilwere analyzed. A descriptive statistical methodology was applied. Results: A total of 119 patients were identified with a mean age of 71.1 years (range 23–97). Of the 119 patients, 53 were male, 66 females. The main mechanism of injury was falls from standing (65) and falls down stairs/bed or in the bath (18). Length of stay was 7.3 days (range 1–54). In total, 85 patients had more than one co-morbidity, 26 had a full trauma assessment and 75 had pan CTs. The mean number of rib fractures was 3.6 and 31 (26%) patients had a pneumothorax and/or haemothorax. A total of 18 chest drains were inserted (all small bore) and one needle aspiration was performed. No cardiothoracic input was required. Isolated chest trauma was present only in 45 patients. All patients had a pain team review, 22 erector spinae catheters were inserted with 2 paravertebral blocks. Overall, 82 patients did not require oxygen, 1 required CPAP and 1 HFNC. 7 needed intensive care transfer. Furthermore, 20 (17%) developed pneumonias and 16 (14%) deaths occurred within 30 days—all were in those with falls from standing. There was no correlation between number of fractured ribs, length of stay and mortality. Conclusions: High level care for thoracic trauma can be performed by a physician led team. Overall, 42% pneumothoraces/haemothoraces were observed. Further large scale randomised trials are warranted for definitive outcomes. Full article </div> </div> <div > (This article belongs to the Special Issue Acute Care and Medication Management in Older Adults) </div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessReview</div> Shedding Light on Targeting Chronic Myeloid Leukemia Stem Cells <div > by <span ><div >Mohammad Houshmand</div>, </span><span ><div >Alireza Kazemi</div>, </span><span ><div >Ali Anjam Najmedini</div>, </span><span ><div >Muhammad Shahzad Ali</div>, </span><span ><div >Valentina Gaidano</div>, </span><span ><div >Alessandro Cignetti</div>, </span><span ><div >Carmen Fava</div>, </span><span ><div >Daniela Cilloni</div>, </span><span ><div >Giuseppe Saglio</div> and </span><span ><div >Paola Circosta</div></span> </div> <div > J. Clin. Med. <b>2021</b>, 10(24), 5805; https://doi.org/10.3390/jcm10245805 (registering DOI) - 11 Dec 2021 </div> <div > Abstract <div > Chronic myeloid leukemia stem cells (CML LSCs) are a rare and quiescent population that are resistant to tyrosine kinase inhibitors (TKI). When TKI therapy is discontinued in CML patients in deep, sustained and apparently stable molecular remission, these cells in approximately half of [...] Read more. </div> <div > Chronic myeloid leukemia stem cells (CML LSCs) are a rare and quiescent population that are resistant to tyrosine kinase inhibitors (TKI). When TKI therapy is discontinued in CML patients in deep, sustained and apparently stable molecular remission, these cells in approximately half of the cases restart to grow, resuming the leukemic process. The elimination of these TKI resistant leukemic stem cells is therefore an essential step in increasing the percentage of those patients who can reach a successful long-term treatment free remission (TFR). The understanding of the biology of the LSCs and the identification of the differences, phenotypic and/or metabolic, that could eventually allow them to be distinguished from the normal hematopoietic stem cells (HSCs) are therefore important steps in designing strategies to target LSCs in a rather selective way, sparing the normal counterparts. Full article </div> </div> <div > (This article belongs to the Special Issue Prognosis and Therapy of Chronic Myeloid Leukemia) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> Alpha Smooth Muscle Actin (αSMA) Immunohistochemistry Use in the Differentiation of Pancreatic Cancer from Chronic Pancreatitis <div > by <span ><div >Katarzyna Winter</div>, </span><span ><div >Monika Dzieniecka</div>, </span><span ><div >Janusz Strzelczyk</div>, </span><span ><div >Małgorzata Wągrowska-Danilewicz</div>, </span><span ><div >Marian Danilewicz</div> and </span><span ><div >Ewa Małecka-Wojcieszko</div></span> </div> <div > J. Clin. Med. <b>2021</b>, 10(24), 5804; https://doi.org/10.3390/jcm10245804 (registering DOI) - 11 Dec 2021 </div> <div > Abstract <div > Aim: Fibrosis is observed both in pancreatic cancer (PDAC) and chronic pancreatitis (CP). The main cells involved in fibrosis are pancreatic stellate cells (PSCs), which activate alpha smooth muscle actin (αSMA), which is considered to be the best-known fibrosis marker. The aim of [...] Read more. </div> <div > Aim: Fibrosis is observed both in pancreatic cancer (PDAC) and chronic pancreatitis (CP). The main cells involved in fibrosis are pancreatic stellate cells (PSCs), which activate alpha smooth muscle actin (αSMA), which is considered to be the best-known fibrosis marker. The aim of the study was to evaluate the expression of the αSMA in patients with PDAC and CP as the possible differentiation marker. Methods: We enrolled 114 patients undergoing pancreatic resection: 83 with PDAC and 31 with CP. Normal fragments of resected specimen from 21 patients represented the control tissue. The immunoexpressions of αSMA were detected in tissue specimens with immunohistochemistry (Abcam antibodies, GB). Results: Mean cytoplasmatic expression of αSMA protein in PDAC stromal cells was significantly higher compared to CP: 2.42 ± 0.37 vs 1.95 ± 0.45 (<i>p</i> &lt; 0.01) and control group 0.61 ± 0.45 (<i>p</i> &lt; 0.01). Strong immunoexpression of the αSMA protein was found in the vast majority (80.7%) of patients with PDAC, in about half (58%) of patients with CP, and not at all in healthy tissue. The expression of αSMA of different intensity was found in all patients with PDAC and CP, while in healthy tissue was minimal or absent. In PDAC patients, αSMA expression was significantly higher in tumors of diameter higher than 3 cm compared to smaller ones (<i>p</i> = 0.017). Conclusions: Presented findings confirm the significant role of fibrosis in both PDAC and CP; however, they do not confirm the role of αSMA as a marker of differentiation. Full article </div> </div> <div > (This article belongs to the Special Issue Pancreatic Cancer: Biomarkers, Risk Factors, Early Detection) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page </div> </div> <div >Open AccessArticle</div> Is It Possible to Predict Clonal Thrombocytosis in Triple-Negative Patients with Isolated Thrombocytosis Based Only on Clinical or Blood Findings? <div > by <span ><div >Tanja Belčič Mikič</div>, </span><span ><div >Bor Vratanar</div>, </span><span ><div >Tadej Pajič</div>, </span><span ><div >Saša Anžej Doma</div>, </span><span ><div >Nataša Debeljak</div>, </span><span ><div >Irena Preložnik Zupan</div>, </span><span ><div >Matjaž Sever</div> and </span><span ><div >Samo Zver</div></span> </div> <div > J. Clin. Med. <b>2021</b>, 10(24), 5803; https://doi.org/10.3390/jcm10245803 (registering DOI) - 11 Dec 2021 </div> <div > Abstract <div > <i>JAK2</i>, <i>MPL,</i> and <i>CALR</i> mutations define clonal thrombocytosis in about 90% of patients with sustained isolated thrombocytosis. In the remainder of patients (triple-negative patients) diagnosing clonal thrombocytosis is especially difficult due to the different underlying conditions and possible inconclusive bone marrow biopsy [...] Read more. </div> <div > <i>JAK2</i>, <i>MPL,</i> and <i>CALR</i> mutations define clonal thrombocytosis in about 90% of patients with sustained isolated thrombocytosis. In the remainder of patients (triple-negative patients) diagnosing clonal thrombocytosis is especially difficult due to the different underlying conditions and possible inconclusive bone marrow biopsy results. The ability to predict patients with sustained isolated thrombocytosis with a potential clonal origin has a prognostic value and warrants further examination. The aim of our study was to define a non-invasive clinical or blood parameter that could help predict clonal thrombocytosis in triple-negative patients. We studied 237 <i>JAK2</i> V617-negative patients who were diagnosed with isolated thrombocytosis and referred to the haematology service. Sixteen routine clinical and blood parameters were included in the logistic regression model which was used to predict the type of thrombocytosis (reactive/clonal). Platelet count and lactate dehydrogenase (LDH) were the only statistically significant predictors of clonal thrombocytosis. The platelet count threshold for the most accurate prediction of clonal or reactive thrombocytosis was 449 × 10<sup>9</sup>/L. Other tested clinical and blood parameters were not statistically significant predictors of clonal thrombocytosis. The level of LDH was significantly higher in <i>CALR</i>-positive patients compared to <i>CALR</i>-negative patients. We did not identify any new clinical or blood parameters that could distinguish clonal from reactive thrombocytosis. When diagnosing clonal thrombocytosis triple-negative patients are most likely to be misdiagnosed. Treatment in patients with suspected triple negative clonal thrombocytosis should not be delayed if cardiovascular risk factors or pregnancy coexist, even in the absence of firm diagnostic criteria. In those cases the approach “better treat more than less” should be followed. Full article </div> </div> <div > (This article belongs to the Special Issue Diagnosis and Management of Blood Diseases) </div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> Measuring and Predicting Maturity to Parenthood: What Has Personality Got to Do with It? <div > by <span ><div >Ariadna Beata Łada-Maśko</div> and </span><span ><div >Maria Kaźmierczak</div></span> </div> <div > J. Clin. Med. <b>2021</b>, 10(24), 5802; https://doi.org/10.3390/jcm10245802 (registering DOI) - 11 Dec 2021 </div> <div > Abstract <div > Maturity to parenthood is essential for taking on parental roles but remains an understudied issue. Still, close relations between maturity and personality dimensions are commonly emphasized. Thus, conducting research on maturity in context of personality seems a valuable research direction. The present research [...] Read more. </div> <div > Maturity to parenthood is essential for taking on parental roles but remains an understudied issue. Still, close relations between maturity and personality dimensions are commonly emphasized. Thus, conducting research on maturity in context of personality seems a valuable research direction. The present research consists of two studies, focusing on the development and validation of Maturity to Parenthood Scale (MPS), in relation to personality, emotional regulation, coping with challenges, and intimate relationship satisfaction. In both studies, childless adults aged 20–35 years took part: (1) 718 participants (<i>M</i><sub>age</sub> = 25.49; <i>SD</i> = 2.89; 479 women), (2) 150 participants (<i>M</i><sub>age</sub> = 23.69; <i>SD</i> = 3.15; 104 women). All the participants had been in an intimate relationship for at least six months at the time of the study, the majority declared their willingness to have children in the future, had higher education, and were professionally active. The results showed that MPS is a reliable, valid measure comprising the following three subscales: valence, behavioral, and cognitive–emotional maturity to parenthood. The findings also confirmed the importance of broad- and narrow-band individual differences and contextual factors for maturity. MPS may be used in psychoeducation, supporting the transition to biological or adoptive/foster parenthood, as well as in medical and psychological care. Full article </div> </div> <div > (This article belongs to the Special Issue Personality Psychology: Clinical Application and Future Directions) </div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> Effect of Intra-Articular Injection of Platelet-Rich Plasma on the Serum Levels of Osteoarthritic Biomarkers in Patients with Unilateral Knee Osteoarthritis <div > by <span ><div >Marek Lacko</div>, </span><span ><div >Denisa Harvanová</div>, </span><span ><div >Lucia Slovinská</div>, </span><span ><div >Martin Matuška</div>, </span><span ><div >Marek Balog</div>, </span><span ><div >Antónia Lacková</div>, </span><span ><div >Timea Špaková</div> and </span><span ><div >Ján Rosocha</div></span> </div> <div > J. Clin. Med. <b>2021</b>, 10(24), 5801; https://doi.org/10.3390/jcm10245801 (registering DOI) - 11 Dec 2021 </div> <div > Abstract <div > Background: The aim of this study is to determine the effect of three doses of intra-articular injection of platelet-rich plasma (PRP) into the osteoarthritic (OA) knee joint on the functional status and on the changes in the levels of specific OA biomarkers in [...] Read more. </div> <div > Background: The aim of this study is to determine the effect of three doses of intra-articular injection of platelet-rich plasma (PRP) into the osteoarthritic (OA) knee joint on the functional status and on the changes in the levels of specific OA biomarkers in blood serum. Methods: Forty patients with unilateral primary knee osteoarthritis were enrolled in this single center, prospective clinical trial. For each patient, three intra-articular PRP injections were administered one week apart. Clinical and laboratory assessment was performed before the first PRP injection (baseline), and 3 months after the third PRP application (3-month follow up). Pain in the affected knee joint was assessed with the Visual Analog Scale for Pain (VAS). Change in clinical status was evaluated with the Western Ontario and McMaster Universities Arthritis Index Questionnaire (WOMAC). Concentrations of 19 biomarkers (EGF, Eotaxin, FGF-2, GRO, IL-10, IL-1RA, IL-8, IP-10, MCP-1, PDGF-AB/BB, RANTES, MMP-3, MMP-13, Collagen type 2, BMP-2, TIMP-1, TIMP-2, TGF beta 1, and COMP) in the serum of studied patients were quantified. Results: At 3-month follow up, there was a significant decrease in the VAS score and significant improvement in the WOMAC score. There was a significant decrease in the levels of Eotaxin, MCP-1, MMP-1, IL-10, EGF, PDGF-AB/BB, TGF- β1 compared to baseline levels. A significant increase in markers BMP-2, COMP, Collagen type 2 and GRO was found at the same time point. There was no significant change in the concentrations of other biomarkers (FGF-2, IL-1RA, IL-8, IL-10, MMP-3, RANTES, TIMP-1, TIMP-3). Conclusions: We found an increase in specific pro-anabolic and anti-inflammatory biomarkers with a concomitant decrease in pro-inflammatory biomarkers at 3 months after three intra-articular applications of PRP. Significant improvement in VAS and WOMAC scores was observed. Treatment with PRP may be an effective therapeutic option with anti-inflammatory and regenerative potential in patients with primary knee OA. Full article </div> </div> <div > (This article belongs to the Topic Orthopaedic Diseases and Innovative Intervention Strategies) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: Supplementary File 1 (ZIP, 333 KiB) </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page </div> </div> <div >Open AccessArticle</div> Associations between Early Surgery and Postoperative Outcomes in Elderly Patients with Distal Femur Fracture: A Retrospective Cohort Study <div > by <span ><div >Norio Yamamoto</div>, </span><span ><div >Hiroyuki Ohbe</div>, </span><span ><div >Yosuke Tomita</div>, </span><span ><div >Takashi Yorifuji</div>, </span><span ><div >Mikio Nakajima</div>, </span><span ><div >Yusuke Sasabuchi</div>, </span><span ><div >Yuki Miyamoto</div>, </span><span ><div >Hiroki Matsui</div>, </span><span ><div >Tomoyuki Noda</div> and </span><span ><div >Hideo Yasunaga</div></span> </div> <div > J. Clin. Med. <b>2021</b>, 10(24), 5800; https://doi.org/10.3390/jcm10245800 (registering DOI) - 11 Dec 2021 </div> <div > Abstract <div > Previous literature has provided conflicting results regarding the associations between early surgery and postoperative outcomes in elderly patients with distal femur fractures. Using data from the Japanese Diagnosis Procedure Combination inpatient database from April 2014 to March 2019, we identified elderly patients who [...] Read more. </div> <div > Previous literature has provided conflicting results regarding the associations between early surgery and postoperative outcomes in elderly patients with distal femur fractures. Using data from the Japanese Diagnosis Procedure Combination inpatient database from April 2014 to March 2019, we identified elderly patients who underwent surgery for distal femur fracture within two days of hospital admission (early surgery group) or at three or more days after hospital admission (delayed surgery group). Of 9678 eligible patients, 1384 (14.3%) were assigned to the early surgery group. One-to-one propensity score matched analyses showed no significant difference in 30-day mortality between the early and delayed groups (0.5% versus 0.5%; risk difference, 0.0%; 95% confidence interval, −0.7% to 0.7%). Patients in the early surgery group had significantly lower proportions of the composite outcome (death or postoperative complications), shorter hospital stays, and lower total hospitalization costs than patients in the delayed surgery group. Our results showed that early surgery within two days of hospital admission for geriatric distal femur fracture was not associated with a reduction in 30-day mortality but was associated with reductions in postoperative complications and total hospitalization costs. Full article </div> </div> <div > (This article belongs to the Special Issue Orthopedic Treatment of Diseases and Fractures in Elderly) </div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page </div> </div> <div >Open AccessReview</div> Long COVID a New Derivative in the Chaos of SARS-CoV-2 Infection: The Emergent Pandemic? <div > by <span ><div >Diego Fernández-Lázaro</div>, </span><span ><div >Nerea Sánchez-Serrano</div>, </span><span ><div >Juan Mielgo-Ayuso</div>, </span><span ><div >Juan Luis García-Hernández</div>, </span><span ><div >Jerónimo J. González-Bernal</div> and </span><span ><div >Jesús Seco-Calvo</div></span> </div> <div > J. Clin. Med. <b>2021</b>, 10(24), 5799; https://doi.org/10.3390/jcm10245799 (registering DOI) - 11 Dec 2021 </div> <div > Abstract <div > Coronavirus disease 2019 (COVID-19) is a multisystem illness caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which can manifest with a multitude of symptoms in the setting of end-organ damage, though it is predominantly respiratory. However, various symptoms may remain after acute [...] Read more. </div> <div > Coronavirus disease 2019 (COVID-19) is a multisystem illness caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which can manifest with a multitude of symptoms in the setting of end-organ damage, though it is predominantly respiratory. However, various symptoms may remain after acute SARS-CoV-2 infection, and this condition is referred to as “Long COVID” (LC). Patients with LC may develop multi-organ symptom complex that remains 4–12 weeks after the acute phase of illness, with symptoms intermittently persisting over time. The main symptoms are fatigue, post-exertional malaise, cognitive dysfunction, and limitation of functional capacity. Pediatric patients developed the main symptoms of LC like those described in adults, although there may be variable presentations of LC in children. The underlying mechanisms of LC are not clearly known, although they may involve pathophysiological changes generated by virus persistence, immunological alterations secondary to virus–host interaction, tissue damage of inflammatory origin and hyperactivation of coagulation. Risk factors for developing LC would be female sex, more than five early symptoms, early dyspnea, previous psychiatric disorders, and alterations in immunological, inflammatory and coagulation parameters. There is currently no specific treatment for LC, but it could include pharmacological treatments to treat symptoms, supplements to restore nutritional, metabolic, and gut flora balance, and functional treatments for the most disabling symptoms. In summary, this study aims to show the scientific community the current knowledge of LC. Full article </div> </div> <div > (This article belongs to the Special Issue Post-COVID Symptoms in Long-Haulers: Definition, Identification, Mechanisms, and Management) </div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> Radiographs and MRI of the Cervical Spine in Juvenile Idiopathic Arthritis: A Cross-Sectional Retrospective Study <div > by <span ><div >Mateusz Kotecki</div>, </span><span ><div >Piotr Gietka</div>, </span><span ><div >Magdalena Posadzy</div> and </span><span ><div >Iwona Sudoł-Szopińska</div></span> </div> <div > J. Clin. Med. <b>2021</b>, 10(24), 5798; https://doi.org/10.3390/jcm10245798 (registering DOI) - 11 Dec 2021 </div> <div > Abstract <div > Background: Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease among children. In some patients, cervical spine arthritis remains a serious and chronic manifestation of JIA. The aim of this study was to assess the frequency of cervical spine lesions on radiographs [...] Read more. </div> <div > Background: Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease among children. In some patients, cervical spine arthritis remains a serious and chronic manifestation of JIA. The aim of this study was to assess the frequency of cervical spine lesions on radiographs and MRI in JIA patients with clinical signs of cervical spine involvement and to verify if with the addition of MRI, the use of radiographs could be abandoned. Methods: This retrospective study evaluated consecutive 34 children (25 girls; aged 6–18 years, median 15.5 years) with JIA and with clinical involvement of cervical spine. In each patient, both radiographs and MRI of the cervical spine were performed. Imaging findings were correlated with clinical and laboratory data. Results: The cervical spine was affected in 35% of patients. The most frequent lesions were subaxial subluxations (SAS; 24%), apophyseal joint ankylosis (9%), and C1/C2 joint lesions (9%). Anterior atlanto-axial subluxation (AAS) was diagnosed only by radiography, and most of the SAS were seen on radiography, whereas only a few on MRI. Reversely, C1/C2 soft tissue involvement were seen on MRI only. Cervical spine involvement was associated with raised ESR (<i>p</i> = 0.012) and CRP (<i>p</i> = 0.014). Conclusions: The cervical spine lesions are still frequent complication of JIA affecting up to 35% of JIA patients. Most of them develop serious complications, such as AAS and ankylosis. Despite advantages of MRI in terms of the imaging of the atlanto-axial region radiography shows superiority in diagnosis of AAS and SAS. Full article </div> </div> <div > (This article belongs to the Special Issue Diagnostic Imaging of Arthritis) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> Omentin Is Independently Associated with Stroke Severity and Ipsilateral Carotid Artery Stenosis in Patients with Acute Cerebral Ischemia <div > by <span ><div >Maria Chondrogianni</div>, </span><span ><div >Vaia Lambadiari</div>, </span><span ><div >Aristeidis H. Katsanos</div>, </span><span ><div >Maria Ioanna Stefanou</div>, </span><span ><div >Palaiodimou Lina</div>, </span><span ><div >Alexandros Stavros Triantafyllou</div>, </span><span ><div >Georgios Karagiannis</div>, </span><span ><div >Vasileios Konstantakos</div>, </span><span ><div >Michael Ioakeimidis</div>, </span><span ><div >Sokratis Triantafyllou</div>, </span><span ><div >Christina Zompola</div>, </span><span ><div >Chryssa Liantinioti</div>, </span><span ><div >Alexandra Pappa</div>, </span><span ><div >Ioannis Rizos</div>, </span><span ><div >Konstantinos Voumvourakis</div>, </span><span ><div >Georgios Tsivgoulis</div> and </span><span ><div >Eleni Boutati</div></span> </div> <div > J. Clin. Med. <b>2021</b>, 10(24), 5797; https://doi.org/10.3390/jcm10245797 (registering DOI) - 11 Dec 2021 </div> <div > Abstract <div > Mounting evidence indicates an association between adipokines and inflammation-related atherosclerosis. Here, we sought to investigate the association of vaspin and omentin with clinical characteristics and outcomes of patients with acute cerebral ischemia (ACI). Consecutive ACI patients were evaluated within 24 h from symptom-onset. [...] Read more. </div> <div > Mounting evidence indicates an association between adipokines and inflammation-related atherosclerosis. Here, we sought to investigate the association of vaspin and omentin with clinical characteristics and outcomes of patients with acute cerebral ischemia (ACI). Consecutive ACI patients were evaluated within 24 h from symptom-onset. Stroke aetiology was classified using TOAST criteria. Adipokines were assayed using quantikine enzyme immunoassay commercially available kits. Stroke severity was assessed by NIHSS-score, and ipsilateral carotid stenosis (≥50% by NASCET criteria) by ultrasound and CT/MR angiography. Major cerebrovascular events were assessed at three months. We included 135 ACI patients (05 (78%) and 30 (22%) with acute ischemic stroke and transient ischemic attack, respectively; mean age ± SD: 59 ± 10 years; 68% men; median NIHSS-score: 3 (IQR:1–7)). Omentin was strongly correlated to admission stroke severity (Spearman rho coefficient: +0.303; <i>p</i> &lt; 0.001). Patients with ipsilateral carotid stenosis had higher omentin levels compared to patients without stenosis (13.3 ± 8.9 ng/mL vs. 9.5 ± 5.5 ng/mL, <i>p</i> = 0.014). Increasing omentin levels were independently associated with higher stroke severity (linear regression coefficient = 0.290; 95%CI: 0.063–0.516; <i>p</i> = 0.002) and ipsilateral carotid stenosis (linear regression coefficient = 3.411; 95%CI: 0.194–6.628; <i>p</i> = 0.038). No association of vaspin with clinical characteristics and outcomes was found. Circulating omentin may represent a biomarker for the presence of atherosclerotic plaque, associated with higher stroke severity in ACI patients. Full article </div> </div> <div > (This article belongs to the Special Issue New Frontiers in Cerebrovascular Disorders) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessReview</div> Autoimmune Diseases of Digestive Organs—A Multidisciplinary Challenge: A Focus on Hepatopancreatobiliary Manifestation <div > by <span ><div >Lumir Kunovsky</div>, </span><span ><div >Petr Dite</div>, </span><span ><div >Petr Jabandziev</div>, </span><span ><div >Zdenek Kala</div>, </span><span ><div >Jitka Vaculova</div>, </span><span ><div >Tomas Andrasina</div>, </span><span ><div >Matej Hrunka</div>, </span><span ><div >Martina Bojkova</div> and </span><span ><div >Jan Trna</div></span> </div> <div > J. Clin. Med. <b>2021</b>, 10(24), 5796; https://doi.org/10.3390/jcm10245796 (registering DOI) - 11 Dec 2021 </div> <div > Abstract <div > It is well known that some pathological conditions, especially of autoimmune etiology, are associated with the HLA (human leukocyte antigen) phenotype. Among these diseases, we include celiac disease, inflammatory bowel disease, autoimmune enteropathy, autoimmune hepatitis, primary sclerosing cholangitis and primary biliary cholangitis. Immunoglobulin [...] Read more. </div> <div > It is well known that some pathological conditions, especially of autoimmune etiology, are associated with the HLA (human leukocyte antigen) phenotype. Among these diseases, we include celiac disease, inflammatory bowel disease, autoimmune enteropathy, autoimmune hepatitis, primary sclerosing cholangitis and primary biliary cholangitis. Immunoglobulin G4-related diseases (IgG4-related diseases) constitute a second group of autoimmune gastrointestinal, hepatobiliary and pancreatic illnesses. IgG4-related diseases are systemic and rare autoimmune illnesses. They often are connected with chronic inflammation and fibrotic reaction that can occur in any organ of the body. The most typical feature of these diseases is a mononuclear infiltrate with IgG4-positive plasma cells and self-sustaining inflammatory response. In this review, we focus especially upon the hepatopancreatobiliary system, autoimmune pancreatitis and IgG4-related sclerosing cholangitis. The cooperation of the gastroenterologist, radiologist, surgeon and histopathologist is crucial for establishing correct diagnoses and appropriate treatment, especially in IgG4 hepatopancreatobiliary diseases. Full article </div> </div> <div > (This article belongs to the Special Issue Gastrointestinal Tract Disorders) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> Immunohistochemical Expression of Wnt-4 Protein in Clear Cell Renal Carcinoma <div > by <span ><div >Oliver Pavlovic</div>, </span><span ><div >Tvrtko Hudolin</div>, </span><span ><div >Ivan Miskulin</div>, </span><span ><div >Stela Bulimbasic</div>, </span><span ><div >Marijana Coric</div>, </span><span ><div >Josip Perkovic</div> and </span><span ><div >Toni Zekulic</div></span> </div> <div > J. Clin. Med. <b>2021</b>, 10(24), 5795; https://doi.org/10.3390/jcm10245795 (registering DOI) - 11 Dec 2021 </div> <div > Abstract <div > Wingless binding integration site proteins (Wnt) have an important role in normal kidney development and in various kidney diseases. They are required for complete epithelial differentiation and normal nephron formation. Changes in these proteins could also have important role in carcinogenesis. This study [...] Read more. </div> <div > Wingless binding integration site proteins (Wnt) have an important role in normal kidney development and in various kidney diseases. They are required for complete epithelial differentiation and normal nephron formation. Changes in these proteins could also have important role in carcinogenesis. This study included 185 patients with clear cell renal carcinoma (ccRCC) in whom immunohistochemical expression of Wnt-4 protein in healthy and tumorous tissue after surgery was investigated. There was higher expression of Wnt-4 in healthy than in tumor tissue. No difference between Fuhrman’s grade and Wnt-4 expression was found. A poor negative correlation between tumor size and Wnt-4 expression was found. Patients with suspected metastatic diseases had higher Wnt-4 expression. There was no difference in survival rates between Wnt-4 negative and positive groups. In our study we have shown that high Wnt-4 expression in healthy tissue decreases in low-grade tumors but then increases in high-grade tumors, suggesting that tumor progression requires Wnt-4 activation or reactivation. Full article </div> </div> <div > (This article belongs to the Special Issue Molecular Targets and Chemoprevention (Tumor Growth and Metastasis)) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page </div> </div> <div >Open AccessArticle</div> Uterine Adenomyosis Treated by Linzagolix, an Oral Gonadotropin-Releasing Hormone Receptor Antagonist: A Pilot Study with a New ’Hit Hard First and Then Maintain’ Regimen of Administration <div > by <span ><div >Jacques Donnez</div>, </span><span ><div >Olivier Donnez</div>, </span><span ><div >Jean Tourniaire</div>, </span><span ><div >Michel Brethous</div>, </span><span ><div >Elke Bestel</div>, </span><span ><div >Elizabeth Garner</div>, </span><span ><div >Sébastien Charpentier</div>, </span><span ><div >Andrew Humberstone</div> and </span><span ><div >Ernest Loumaye</div></span> </div> <div > J. Clin. Med. <b>2021</b>, 10(24), 5794; https://doi.org/10.3390/jcm10245794 (registering DOI) - 10 Dec 2021 </div> <div > Abstract <div > (1) Background: The aim of the present pilot study was to study the effect of a new oral gonadotropin-releasing hormone antagonist on adenomyosis. (2) Methods: Eight premenopausal women, aged between 37 and 45 years, presenting with heavy menstrual bleeding, pelvic pain, and dysmenorrhea [...] Read more. </div> <div > (1) Background: The aim of the present pilot study was to study the effect of a new oral gonadotropin-releasing hormone antagonist on adenomyosis. (2) Methods: Eight premenopausal women, aged between 37 and 45 years, presenting with heavy menstrual bleeding, pelvic pain, and dysmenorrhea due to diffuse and disseminated uterine adenomyosis, confirmed by magnetic resonance imaging (MRI), received 200 mg linzagolix once daily for a period of 12 weeks, after which they were switched to 100 mg linzagolix once daily for another 12 weeks. The primary efficacy endpoint was the change in volume of the adenomyotic uterus from baseline to 24 weeks, evaluated by MRI. Secondary efficacy endpoints included the change in uterine volume from baseline to 12 and 36 weeks by MRI, and also weeks 12, 24, and 36 assessed by transvaginal ultrasound (TVUS). Other endpoints were overall pelvic pain, dysmenorrhea, non-menstrual pelvic pain, dyspareunia, amenorrhea, quality of life measures, bone mineral density (BMD), junctional zone thickness, and serum estradiol values. (3) Results: Median serum estradiol was suppressed below 20 pg/mL during the 12 weeks on linzagolix 200 mg, and maintained below 60 pg/mL during the second 12 weeks on linzagolix 100 mg. At baseline, the mean ± SD uterine volume was 333 ± 250 cm<sup>3</sup>. After 24 weeks of treatment, it was 204 ± 126 cm<sup>3</sup>, a reduction of 32% (<i>p</i> = 0.0057). After 12 weeks, the mean uterine volume was 159 ± 95 cm<sup>3</sup>, a reduction of 55% from baseline (<i>p</i> = 0.0001). A similar pattern was observed when uterine volume was assessed by TVUS. Improvements in overall pelvic pain, dysmenorrhea, non-menstrual pelvic pain, dyspareunia, and dyschezia, as well as quality of life measured using the EHP-30 were also observed. Mean percentage BMD loss at 24 weeks was, respectively, −2.4%, −1.3%, and −4.1% for the spine, femoral neck, and total hip. The most common adverse events were hot flushes, which occurred in 6/8 women during the first 12 weeks, and 1/8 women between 12 and 24 weeks. (4) Conclusions: Linzagolix at a dose of 200 mg/day reduced uterine volume, and improved clinically relevant symptoms. Treatment with 100 mg thereafter retains the therapeutic benefits of the starting dose while minimizing side effects. This ‘hit hard first and then maintain’ approach may be the optimal way to treat women with symptomatic adenomyosis. Full article </div> </div> <div > (This article belongs to the Special Issue Fertility Preservation and Conservative Therapy in Malignant and Benign Gynecological Diseases) </div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page </div> </div> <div >Open AccessArticle</div> The Relationship between Initial Tacrolimus Metabolism Rate and Recipients Body Composition in Kidney Transplantation <div > by <span ><div >Aureliusz Kolonko</div>, </span><span ><div >Patrycja Pokora</div>, </span><span ><div >Natalia Słabiak-Błaż</div>, </span><span ><div >Beata Czerwieńska</div>, </span><span ><div >Henryk Karkoszka</div>, </span><span ><div >Piotr Kuczera</div>, </span><span ><div >Grzegorz Piecha</div> and </span><span ><div >Andrzej Więcek</div></span> </div> <div > J. Clin. Med. <b>2021</b>, 10(24), 5793; https://doi.org/10.3390/jcm10245793 (registering DOI) - 10 Dec 2021 </div> <div > Abstract <div > There are several premises that the body composition of kidney transplant recipients may play a role in tacrolimus metabolism early after transplantation. The present study aimed at analyzing the relationship between the body composition parameters assessed by bioimpedance analysis (BIA) and initial tacrolimus [...] Read more. </div> <div > There are several premises that the body composition of kidney transplant recipients may play a role in tacrolimus metabolism early after transplantation. The present study aimed at analyzing the relationship between the body composition parameters assessed by bioimpedance analysis (BIA) and initial tacrolimus metabolism. Immediately prior to transplantation, BIA using InBody 770 device was performed in 122 subjects. Tacrolimus concentration-to-dose (C/D) ratio was calculated based on the first blood trough level measurement. There was no difference in phase angle, visceral fat area, lean body mass index (LBMI) and the proportion of lean mass as a percentage of total body mass between the subgroups of slow and fast metabolizers. However, subjects with LBMI ≥ median value of 18.7 kg/m<sup>2</sup>, despite similar initial tacrolimus dose per kg of body weight, were characterized by a significantly lower tacrolimus C/D ratio (median 1.39 vs. 1.67, respectively; <i>p </i>&lt; 0.05) in comparison with the subgroup of lower LBMI. Multivariate regression analysis confirmed that age (r<sub>partial</sub> = 0.322; <i>p </i>&lt; 0.001) and LBMI (r<sub>partial</sub> = −0.254; <i>p </i>&lt; 0.01) independently influenced the tacrolimus C/D ratio. A LBMI assessed by BIA may influence the tacrolimus metabolism in the early post-transplant period and can be a useful in the optimization of initial tacrolimus dosing. Full article </div> </div> <div > (This article belongs to the Special Issue Progress and Recent Advances in Solid Organ Transplantation) </div> </div> </div> </div> <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: Supplementary File 1 (ZIP, 133 KiB) </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page </div> </div> <div >Open AccessArticle</div> Relationship between Serum Kallistatin and Afamin and Anthropometric Factors Associated with Obesity and of Being Overweight in Patients after Myocardial Infarction and without Myocardial Infarction <div > by <span ><div >Grzegorz Józef Nowicki</div>, </span><span ><div >Barbara Ślusarska</div>, </span><span ><div >Maciej Polak</div>, </span><span ><div >Katarzyna Naylor</div> and </span><span ><div >Tomasz Kocki</div></span> </div> <div > J. Clin. Med. <b>2021</b>, 10(24), 5792; https://doi.org/10.3390/jcm10245792 (registering DOI) - 10 Dec 2021 </div> <div > Abstract <div > Extensive clinical and epidemiological evidence has linked obesity to a broad spectrum of cardiovascular disease (CVD), including coronary disease, heart failure, hypertension, cerebrovascular disease, atrial fibrillation, ventricular arrhythmias, and sudden death. In addition, increasing knowledge of regulatory peptides has allowed an assessment of [...] Read more. </div> <div > Extensive clinical and epidemiological evidence has linked obesity to a broad spectrum of cardiovascular disease (CVD), including coronary disease, heart failure, hypertension, cerebrovascular disease, atrial fibrillation, ventricular arrhythmias, and sudden death. In addition, increasing knowledge of regulatory peptides has allowed an assessment of their role in various non-communicable diseases, including CVD. The study assessed the concentration of kallistatin and afamin in the blood serum of patients after a myocardial infarction and without a cardiovascular event, and determined the relationship between the concentration of kallistatin and afamin and the anthropometric indicators of being overweight and of obesity in these groups. Serum kallistatin and afamin were quantified by ELISA tests in a cross-sectional study of 160 patients who were divided into two groups: study group (SG) (<i>n</i> = 80) and another with no cardiovascular event (CG) (<i>n</i> = 80). Serum kallistatin concentration was significantly higher in the SG (<i>p </i>&lt; 0.001), while the level of afamin was significantly lower in this group (<i>p </i>&lt; 0.001). In addition, a positive correlation was observed in the SG between the afamin concentration and the waist to hip ratio (WHR), lipid accumulation product (LAP) and the triglyceride glucose index (TyG index). In the CG, the concentration of kallistatin positively correlated with the LAP and TyG index, while the concentration of afamin positively correlated with all the examined parameters: body mass index (BMI), waist circumference (WC), hip circumference (HC), waist to hip ratio (WHtR), visceral adiposity index (VAI), LAP and TyG index. Serum kallistatin and afamin concentrations are associated with the anthropometric parameters related to being overweight and to obesity, especially to those describing the visceral distribution of adipose tissue and metabolic disorders related to excessive fatness. Full article </div> </div> <div > (This article belongs to the Special Issue (Cardio-)Vascular System in Health and Disease: Current Update and Perspectives) </div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page </div> </div> <div >Open AccessReview</div> An Overview of Robotic Capsules for Drug Delivery to the Gastrointestinal Tract <div > by <span ><div >Pablo Cortegoso Valdivia</div>, </span><span ><div >Alexander R. Robertson</div>, </span><span ><div >Nanne K. H. De Boer</div>, </span><span ><div >Wojciech Marlicz</div> and </span><span ><div >Anastasios Koulaouzidis</div></span> </div> <div > J. Clin. Med. <b>2021</b>, 10(24), 5791; https://doi.org/10.3390/jcm10245791 (registering DOI) - 10 Dec 2021 </div> <div > Abstract <div > The introduction of capsule endoscopy two decades ago marked the beginning of the “small bowel revolution”. Since then, the rapid evolution of microtechnology has allowed the development of drug delivery systems (DDS) designed to address some of the needs that are not met [...] Read more. </div> <div > The introduction of capsule endoscopy two decades ago marked the beginning of the “small bowel revolution”. Since then, the rapid evolution of microtechnology has allowed the development of drug delivery systems (DDS) designed to address some of the needs that are not met by standard drug delivery. To overcome the complex anatomy and physiology of the gastrointestinal (GI) tract, several DDS have been developed, including many prototypes being designed, built and eventually produced with ingenious drug-release mechanisms and anchoring systems allowing targeted therapy. This review highlights the currently available systems for drug delivery in the GI tract and discusses the needs, limitations, and future considerations of these technologies. Full article </div> </div> <div > (This article belongs to the Special Issue Current and Emerging Technologies Applications of Endoscopy in Clinical Practice) </div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> Oral Mucositis Association with Periodontal Status: A Retrospective Analysis of 496 Patients Undergoing Hematopoietic Stem Cell Transplantation <div > by <span ><div >Vladimíra Radochová</div>, </span><span ><div >Martin Šembera</div>, </span><span ><div >Radovan Slezák</div>, </span><span ><div >Ondřej Heneberk</div> and </span><span ><div >Jakub Radocha</div></span> </div> <div > J. Clin. Med. <b>2021</b>, 10(24), 5790; https://doi.org/10.3390/jcm10245790 (registering DOI) - 10 Dec 2021 </div> <div > Abstract <div > Background: Hematopoietic stem cell transplantation (HSCT) can induce serious oral complications, including oral mucositis (OM). The presence of periodontal inflammation before HSCT is believed to be associated with OM. The aim of our study was to determine the prevalence and severity of OM [...] Read more. </div> <div > Background: Hematopoietic stem cell transplantation (HSCT) can induce serious oral complications, including oral mucositis (OM). The presence of periodontal inflammation before HSCT is believed to be associated with OM. The aim of our study was to determine the prevalence and severity of OM in patients undergoing HSCT and its relation to periodontal status. Patients and methods: This is a retrospective study of patients who underwent HSCT and a detailed dental examination between 2007 and 2015. The dental and periodontal status of all patients was evaluated by clinical and radiographic examination prior to HSCT. Oral health was assessed with the gingival index, the the community periodontal index, presence of plaque-related gingivitis, and marginal periodontitis. During the HSCT period, patients were examined daily for the presence of OM, which was graded according to World Health Organization (WHO) classification if present. The patients were assigned to the groups according to type of transplantation: autologous HSCT, myeloablative allogeneic HSCT, and non-myeloablative allogeneic HSCT. Results: A total of 496 patients were included in the study. OM was present in 314 of 496 patients (63.3%): 184/251 (73.3%) in the autologous group, 100/151 (66.2%) in the myeloablative allogeneic group, and 30/94 (31.9%) in the nonmyeloablative allogeneic group. Significantly more patients suffered from OM in the autologous and myeloablative groups versus the nonmyeloablative conditioning group (<i>p</i> &lt; 0.001). The presence of periodontal inflammation did not significantly differ among the groups. There was only a borderline trend for the higher prevalence of OM in the non-myeloablative allogeneic nonmyeloablative group when periodontal inflammation was present (0.073939). Conclusions: Oral mucositis prevalence and severity after stem cell transplantation is not widely affected by the oral hygiene and periodontal disease presence before HSCT. We confirmed the wide-known connection of the conditioning regimen intensity to the prevalence of OM. Full article </div> </div> <div > (This article belongs to the Section Stomatology) </div> </div> </div> </div> </div> <div > More Articles... </div> </div> </div> </div> <div > <div > <div > <div > <a > Submit to <i>JCM</i> </a> Review for JCM <div > Share </div> </div> <div > <h2 >Journal Menu</h2> ► ▼ Journal Menu <ul > <li > <ul> <li > JCM Home </li> <li > Aims Scope </li> <li > Editorial Board </li> <li > Reviewer Board </li> <li > Topical Advisory Panel </li> <li > Instructions for Authors </li> <li > Special Issues </li> <li > Sections Collections </li> <li > Article Processing Charge </li> <li > Indexing Archiving </li> <li > Editor's Choice Articles </li> <li > Most Cited Viewed </li> <li > Journal Statistics </li> <li > Journal History </li> <li > Journal Awards </li> <li > Society Collaborations </li> <li > Editorial Office </li> </ul> </li> </ul> </div> <h2 >Journal Browser</h2> ► ▼ Journal Browser <div > <div > <ul > <li > <a > <i > arrow_forward_ios </i> Forthcoming issue </a> <a > <i > arrow_forward_ios </i> Current issue </a> </li> <div > <div > <div > <li > Vol. 10 (2021) </li> <li > Vol. 9 (2020) </li> <li > Vol. 8 (2019) </li> <li > Vol. 7 (2018) </li> <li > Vol. 6 (2017) </li> <li > Vol. 5 (2016) </li> <li > Vol. 4 (2015) </li> <li > Vol. 3 (2014) </li> <li > Vol. 2 (2013) </li> <li > Vol. 1 (2012) </li> </div> </div> </div> </ul> </div> </div> </div> </div> <div > <div > <h2>Highly Accessed Articles</h2> </div> <div > <div > View More... </div> </div> </div> <div > <div > <h2>Latest Books</h2> </div> <div > <div > More Open Access Books... </div> </div> </div> </div> <div > <div > <div > <h2>E-Mail Alert</h2> </div> </div> <div > <div > <h2>News</h2> </div> <div > <div > 22 November 2021 720 MDPI Editorial Board Members Receiving "2021 Highly Cited Researchers" Distinction </div> <div > 16 November 2021 Topical Advisory Panel Established to Support Editorial Board </div> <div > 25 October 2021 Open Access Week 2021 | It Matters How We Open Knowledge: Building Structural Equity, 25–31 October </div> <div > More News Announcements... </div> </div> </div> <div > <div > <h2>Topics</h2> </div> <div > <div ><div> Topic in IJMS, Biomedicines, Antioxidants, CIMB, JCM</div> Sterile Inflammation in Solid Organ Transplantation Editors-in-Chief: Jerzy W. Kupiec-Weglinski, Joan Roselló-Catafau, René Adam, Teresa Carbonell Camós, Arnau Panisello-RosellóDeadline: 10 February 2022</div> <div ><div> Topic in Applied Sciences, JCM, Dentistry Journal, IJMS, MPs</div> Advances in Dental Biomaterials and Oral Tissues Engineering Editors-in-Chief: Gianrico Spagnuolo, Marco TatulloDeadline: 31 March 2022</div> <div ><div> Topic in Biomedicines, Viruses, JoF, Microorganisms, JCM</div> Infectious Diseases Editor-in-Chief: Célia F. RodriguesDeadline: 31 May 2022</div> <div ><div> Topic in Materials, Dentistry Journal, JCM, JFB</div> New Frontiers and Boundaries in the Use of Biomaterials in Dentistry Editors-in-Chief: Daniele Botticelli, Adriano Piattelli, Gabi ChaushuDeadline: 10 June 2022</div> <div > More Topics </div> </div> </div> <div > <div > <h2>Conferences</h2> </div> <div > <div > Announce Your Conference </div> <div > 9 January 2021–9 January 2022 New Ultrasonographic Techniques for the Study of the Inferior Vena Cava to Guide Patient Management in Different Clinical Contexts</div> <div > 18–19 February 2022 6th International 4 Corners of Cardiology Meeting</div> <div > 17–20 July 2022 15th International Neurotrauma Symposium</div> <div > More Conferences... </div> </div> </div> <div > <div > <h2>Special Issues</h2> </div> <div > <div > Edit a Special Issue </div> <div ><div> Special Issue in JCM</div> Update on Diagnostic, Antibiotic Treatment, and Prevention of Infections in Critically Ill Patients Guest Editor: Erlangga YusufDeadline: 15 December 2021</div> <div ><div> Special Issue in JCM</div> Molecular Epidemiology in Hepatitis C Virus (HCV) Infection: Studies of Viral and Human Genomes Guest Editors: Salvador Resino, Isidoro MartínezDeadline: 31 December 2021</div> <div ><div> Special Issue in JCM</div> Natural History and Clinical Consequences of Hepatitis B Virus (HBV) Infection Guest Editor: Cristina StasiDeadline: 1 January 2022</div> <div ><div> Special Issue in JCM</div> Peripheral Artery Disease: From Diagnosis to Treatment Guest Editor: Guillaume MaheDeadline: 10 January 2022</div> <div > More Special Issues </div> </div> </div> <div > <div > <h2>Topical Collections</h2> </div> <div > <div ><div> Topical Collection in JCM</div> State-of-the-Art in Inflammatory Bowel Disease Collection Editors: Stefanos Bonovas, Daniele Piovani</div> <div ><div> Topical Collection in JCM</div> Novel Coronavirus Pandemic: Public Health, Epidemiological, and Multi-Disciplinary Research Collection Editors: Paulo Jorge Nogueira, Miguel de Araújo Nobre</div> <div ><div> Topical Collection in JCM</div> Bariatric Surgery: Latest Advances and Prospects Collection Editor: David Benaiges Boix</div> <div ><div> Topical Collection in JCM</div> Implant Dentistry—Trends, Challenges and Innovations Collection Editor: Miguel de Araújo Nobre</div> <div > More Topical Collections </div> </div> </div> <div > <div > <h2>Jobs in Research</h2> </div> <div > <div > Post New Job Opening </div> </div> </div> </div> </div> </div> </section> <div > <div > J. Clin. Med., EISSN 2077-0383, Published by MDPI <span> Disclaimer <div > The statements, opinions and data contained in the journal Journal of Clinical Medicine are solely those of the individual authors and contributors and not of the publisher and the editor(s). MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. </div> </span> <div > RSS Content Alert </div> </div> <div > <div > <h3> Further Information </h3> Article Processing Charges <a > Pay an Invoice </a> <a > Open Access Policy </a> <a > Contact MDPI </a> <a > Jobs at MDPI </a> </div> <div > <h3> Guidelines </h3> <a > For Authors </a> <a > For Reviewers </a> <a > For Editors </a> <a > For Librarians </a> <a > For Publishers </a> <a > For Societies </a> </div> <div > <h3> MDPI Initiatives </h3> <a > Sciforum </a> <a > MDPI Books </a> <a > Preprints </a> <a > Scilit </a> <a > SciProfiles </a> <a > Encyclopedia </a> <a > JAMS </a> <a > Proceedings Series </a> </div> <div > <h3> Follow MDPI </h3> <a > LinkedIn </a> <a > Facebook </a> <a > Twitter </a> </div> </div> <div > <div > <div > © 1996-2021 MDPI (Basel, Switzerland) unless otherwise stated </div> <div > <a > Disclaimer </a> <div > The statements, opinions and data contained in the journals are solely those of the individual authors and contributors and not of the publisher and the editor(s). MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. </div> <a > Terms and Conditions </a> <a > Privacy Policy </a> </div> </div> </div> </div> <div > <div > We use cookies on our website to ensure you get the best experience. Read more about our cookies <a >here</a>. </div> <div > <a >Accept</a> </div> </div> <div > <div > We have just recently launched a new version of our website. Help us to further improve by taking part in this short 5 minute survey here. here. </div> <div > <a >Never show this again</a> </div> </div> </div> <div > <div > <div > <h2 >Share Link</h2> </div> <div > <a >Copy</a> </div> </div> <a > <i >clear</i> </a> </div> <div > <div > <div > <h2 >Share</h2> </div> </div> <a > <i >clear</i> </a> </div> <a >Back to TopTop</a> </body>'</script>

      </head>
        <body class="valid" valid="valid" title="valid: True, node: 1, tag: body, level: 1" node_number="1"> <div class="valid" valid="valid" title="valid: True, node: 2, tag: div, level: 2" node_number="2"> <div class="valid" valid="valid" title="valid: True, node: 3, tag: div, level: 3" node_number="3"> <div class="valid" valid="valid" title="valid: True, node: 4, tag: div, level: 4" node_number="4"> <a class="valid" valid="valid" title="valid: True, node: 5, tag: a, level: 5" node_number="5"> <h2 class="valid" valid="valid" title="valid: True, node: 6, tag: h2, level: 6" node_number="6">25th Anniversary</h2> </a> <a class="valid" valid="valid" title="valid: True, node: 7, tag: a, level: 5" node_number="7"> <h2 class="valid" valid="valid" title="valid: True, node: 8, tag: h2, level: 6" node_number="8">Journals</h2> </a> <div class="valid" valid="valid" title="valid: True, node: 9, tag: div, level: 5" node_number="9"> <div class="valid" valid="valid" title="valid: True, node: 10, tag: div, level: 6" node_number="10"> <h2 class="valid" valid="valid" title="valid: True, node: 11, tag: h2, level: 7" node_number="11">Information</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 12, tag: div, level: 6" node_number="12"> <div class="valid" valid="valid" title="valid: True, node: 13, tag: div, level: 7" node_number="13"> <div class="valid" valid="valid" title="valid: True, node: 14, tag: div, level: 8" node_number="14"> <a class="valid" valid="valid" title="valid: True, node: 15, tag: a, level: 9" node_number="15">For Authors</a> <a class="valid" valid="valid" title="valid: True, node: 16, tag: a, level: 9" node_number="16">For Reviewers</a> <a class="valid" valid="valid" title="valid: True, node: 17, tag: a, level: 9" node_number="17">For Editors</a> <a class="valid" valid="valid" title="valid: True, node: 18, tag: a, level: 9" node_number="18">For Librarians</a> <a class="valid" valid="valid" title="valid: True, node: 19, tag: a, level: 9" node_number="19">For Publishers</a> <a class="valid" valid="valid" title="valid: True, node: 20, tag: a, level: 9" node_number="20">For Societies</a> </div> <div class="valid" valid="valid" title="valid: True, node: 21, tag: div, level: 8" node_number="21"> <a class="valid" valid="valid" title="valid: True, node: 22, tag: a, level: 9" node_number="22">Article Processing Charges</a> <a class="valid" valid="valid" title="valid: True, node: 23, tag: a, level: 9" node_number="23">Open Access Policy</a> <a class="valid" valid="valid" title="valid: True, node: 24, tag: a, level: 9" node_number="24">Institutional Open Access Program</a> <a class="valid" valid="valid" title="valid: True, node: 25, tag: a, level: 9" node_number="25">Editorial Process</a> <a class="valid" valid="valid" title="valid: True, node: 26, tag: a, level: 9" node_number="26">Awards</a> <a class="valid" valid="valid" title="valid: True, node: 27, tag: a, level: 9" node_number="27">Research and Publication Ethics</a> </div> </div> </div> </div> <a class="valid" valid="valid" title="valid: True, node: 28, tag: a, level: 5" node_number="28"> <h2 class="valid" valid="valid" title="valid: True, node: 29, tag: h2, level: 6" node_number="29">Author Services</h2> </a> <div class="valid" valid="valid" title="valid: True, node: 30, tag: div, level: 5" node_number="30"> <div class="valid" valid="valid" title="valid: True, node: 31, tag: div, level: 6" node_number="31"> <h2 class="valid" valid="valid" title="valid: True, node: 32, tag: h2, level: 7" node_number="32">Initiatives</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 33, tag: div, level: 6" node_number="33"> <div class="valid" valid="valid" title="valid: True, node: 34, tag: div, level: 7" node_number="34"> <div class="valid" valid="valid" title="valid: True, node: 35, tag: div, level: 8" node_number="35"> <a class="valid" valid="valid" title="valid: True, node: 36, tag: a, level: 9" node_number="36">Sciforum</a> <a class="valid" valid="valid" title="valid: True, node: 37, tag: a, level: 9" node_number="37">MDPI Books</a> <a class="valid" valid="valid" title="valid: True, node: 38, tag: a, level: 9" node_number="38">Preprints</a> <a class="valid" valid="valid" title="valid: True, node: 39, tag: a, level: 9" node_number="39">Scilit</a> <a class="valid" valid="valid" title="valid: True, node: 40, tag: a, level: 9" node_number="40">SciProfiles</a> <a class="valid" valid="valid" title="valid: True, node: 41, tag: a, level: 9" node_number="41">Encyclopedia</a> <a class="valid" valid="valid" title="valid: True, node: 42, tag: a, level: 9" node_number="42">JAMS</a> <a class="valid" valid="valid" title="valid: True, node: 43, tag: a, level: 9" node_number="43">Proceedings Series</a> </div> </div> </div> </div> <a class="valid" valid="valid" title="valid: True, node: 44, tag: a, level: 5" node_number="44"> <h2 class="valid" valid="valid" title="valid: True, node: 45, tag: h2, level: 6" node_number="45">About</h2> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 46, tag: div, level: 4" node_number="46"> <a class="valid" valid="valid" title="valid: True, node: 47, tag: a, level: 5" node_number="47">Sign In / Sign Up</a> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 48, tag: div, level: 2" node_number="48"> <h2 class="valid" valid="valid" title="valid: True, node: 49, tag: h2, level: 3" node_number="49">Notice</h2> <a class="valid" valid="valid" title="valid: True, node: 50, tag: a, level: 3" node_number="50"> <i class="valid" valid="valid" title="valid: True, node: 51, tag: i, level: 4" node_number="51">clear</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 52, tag: div, level: 2" node_number="52"> <div class="valid" valid="valid" title="valid: True, node: 53, tag: div, level: 3" node_number="53"> <div class="valid" valid="valid" title="valid: True, node: 54, tag: div, level: 4" node_number="54"> <h2 class="valid" valid="valid" title="valid: True, node: 55, tag: h2, level: 5" node_number="55">Notice</h2> <p class="valid" valid="valid" title="valid: True, node: 56, tag: p, level: 5" node_number="56"> You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader. </p> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 57, tag: div, level: 3" node_number="57"> <div class="valid" valid="valid" title="valid: True, node: 58, tag: div, level: 4" node_number="58"> <a class="valid" valid="valid" title="valid: True, node: 59, tag: a, level: 5" node_number="59">Continue</a> <a class="valid" valid="valid" title="valid: True, node: 60, tag: a, level: 5" node_number="60">Cancel</a> </div> </div> <a class="valid" valid="valid" title="valid: True, node: 61, tag: a, level: 3" node_number="61"> <i class="valid" valid="valid" title="valid: True, node: 62, tag: i, level: 4" node_number="62">clear</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 63, tag: div, level: 2" node_number="63"> <p class="valid" valid="valid" title="valid: True, node: 64, tag: p, level: 3" node_number="64"> All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. </p> </div> <div class="valid" valid="valid" title="valid: True, node: 65, tag: div, level: 2" node_number="65"> <p class="valid" valid="valid" title="valid: True, node: 66, tag: p, level: 3" node_number="66"> Feature Papers represent the most advanced research with significant potential for high impact in the field. Feature Papers are submitted upon individual invitation or recommendation by the scientific editors and undergo peer review prior to publication. </p> <p class="valid" valid="valid" title="valid: True, node: 67, tag: p, level: 3" node_number="67"> The Feature Paper can be either an original research article, a substantial novel research study that often involves several techniques or approaches, or a comprehensive review paper with concise and precise updates on the latest progress in the field that systematically reviews the most exciting advances in scientific literature. This type of paper provides an outlook on future directions of research or possible applications. </p> </div> <div class="valid" valid="valid" title="valid: True, node: 68, tag: div, level: 2" node_number="68"> <p class="valid" valid="valid" title="valid: True, node: 69, tag: p, level: 3" node_number="69"> Editor&#8217;s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to authors, or important in this field. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal. </p> </div> <div class="valid" valid="valid" title="valid: True, node: 70, tag: div, level: 2" node_number="70"> <div class="valid" valid="valid" title="valid: True, node: 71, tag: div, level: 3" node_number="71">  </div> <section class="valid" valid="valid" title="valid: True, node: 72, tag: section, level: 3" node_number="72"> <header class="valid" valid="valid" title="valid: True, node: 73, tag: header, level: 4" node_number="73"> <div class="valid" valid="valid" title="valid: True, node: 74, tag: div, level: 5" node_number="74"> <div class="valid" valid="valid" title="valid: True, node: 75, tag: div, level: 6" node_number="75"> <div class="valid" valid="valid" title="valid: True, node: 76, tag: div, level: 7" node_number="76"> <ul class="valid" valid="valid" title="valid: True, node: 77, tag: ul, level: 8" node_number="77"> <li class="valid" valid="valid" title="valid: True, node: 78, tag: li, level: 9" node_number="78"> <a class="valid" valid="valid" title="valid: True, node: 79, tag: a, level: 10" node_number="79">25th Anniversary</a> </li> <li class="valid" valid="valid" title="valid: True, node: 80, tag: li, level: 9" node_number="80"> <a class="valid" valid="valid" title="valid: True, node: 81, tag: a, level: 10" node_number="81">Journals</a> </li> <li class="valid" valid="valid" title="valid: True, node: 82, tag: li, level: 9" node_number="82"> <a class="valid" valid="valid" title="valid: True, node: 83, tag: a, level: 10" node_number="83">Information</a> <ul class="valid" valid="valid" title="valid: True, node: 84, tag: ul, level: 10" node_number="84"> <li class="valid" valid="valid" title="valid: True, node: 85, tag: li, level: 11" node_number="85"> <div class="valid" valid="valid" title="valid: True, node: 86, tag: div, level: 12" node_number="86"> <div class="valid" valid="valid" title="valid: True, node: 87, tag: div, level: 13" node_number="87"> <ul class="valid" valid="valid" title="valid: True, node: 88, tag: ul, level: 14" node_number="88"> <li title="valid: False, node: 89, tag: li, level: 15" node_number="89"> <a title="valid: False, node: 90, tag: a, level: 16" node_number="90">For Authors</a> </li> <li title="valid: False, node: 91, tag: li, level: 15" node_number="91"> <a title="valid: False, node: 92, tag: a, level: 16" node_number="92">For Reviewers</a> </li> <li title="valid: False, node: 93, tag: li, level: 15" node_number="93"> <a title="valid: False, node: 94, tag: a, level: 16" node_number="94">For Editors</a> </li> <li title="valid: False, node: 95, tag: li, level: 15" node_number="95"> <a title="valid: False, node: 96, tag: a, level: 16" node_number="96">For Librarians</a> </li> <li title="valid: False, node: 97, tag: li, level: 15" node_number="97"> <a title="valid: False, node: 98, tag: a, level: 16" node_number="98">For Publishers</a> </li> <li title="valid: False, node: 99, tag: li, level: 15" node_number="99"> <a title="valid: False, node: 100, tag: a, level: 16" node_number="100">For Societies</a> </li> </ul> </div> <div class="valid" valid="valid" title="valid: True, node: 101, tag: div, level: 13" node_number="101"> <ul class="valid" valid="valid" title="valid: True, node: 102, tag: ul, level: 14" node_number="102"> <li title="valid: False, node: 103, tag: li, level: 15" node_number="103"> <a title="valid: False, node: 104, tag: a, level: 16" node_number="104">Article Processing Charges</a> </li> <li title="valid: False, node: 105, tag: li, level: 15" node_number="105"> <a title="valid: False, node: 106, tag: a, level: 16" node_number="106">Open Access Policy</a> </li> <li title="valid: False, node: 107, tag: li, level: 15" node_number="107"> <a title="valid: False, node: 108, tag: a, level: 16" node_number="108">Institutional Open Access Program</a> </li> <li title="valid: False, node: 109, tag: li, level: 15" node_number="109"> <a title="valid: False, node: 110, tag: a, level: 16" node_number="110">Editorial Process</a> </li> <li title="valid: False, node: 111, tag: li, level: 15" node_number="111"> <a title="valid: False, node: 112, tag: a, level: 16" node_number="112">Awards</a> </li> <li title="valid: False, node: 113, tag: li, level: 15" node_number="113"> <a title="valid: False, node: 114, tag: a, level: 16" node_number="114">Research and Publication Ethics</a> </li> </ul> </div> </div> </li> </ul> </li> <li class="valid" valid="valid" title="valid: True, node: 115, tag: li, level: 9" node_number="115"> <a class="valid" valid="valid" title="valid: True, node: 116, tag: a, level: 10" node_number="116">Author Services</a> </li> <li class="valid" valid="valid" title="valid: True, node: 117, tag: li, level: 9" node_number="117"> <a class="valid" valid="valid" title="valid: True, node: 118, tag: a, level: 10" node_number="118">Initiatives</a> <ul class="valid" valid="valid" title="valid: True, node: 119, tag: ul, level: 10" node_number="119"> <li class="valid" valid="valid" title="valid: True, node: 120, tag: li, level: 11" node_number="120"> <div class="valid" valid="valid" title="valid: True, node: 121, tag: div, level: 12" node_number="121"> <div class="valid" valid="valid" title="valid: True, node: 122, tag: div, level: 13" node_number="122"> <ul class="valid" valid="valid" title="valid: True, node: 123, tag: ul, level: 14" node_number="123"> <li title="valid: False, node: 124, tag: li, level: 15" node_number="124"> <a title="valid: False, node: 125, tag: a, level: 16" node_number="125"> Sciforum </a> </li> <li title="valid: False, node: 126, tag: li, level: 15" node_number="126"> <a title="valid: False, node: 127, tag: a, level: 16" node_number="127"> MDPI Books </a> </li> <li title="valid: False, node: 128, tag: li, level: 15" node_number="128"> <a title="valid: False, node: 129, tag: a, level: 16" node_number="129"> Preprints </a> </li> <li title="valid: False, node: 130, tag: li, level: 15" node_number="130"> <a title="valid: False, node: 131, tag: a, level: 16" node_number="131"> Scilit </a> </li> <li title="valid: False, node: 132, tag: li, level: 15" node_number="132"> <a title="valid: False, node: 133, tag: a, level: 16" node_number="133"> SciProfiles </a> </li> <li title="valid: False, node: 134, tag: li, level: 15" node_number="134"> <a title="valid: False, node: 135, tag: a, level: 16" node_number="135"> Encyclopedia </a> </li> <li title="valid: False, node: 136, tag: li, level: 15" node_number="136"> <a title="valid: False, node: 137, tag: a, level: 16" node_number="137"> JAMS </a> </li> <li title="valid: False, node: 138, tag: li, level: 15" node_number="138"> <a title="valid: False, node: 139, tag: a, level: 16" node_number="139"> Proceedings Series </a> </li> </ul> </div> </div> </li> </ul> </li> <li class="valid" valid="valid" title="valid: True, node: 140, tag: li, level: 9" node_number="140"> <a class="valid" valid="valid" title="valid: True, node: 141, tag: a, level: 10" node_number="141">About</a> </li> </ul> </div> <div class="valid" valid="valid" title="valid: True, node: 142, tag: div, level: 7" node_number="142"> <div class="valid" valid="valid" title="valid: True, node: 143, tag: div, level: 8" node_number="143"> <a class="valid" valid="valid" title="valid: True, node: 144, tag: a, level: 9" node_number="144">Sign In / Sign Up</a> <a class="valid" valid="valid" title="valid: True, node: 145, tag: a, level: 9" node_number="145">Submit</a> </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 146, tag: div, level: 5" node_number="146"> <div class="valid" valid="valid" title="valid: True, node: 147, tag: div, level: 6" node_number="147"> <div class="valid" valid="valid" title="valid: True, node: 148, tag: div, level: 7" node_number="148"> <div class="valid" valid="valid" title="valid: True, node: 149, tag: div, level: 8" node_number="149"> <a class="valid" valid="valid" title="valid: True, node: 150, tag: a, level: 9" node_number="150"> Covered in: PubMed </a> </div></div> <div class="valid" valid="valid" title="valid: True, node: 151, tag: div, level: 7" node_number="151"> <div class="valid" valid="valid" title="valid: True, node: 152, tag: div, level: 8" node_number="152"> <a class="valid" valid="valid" title="valid: True, node: 153, tag: a, level: 9" node_number="153"> IMPACTFACTOR 4.242 </a> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 154, tag: div, level: 6" node_number="154"> Journals </div> <div class="valid" valid="valid" title="valid: True, node: 155, tag: div, level: 6" node_number="155"> JCM </div> </div> </header> <div class="valid" valid="valid" title="valid: True, node: 156, tag: div, level: 4" node_number="156"> <div class="valid" valid="valid" title="valid: True, node: 157, tag: div, level: 5" node_number="157"> <div class="valid" valid="valid" title="valid: True, node: 158, tag: div, level: 6" node_number="158"> <div class="valid" valid="valid" title="valid: True, node: 159, tag: div, level: 7" node_number="159"> <div class="valid" valid="valid" title="valid: True, node: 160, tag: div, level: 8" node_number="160"> <ul class="valid" valid="valid" title="valid: True, node: 161, tag: ul, level: 9" node_number="161"> <li class="valid" valid="valid" title="valid: True, node: 162, tag: li, level: 10" node_number="162"> <a class="valid" valid="valid" title="valid: True, node: 163, tag: a, level: 11" node_number="163"> <div class="valid" valid="valid" title="valid: True, node: 164, tag: div, level: 12" node_number="164"> Targeting Inflammatory Signaling in Prostate Cancer Castration Resistance </div> </a> </li> <li class="valid" valid="valid" title="valid: True, node: 165, tag: li, level: 10" node_number="165"> <a class="valid" valid="valid" title="valid: True, node: 166, tag: a, level: 11" node_number="166"> <div class="valid" valid="valid" title="valid: True, node: 167, tag: div, level: 12" node_number="167"> Immunotherapy Monitoring with Immune Checkpoint Inhibitors Based on [<sup class="valid" valid="valid" title="valid: True, node: 168, tag: sup, level: 13" node_number="168">18</sup>F]FDG PET/CT in Metastatic Melanomas and Lung Cancer </div> </a> </li> </ul> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 169, tag: div, level: 7" node_number="169"> <div class="valid" valid="valid" title="valid: True, node: 170, tag: div, level: 8" node_number="170"> <h2 class="valid" valid="valid" title="valid: True, node: 171, tag: h2, level: 9" node_number="171">Journal Description</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 172, tag: div, level: 8" node_number="172"> <div class="valid" valid="valid" title="valid: True, node: 173, tag: div, level: 9" node_number="173"> <h1 class="valid" valid="valid" title="valid: True, node: 174, tag: h1, level: 10" node_number="174"> Journal of Clinical Medicine </h1> <div class="valid" valid="valid" title="valid: True, node: 175, tag: div, level: 10" node_number="175"> Journal of Clinical Medicine is an international,&#160;<a class="valid" valid="valid" title="valid: True, node: 176, tag: a, level: 11" node_number="176">peer-reviewed</a>, open access journal of clinical medicine, published semimonthly online by MDPI. The&#160;<a class="valid" valid="valid" title="valid: True, node: 177, tag: a, level: 11" node_number="177">International Bone Research Association</a> (IBRA), <a class="valid" valid="valid" title="valid: True, node: 178, tag: a, level: 11" node_number="178">Italian Resuscitation Council</a> (IRC), <a class="valid" valid="valid" title="valid: True, node: 179, tag: a, level: 11" node_number="179">Nuclear Medicine Discovery</a> (Nu.Me.D.), <a class="valid" valid="valid" title="valid: True, node: 180, tag: a, level: 11" node_number="180">Spanish Society of Hematology and Hemotherapy</a> (SEHH),&#160;<a class="valid" valid="valid" title="valid: True, node: 181, tag: a, level: 11" node_number="181">Japan Association for Clinical Engineers</a> (JACE) and&#160;<a class="valid" valid="valid" title="valid: True, node: 182, tag: a, level: 11" node_number="182">European Independent Foundation in Angiology/ Vascular Medicine</a> (VAS) are all affiliated with JCM, and their members receive a discount on article processing charges. <ul class="valid" valid="valid" title="valid: True, node: 183, tag: ul, level: 11" node_number="183"> <li class="valid" valid="valid" title="valid: True, node: 184, tag: li, level: 12" node_number="184">Open Access&#8212; free for readers, with <a class="valid" valid="valid" title="valid: True, node: 185, tag: a, level: 13" node_number="185">article processing charges (APC)</a> paid by authors or their institutions.</li> <li class="valid" valid="valid" title="valid: True, node: 186, tag: li, level: 12" node_number="186">High Visibility:&#160;indexed within <a class="valid" valid="valid" title="valid: True, node: 187, tag: a, level: 13" node_number="187">Scopus</a>,&#160;<a class="valid" valid="valid" title="valid: True, node: 188, tag: a, level: 13" node_number="188">SCIE (Web of Science)</a>, <a class="valid" valid="valid" title="valid: True, node: 189, tag: a, level: 13" node_number="189">PubMed</a>, <a class="valid" valid="valid" title="valid: True, node: 190, tag: a, level: 13" node_number="190">PMC</a>, <a class="valid" valid="valid" title="valid: True, node: 191, tag: a, level: 13" node_number="191">Embase</a>, <a class="valid" valid="valid" title="valid: True, node: 192, tag: a, level: 13" node_number="192">CAPlus / SciFinder</a>, and many <a class="valid" valid="valid" title="valid: True, node: 193, tag: a, level: 13" node_number="193">other databases</a>.</li> <li class="valid" valid="valid" title="valid: True, node: 194, tag: li, level: 12" node_number="194">Journal Rank:&#160;JCR&#160;- Q1 (Medicine, General Internal)</li> <li class="valid" valid="valid" title="valid: True, node: 195, tag: li, level: 12" node_number="195">Rapid Publication: manuscripts are peer-reviewed and a first decision provided to authors approximately 19.3 days after submission; acceptance to publication is undertaken in 3.6 days (median values for papers published in this journal in the first half of 2021).</li> <li class="valid" valid="valid" title="valid: True, node: 196, tag: li, level: 12" node_number="196">Recognition of Reviewers: reviewers who provide timely, thorough peer-review reports receive vouchers entitling them to a discount on the APC of their next publication in any MDPI journal, in appreciation of the work done.</li> <li class="valid" valid="valid" title="valid: True, node: 197, tag: li, level: 12" node_number="197">Companion journals for&#160;JCM include: Epidemiologia, <a class="valid" valid="valid" title="valid: True, node: 198, tag: a, level: 13" node_number="198">Transplantology</a>, <a class="valid" valid="valid" title="valid: True, node: 199, tag: a, level: 13" node_number="199">Uro</a>,&#160;<a class="valid" valid="valid" title="valid: True, node: 200, tag: a, level: 13" node_number="200">Sinusitis</a>, <a class="valid" valid="valid" title="valid: True, node: 201, tag: a, level: 13" node_number="201">Rheumato</a>, <a class="valid" valid="valid" title="valid: True, node: 202, tag: a, level: 13" node_number="202">Biologics</a> and <a class="valid" valid="valid" title="valid: True, node: 203, tag: a, level: 13" node_number="203">Current Ophthalmology</a>.</li> </ul> </div> <div class="valid" valid="valid" title="valid: True, node: 204, tag: div, level: 10" node_number="204"> Impact Factor: 4.242 (2020) ; 5-Year Impact Factor: 4.567 (2020) </div> <div class="valid" valid="valid" title="valid: True, node: 205, tag: div, level: 10" node_number="205"> <a class="valid" valid="valid" title="valid: True, node: 206, tag: a, level: 11" node_number="206"> <i class="valid" valid="valid" title="valid: True, node: 207, tag: i, level: 12" node_number="207">subject</i> Imprint Information </a> <a class="valid" valid="valid" title="valid: True, node: 208, tag: a, level: 11" node_number="208"> <i class="valid" valid="valid" title="valid: True, node: 209, tag: i, level: 12" node_number="209">get_app</i> Journal Flyer </a> <a class="valid" valid="valid" title="valid: True, node: 210, tag: a, level: 11" node_number="210"> Open Access </a> ISSN: 2077-0383 </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 211, tag: div, level: 7" node_number="211"> <div class="valid" valid="valid" title="valid: True, node: 212, tag: div, level: 8" node_number="212"> <h2 class="valid" valid="valid" title="valid: True, node: 213, tag: h2, level: 9" node_number="213">Latest Articles</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 214, tag: div, level: 8" node_number="214"> <div class="valid" valid="valid" title="valid: True, node: 215, tag: div, level: 9" node_number="215"> <div class="valid" valid="valid" title="valid: True, node: 216, tag: div, level: 10" node_number="216"> <div class="valid" valid="valid" title="valid: True, node: 217, tag: div, level: 11" node_number="217"> <div class="valid" valid="valid" title="valid: True, node: 218, tag: div, level: 12" node_number="218"> <a class="valid" valid="valid" title="valid: True, node: 219, tag: a, level: 13" node_number="219"> <i class="valid" valid="valid" title="valid: True, node: 220, tag: i, level: 14" node_number="220">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 221, tag: div, level: 12" node_number="221"> <a class="valid" valid="valid" title="valid: True, node: 222, tag: a, level: 13" node_number="222"> <i class="valid" valid="valid" title="valid: True, node: 223, tag: i, level: 14" node_number="223">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 224, tag: div, level: 13" node_number="224"> View online as: <a class="valid" valid="valid" title="valid: True, node: 225, tag: a, level: 14" node_number="225">Abstract Page</a> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 226, tag: div, level: 12" node_number="226">Open AccessArticle</div> Analysis of Indications for Voiding Cystography in Children <div class="valid" valid="valid" title="valid: True, node: 227, tag: div, level: 12" node_number="227"> by <span class="valid" valid="valid" title="valid: True, node: 228, tag: span, level: 13" node_number="228"><div class="valid" valid="valid" title="valid: True, node: 229, tag: div, level: 14" node_number="229">Natalia Kopiczko</div>, </span><span class="valid" valid="valid" title="valid: True, node: 230, tag: span, level: 13" node_number="230"><div class="valid" valid="valid" title="valid: True, node: 231, tag: div, level: 14" node_number="231">Aleksandra Dzik-Sawczuk</div>, </span><span class="valid" valid="valid" title="valid: True, node: 232, tag: span, level: 13" node_number="232"><div class="valid" valid="valid" title="valid: True, node: 233, tag: div, level: 14" node_number="233">Karolina Szwarc</div>, </span><span class="valid" valid="valid" title="valid: True, node: 234, tag: span, level: 13" node_number="234"><div class="valid" valid="valid" title="valid: True, node: 235, tag: div, level: 14" node_number="235">Anna Czy&#380;</div> and </span><span class="valid" valid="valid" title="valid: True, node: 236, tag: span, level: 13" node_number="236"><div class="valid" valid="valid" title="valid: True, node: 237, tag: div, level: 14" node_number="237">Anna Wasilewska</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 238, tag: div, level: 12" node_number="238"> J. Clin. Med. <b class="valid" valid="valid" title="valid: True, node: 239, tag: b, level: 13" node_number="239">2021</b>, 10(24), 5809; https://doi.org/10.3390/jcm10245809 (registering&#160;DOI) - 11 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 240, tag: div, level: 12" node_number="240"> Abstract <div class="valid" valid="valid" title="valid: True, node: 241, tag: div, level: 13" node_number="241"> In this study, we report the experience of our center with the prognosis of vesicoureteral reflux, depending on the indications for voiding cystography, during a 12-year period. Retrospective analysis included 4302 children who were analyzed according to the indication for voiding cystography: (1) [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 242, tag: div, level: 13" node_number="242"> In this study, we report the experience of our center with the prognosis of vesicoureteral reflux, depending on the indications for voiding cystography, during a 12-year period. Retrospective analysis included 4302 children who were analyzed according to the indication for voiding cystography: (1) a febrile urinary tract infection, (2) urinary tract malformations on ultrasonography and (3) lower urinary tract dysfunction. Vesicoureteral reflux was found in 917 patients (21.32%; 24.1% of girls and 17.9% of boys). In group (1), reflux was found in 437/1849 cases (23.63%), group (2) in 324/1388 cases (23.34%) and group (3) in 156/1065 cases (14.65%). A significantly lower prevalence of reflux and its lower degree was found in children from group (3) when compared to other groups (<i class="valid" valid="valid" title="valid: True, node: 243, tag: i, level: 14" node_number="243">p</i> &lt; 0.01). VURs were confirmed in over 20% of children with urinary tract malformations on ultrasonography or after a febrile urinary tract infection, suggesting the need for voiding cystography in these children. Indications for this examination in children with lower urinary tract dysfunction should be limited. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 244, tag: div, level: 12" node_number="244"> (This article belongs to the Special Issue Pediatric and Adolescent Nephrology Facing the Future: Diagnostic Advances and Prognostic Biomarkers in Everyday Practice) </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 245, tag: div, level: 9" node_number="245"> <div class="valid" valid="valid" title="valid: True, node: 246, tag: div, level: 10" node_number="246"> <div class="valid" valid="valid" title="valid: True, node: 247, tag: div, level: 11" node_number="247"> <div class="valid" valid="valid" title="valid: True, node: 248, tag: div, level: 12" node_number="248"> <div class="valid" valid="valid" title="valid: True, node: 249, tag: div, level: 13" node_number="249"> <a class="valid" valid="valid" title="valid: True, node: 250, tag: a, level: 14" node_number="250"> <i title="valid: False, node: 251, tag: i, level: 15" node_number="251">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 252, tag: div, level: 13" node_number="252"> <a class="valid" valid="valid" title="valid: True, node: 253, tag: a, level: 14" node_number="253"> <i title="valid: False, node: 254, tag: i, level: 15" node_number="254">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 255, tag: div, level: 14" node_number="255"> View online as: Abstract Page </div> </div> <div class="valid" valid="valid" title="valid: True, node: 256, tag: div, level: 13" node_number="256">Open AccessReview</div> Advances in Diagnostic Imaging for Cardiac Sarcoidosis <div class="valid" valid="valid" title="valid: True, node: 257, tag: div, level: 13" node_number="257"> by <span class="valid" valid="valid" title="valid: True, node: 258, tag: span, level: 14" node_number="258"><div title="valid: False, node: 259, tag: div, level: 15" node_number="259">Osamu Manabe</div>, </span><span class="valid" valid="valid" title="valid: True, node: 260, tag: span, level: 14" node_number="260"><div title="valid: False, node: 261, tag: div, level: 15" node_number="261">Noriko Oyama-Manabe</div>, </span><span class="valid" valid="valid" title="valid: True, node: 262, tag: span, level: 14" node_number="262"><div title="valid: False, node: 263, tag: div, level: 15" node_number="263">Tadao Aikawa</div>, </span><span class="valid" valid="valid" title="valid: True, node: 264, tag: span, level: 14" node_number="264"><div title="valid: False, node: 265, tag: div, level: 15" node_number="265">Satonori Tsuneta</div> and </span><span class="valid" valid="valid" title="valid: True, node: 266, tag: span, level: 14" node_number="266"><div title="valid: False, node: 267, tag: div, level: 15" node_number="267">Nagara Tamaki</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 268, tag: div, level: 13" node_number="268"> J. Clin. Med. <b class="valid" valid="valid" title="valid: True, node: 269, tag: b, level: 14" node_number="269">2021</b>, 10(24), 5808; https://doi.org/10.3390/jcm10245808 (registering&#160;DOI) - 11 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 270, tag: div, level: 13" node_number="270"> Abstract <div class="valid" valid="valid" title="valid: True, node: 271, tag: div, level: 14" node_number="271"> Sarcoidosis is a systemic granulomatous disease of unknown etiology, and its clinical presentation depends on the affected organ. Cardiac sarcoidosis (CS) is one of the leading causes of death among patients with sarcoidosis. The clinical manifestations of CS are heterogeneous, and range from [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 272, tag: div, level: 14" node_number="272"> Sarcoidosis is a systemic granulomatous disease of unknown etiology, and its clinical presentation depends on the affected organ. Cardiac sarcoidosis (CS) is one of the leading causes of death among patients with sarcoidosis. The clinical manifestations of CS are heterogeneous, and range from asymptomatic to life-threatening arrhythmias and progressive heart failure due to the extent and location of granulomatous inflammation in the myocardium. Advances in imaging techniques have played a pivotal role in the evaluation of CS because histological diagnoses obtained by myocardial biopsy tend to have lower sensitivity. The diagnosis of CS is challenging, and several approaches, notably those using positron emission tomography and cardiac magnetic resonance imaging (MRI), have been reported. Delayed-enhanced computed tomography (CT) may also be used for diagnosing CS in patients with MRI-incompatible devices and allows acceptable evaluation of myocardial hyperenhancement in such patients. This article reviews the advances in imaging techniques for the evaluation of CS. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 273, tag: div, level: 13" node_number="273"> (This article belongs to the Special Issue New Frontiers in the Diagnosis of Sarcoidosis) </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 274, tag: div, level: 10" node_number="274"> <div class="valid" valid="valid" title="valid: True, node: 275, tag: div, level: 11" node_number="275"> <div class="valid" valid="valid" title="valid: True, node: 276, tag: div, level: 12" node_number="276"> <div class="valid" valid="valid" title="valid: True, node: 277, tag: div, level: 13" node_number="277"> <a class="valid" valid="valid" title="valid: True, node: 278, tag: a, level: 14" node_number="278"> <i title="valid: False, node: 279, tag: i, level: 15" node_number="279">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 280, tag: div, level: 13" node_number="280"> <a class="valid" valid="valid" title="valid: True, node: 281, tag: a, level: 14" node_number="281"> <i title="valid: False, node: 282, tag: i, level: 15" node_number="282">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 283, tag: div, level: 14" node_number="283"> View online as: Abstract Page </div> </div> <div class="valid" valid="valid" title="valid: True, node: 284, tag: div, level: 13" node_number="284">Open AccessArticle</div> Prognostic Implications of a Modified Seattle Heart Failure Model Score following Transcatheter Aortic Valve Replacement <div class="valid" valid="valid" title="valid: True, node: 285, tag: div, level: 13" node_number="285"> by <span class="valid" valid="valid" title="valid: True, node: 286, tag: span, level: 14" node_number="286"><div title="valid: False, node: 287, tag: div, level: 15" node_number="287">Teruhiko Imamura</div>, </span><span class="valid" valid="valid" title="valid: True, node: 288, tag: span, level: 14" node_number="288"><div title="valid: False, node: 289, tag: div, level: 15" node_number="289">Nikhil Narang</div>, </span><span class="valid" valid="valid" title="valid: True, node: 290, tag: span, level: 14" node_number="290"><div title="valid: False, node: 291, tag: div, level: 15" node_number="291">Hiroshi Onoda</div>, </span><span class="valid" valid="valid" title="valid: True, node: 292, tag: span, level: 14" node_number="292"><div title="valid: False, node: 293, tag: div, level: 15" node_number="293">Shuhei Tanaka</div>, </span><span class="valid" valid="valid" title="valid: True, node: 294, tag: span, level: 14" node_number="294"><div title="valid: False, node: 295, tag: div, level: 15" node_number="295">Ryuichi Ushijima</div>, </span><span class="valid" valid="valid" title="valid: True, node: 296, tag: span, level: 14" node_number="296"><div title="valid: False, node: 297, tag: div, level: 15" node_number="297">Mitsuo Sobajima</div>, </span><span class="valid" valid="valid" title="valid: True, node: 298, tag: span, level: 14" node_number="298"><div title="valid: False, node: 299, tag: div, level: 15" node_number="299">Nobuyuki Fukuda</div>, </span><span class="valid" valid="valid" title="valid: True, node: 300, tag: span, level: 14" node_number="300"><div title="valid: False, node: 301, tag: div, level: 15" node_number="301">Hiroshi Ueno</div> and </span><span class="valid" valid="valid" title="valid: True, node: 302, tag: span, level: 14" node_number="302"><div title="valid: False, node: 303, tag: div, level: 15" node_number="303">Koichiro Kinugawa</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 304, tag: div, level: 13" node_number="304"> J. Clin. Med. <b class="valid" valid="valid" title="valid: True, node: 305, tag: b, level: 14" node_number="305">2021</b>, 10(24), 5807; https://doi.org/10.3390/jcm10245807 (registering&#160;DOI) - 11 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 306, tag: div, level: 13" node_number="306"> Abstract <div class="valid" valid="valid" title="valid: True, node: 307, tag: div, level: 14" node_number="307"> Background: The Seattle heart failure model (SHFM) score is a well-known risk predictor of mortality in patients with heart failure. We validated this score in patients receiving transcatheter aortic valve replacement (TAVR) and aimed to generate further risk discrimination by adding invasive hemodynamics [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 308, tag: div, level: 14" node_number="308"> Background: The Seattle heart failure model (SHFM) score is a well-known risk predictor of mortality in patients with heart failure. We validated this score in patients receiving transcatheter aortic valve replacement (TAVR) and aimed to generate further risk discrimination by adding invasive hemodynamics parameters. Methods:<b title="valid: False, node: 309, tag: b, level: 15" node_number="309"> </b>Patients who underwent TAVR at our institute between 2015 and 2020 were included and followed for 2 years from index discharge. Patients were randomly assigned to the derivation cohort or the validation cohort. In the derivation cohort, the original SHFM score was modified by adding baseline hemodynamics parameters to evaluate the primary outcomes: 2-year incidence of mortality or readmission from heart failure. The model performance of the modified SHFM score was evaluated in the validation cohort. Results:<b title="valid: False, node: 310, tag: b, level: 15" node_number="310"> </b>A total of 217 patients (median age: 86 (83, 88) years old, 64 (29%) men) were included. From the derivation cohort (N = 108), a novel modified SHFM score was constructed: 6 &#215; (original SHFM score &lt;88.1%) + 5 &#215; (pulmonary capillary wedge pressure &gt; 14 mmHg) + 4 &#215; (cardiac index &lt; 2.26 L/min/m<sup title="valid: False, node: 311, tag: sup, level: 15" node_number="311">2</sup>), which had an improved discrimination compared with the original model (area under the curve: 0.887 versus 0.679, <i title="valid: False, node: 312, tag: i, level: 15" node_number="312">p</i> = 0.014). In the validation cohort (<i title="valid: False, node: 313, tag: i, level: 15" node_number="313">N</i> = 109), the modified SHFM score showed accurate predictive discrimination of the 2-year cumulative incidence of the primary endpoint into three groups (a low score group with 0&#8211;5 points, 3%; an intermediate score group with 6&#8211;10 points, 12%; and a high score group with 11&#8211;15 points, 43%, <i title="valid: False, node: 314, tag: i, level: 15" node_number="314">p</i> &lt; 0.001). Conclusion:<b title="valid: False, node: 315, tag: b, level: 15" node_number="315"> </b>A modified SHFM score consisting of the original SHFM score and invasive hemodynamics parameters predicted mortality and morbidity following TAVR. Evaluation of the external validity of this score in other cohorts needs further investigation. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 316, tag: div, level: 13" node_number="316"> (This article belongs to the Special Issue Transcatheter Aortic Valve Replacement in 2021 and Beyond) </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 317, tag: div, level: 10" node_number="317"> <div class="valid" valid="valid" title="valid: True, node: 318, tag: div, level: 11" node_number="318"> <div class="valid" valid="valid" title="valid: True, node: 319, tag: div, level: 12" node_number="319"> <div class="valid" valid="valid" title="valid: True, node: 320, tag: div, level: 13" node_number="320"> <a class="valid" valid="valid" title="valid: True, node: 321, tag: a, level: 14" node_number="321"> <i title="valid: False, node: 322, tag: i, level: 15" node_number="322">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 323, tag: div, level: 14" node_number="323"> Supplementary material: Supplementary File 1 (ZIP, 102 KiB) </div> </div> <div class="valid" valid="valid" title="valid: True, node: 324, tag: div, level: 13" node_number="324"> <a class="valid" valid="valid" title="valid: True, node: 325, tag: a, level: 14" node_number="325"> <i title="valid: False, node: 326, tag: i, level: 15" node_number="326">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 327, tag: div, level: 13" node_number="327"> <a class="valid" valid="valid" title="valid: True, node: 328, tag: a, level: 14" node_number="328"> <i title="valid: False, node: 329, tag: i, level: 15" node_number="329">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 330, tag: div, level: 14" node_number="330"> View online as: Abstract Page </div> </div> <div class="valid" valid="valid" title="valid: True, node: 331, tag: div, level: 13" node_number="331">Open AccessArticle</div> Physician-Led Thoracic Trauma Management in a Specialist Emergency Care Centre <div class="valid" valid="valid" title="valid: True, node: 332, tag: div, level: 13" node_number="332"> by <span class="valid" valid="valid" title="valid: True, node: 333, tag: span, level: 14" node_number="333"><div title="valid: False, node: 334, tag: div, level: 15" node_number="334">Jonathan Bates-Powell</div>, </span><span class="valid" valid="valid" title="valid: True, node: 335, tag: span, level: 14" node_number="335"><div title="valid: False, node: 336, tag: div, level: 15" node_number="336">David Basterfield</div>, </span><span class="valid" valid="valid" title="valid: True, node: 337, tag: span, level: 14" node_number="337"><div title="valid: False, node: 338, tag: div, level: 15" node_number="338">Karl Jackson</div> and </span><span class="valid" valid="valid" title="valid: True, node: 339, tag: span, level: 14" node_number="339"><div title="valid: False, node: 340, tag: div, level: 15" node_number="340">Avinash Aujayeb</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 341, tag: div, level: 13" node_number="341"> J. Clin. Med. <b class="valid" valid="valid" title="valid: True, node: 342, tag: b, level: 14" node_number="342">2021</b>, 10(24), 5806; https://doi.org/10.3390/jcm10245806 (registering&#160;DOI) - 11 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 343, tag: div, level: 13" node_number="343"> Abstract <div class="valid" valid="valid" title="valid: True, node: 344, tag: div, level: 14" node_number="344"> Introduction: Falls cause 75% of trauma in patients above 65 years of age, and thoracic trauma is the second commonest injury; rib fractures are the most common thoracic injury. These patients have up to 12% mortality, with 31% developing pneumonias. There is wide [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 345, tag: div, level: 14" node_number="345"> Introduction: Falls cause 75% of trauma in patients above 65 years of age, and thoracic trauma is the second commonest injury; rib fractures are the most common thoracic injury. These patients have up to 12% mortality, with 31% developing pneumonias. There is wide variation in care. Northumbria Healthcare has a team of respiratory consultants, physiotherapists, specialist nurses and anesthetists for thoracic-trauma management on a respiratory support unit. Methods: With Caldicott approval, basic demographics and clinical outcomes of patients admitted with thoracic trauma between 20 August 20&#8211;21 Aprilwere analyzed. A descriptive statistical methodology was applied. Results: A total of 119 patients were identified with a mean age of 71.1 years (range 23&#8211;97). Of the 119 patients, 53 were male, 66 females. The main mechanism of injury was falls from standing (65) and falls down stairs/bed or in the bath (18). Length of stay was 7.3 days (range 1&#8211;54). In total, 85 patients had more than one co-morbidity, 26 had a full trauma assessment and 75 had pan CTs. The mean number of rib fractures was 3.6 and 31 (26%) patients had a pneumothorax and/or haemothorax. A total of 18 chest drains were inserted (all small bore) and one needle aspiration was performed. No cardiothoracic input was required. Isolated chest trauma was present only in 45 patients. All patients had a pain team review, 22 erector spinae catheters were inserted with 2 paravertebral blocks. Overall, 82 patients did not require oxygen, 1 required CPAP and 1 HFNC. 7 needed intensive care transfer. Furthermore, 20 (17%) developed pneumonias and 16 (14%) deaths occurred within 30 days&#8212;all were in those with falls from standing. There was no correlation between number of fractured ribs, length of stay and mortality. Conclusions: High level care for thoracic trauma can be performed by a physician led team. Overall, 42% pneumothoraces/haemothoraces were observed. Further large scale randomised trials are warranted for definitive outcomes. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 346, tag: div, level: 13" node_number="346"> (This article belongs to the Special Issue Acute Care and Medication Management in Older Adults) </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 347, tag: div, level: 10" node_number="347"> <div class="valid" valid="valid" title="valid: True, node: 348, tag: div, level: 11" node_number="348"> <div class="valid" valid="valid" title="valid: True, node: 349, tag: div, level: 12" node_number="349"> <div class="valid" valid="valid" title="valid: True, node: 350, tag: div, level: 13" node_number="350"> <a class="valid" valid="valid" title="valid: True, node: 351, tag: a, level: 14" node_number="351"> <i title="valid: False, node: 352, tag: i, level: 15" node_number="352">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 353, tag: div, level: 13" node_number="353"> <a class="valid" valid="valid" title="valid: True, node: 354, tag: a, level: 14" node_number="354"> <i title="valid: False, node: 355, tag: i, level: 15" node_number="355">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 356, tag: div, level: 14" node_number="356"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 357, tag: div, level: 13" node_number="357">Open AccessReview</div> Shedding Light on Targeting Chronic Myeloid Leukemia Stem Cells <div class="valid" valid="valid" title="valid: True, node: 358, tag: div, level: 13" node_number="358"> by <span class="valid" valid="valid" title="valid: True, node: 359, tag: span, level: 14" node_number="359"><div title="valid: False, node: 360, tag: div, level: 15" node_number="360">Mohammad Houshmand</div>, </span><span class="valid" valid="valid" title="valid: True, node: 361, tag: span, level: 14" node_number="361"><div title="valid: False, node: 362, tag: div, level: 15" node_number="362">Alireza Kazemi</div>, </span><span class="valid" valid="valid" title="valid: True, node: 363, tag: span, level: 14" node_number="363"><div title="valid: False, node: 364, tag: div, level: 15" node_number="364">Ali Anjam Najmedini</div>, </span><span class="valid" valid="valid" title="valid: True, node: 365, tag: span, level: 14" node_number="365"><div title="valid: False, node: 366, tag: div, level: 15" node_number="366">Muhammad Shahzad Ali</div>, </span><span class="valid" valid="valid" title="valid: True, node: 367, tag: span, level: 14" node_number="367"><div title="valid: False, node: 368, tag: div, level: 15" node_number="368">Valentina Gaidano</div>, </span><span class="valid" valid="valid" title="valid: True, node: 369, tag: span, level: 14" node_number="369"><div title="valid: False, node: 370, tag: div, level: 15" node_number="370">Alessandro Cignetti</div>, </span><span class="valid" valid="valid" title="valid: True, node: 371, tag: span, level: 14" node_number="371"><div title="valid: False, node: 372, tag: div, level: 15" node_number="372">Carmen Fava</div>, </span><span class="valid" valid="valid" title="valid: True, node: 373, tag: span, level: 14" node_number="373"><div title="valid: False, node: 374, tag: div, level: 15" node_number="374">Daniela Cilloni</div>, </span><span class="valid" valid="valid" title="valid: True, node: 375, tag: span, level: 14" node_number="375"><div title="valid: False, node: 376, tag: div, level: 15" node_number="376">Giuseppe Saglio</div> and </span><span class="valid" valid="valid" title="valid: True, node: 377, tag: span, level: 14" node_number="377"><div title="valid: False, node: 378, tag: div, level: 15" node_number="378">Paola Circosta</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 379, tag: div, level: 13" node_number="379"> J. Clin. Med. <b class="valid" valid="valid" title="valid: True, node: 380, tag: b, level: 14" node_number="380">2021</b>, 10(24), 5805; https://doi.org/10.3390/jcm10245805 (registering&#160;DOI) - 11 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 381, tag: div, level: 13" node_number="381"> Abstract <div class="valid" valid="valid" title="valid: True, node: 382, tag: div, level: 14" node_number="382"> Chronic myeloid leukemia stem cells (CML LSCs) are a rare and quiescent population that are resistant to tyrosine kinase inhibitors (TKI). When TKI therapy is discontinued in CML patients in deep, sustained and apparently stable molecular remission, these cells in approximately half of [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 383, tag: div, level: 14" node_number="383"> Chronic myeloid leukemia stem cells (CML LSCs) are a rare and quiescent population that are resistant to tyrosine kinase inhibitors (TKI). When TKI therapy is discontinued in CML patients in deep, sustained and apparently stable molecular remission, these cells in approximately half of the cases restart to grow, resuming the leukemic process. The elimination of these TKI resistant leukemic stem cells is therefore an essential step in increasing the percentage of those patients who can reach a successful long-term treatment free remission (TFR). The understanding of the biology of the LSCs and the identification of the differences, phenotypic and/or metabolic, that could eventually allow them to be distinguished from the normal hematopoietic stem cells (HSCs) are therefore important steps in designing strategies to target LSCs in a rather selective way, sparing the normal counterparts. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 384, tag: div, level: 13" node_number="384"> (This article belongs to the Special Issue Prognosis and Therapy of Chronic Myeloid Leukemia) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 385, tag: div, level: 13" node_number="385"><div class="valid" valid="valid" title="valid: True, node: 386, tag: div, level: 14" node_number="386"><div title="valid: False, node: 387, tag: div, level: 15" node_number="387"><p title="valid: False, node: 388, tag: p, level: 16" node_number="388">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 389, tag: div, level: 10" node_number="389"> <div class="valid" valid="valid" title="valid: True, node: 390, tag: div, level: 11" node_number="390"> <div class="valid" valid="valid" title="valid: True, node: 391, tag: div, level: 12" node_number="391"> <div class="valid" valid="valid" title="valid: True, node: 392, tag: div, level: 13" node_number="392"> <a class="valid" valid="valid" title="valid: True, node: 393, tag: a, level: 14" node_number="393"> <i title="valid: False, node: 394, tag: i, level: 15" node_number="394">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 395, tag: div, level: 13" node_number="395"> <a class="valid" valid="valid" title="valid: True, node: 396, tag: a, level: 14" node_number="396"> <i title="valid: False, node: 397, tag: i, level: 15" node_number="397">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 398, tag: div, level: 14" node_number="398"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 399, tag: div, level: 13" node_number="399">Open AccessArticle</div> Alpha Smooth Muscle Actin (&#945;SMA) Immunohistochemistry Use in the Differentiation of Pancreatic Cancer from Chronic Pancreatitis <div class="valid" valid="valid" title="valid: True, node: 400, tag: div, level: 13" node_number="400"> by <span class="valid" valid="valid" title="valid: True, node: 401, tag: span, level: 14" node_number="401"><div title="valid: False, node: 402, tag: div, level: 15" node_number="402">Katarzyna Winter</div>, </span><span class="valid" valid="valid" title="valid: True, node: 403, tag: span, level: 14" node_number="403"><div title="valid: False, node: 404, tag: div, level: 15" node_number="404">Monika Dzieniecka</div>, </span><span class="valid" valid="valid" title="valid: True, node: 405, tag: span, level: 14" node_number="405"><div title="valid: False, node: 406, tag: div, level: 15" node_number="406">Janusz Strzelczyk</div>, </span><span class="valid" valid="valid" title="valid: True, node: 407, tag: span, level: 14" node_number="407"><div title="valid: False, node: 408, tag: div, level: 15" node_number="408">Ma&#322;gorzata W&#261;growska-Danilewicz</div>, </span><span class="valid" valid="valid" title="valid: True, node: 409, tag: span, level: 14" node_number="409"><div title="valid: False, node: 410, tag: div, level: 15" node_number="410">Marian Danilewicz</div> and </span><span class="valid" valid="valid" title="valid: True, node: 411, tag: span, level: 14" node_number="411"><div title="valid: False, node: 412, tag: div, level: 15" node_number="412">Ewa Ma&#322;ecka-Wojcieszko</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 413, tag: div, level: 13" node_number="413"> J. Clin. Med. <b class="valid" valid="valid" title="valid: True, node: 414, tag: b, level: 14" node_number="414">2021</b>, 10(24), 5804; https://doi.org/10.3390/jcm10245804 (registering&#160;DOI) - 11 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 415, tag: div, level: 13" node_number="415"> Abstract <div class="valid" valid="valid" title="valid: True, node: 416, tag: div, level: 14" node_number="416"> Aim: Fibrosis is observed both in pancreatic cancer (PDAC) and chronic pancreatitis (CP). The main cells involved in fibrosis are pancreatic stellate cells (PSCs), which activate alpha smooth muscle actin (&#945;SMA), which is considered to be the best-known fibrosis marker. The aim of [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 417, tag: div, level: 14" node_number="417"> Aim: Fibrosis is observed both in pancreatic cancer (PDAC) and chronic pancreatitis (CP). The main cells involved in fibrosis are pancreatic stellate cells (PSCs), which activate alpha smooth muscle actin (&#945;SMA), which is considered to be the best-known fibrosis marker. The aim of the study was to evaluate the expression of the &#945;SMA in patients with PDAC and CP as the possible differentiation marker. Methods: We enrolled 114 patients undergoing pancreatic resection: 83 with PDAC and 31 with CP. Normal fragments of resected specimen from 21 patients represented the control tissue. The immunoexpressions of &#945;SMA were detected in tissue specimens with immunohistochemistry (Abcam antibodies, GB). Results: Mean cytoplasmatic expression of &#945;SMA protein in PDAC stromal cells was significantly higher compared to CP: 2.42 &#177; 0.37 vs 1.95 &#177; 0.45 (<i title="valid: False, node: 418, tag: i, level: 15" node_number="418">p</i> &lt; 0.01) and control group 0.61 &#177; 0.45 (<i title="valid: False, node: 419, tag: i, level: 15" node_number="419">p</i> &lt; 0.01). Strong immunoexpression of the &#945;SMA protein was found in the vast majority (80.7%) of patients with PDAC, in about half (58%) of patients with CP, and not at all in healthy tissue. The expression of &#945;SMA of different intensity was found in all patients with PDAC and CP, while in healthy tissue was minimal or absent. In PDAC patients, &#945;SMA expression was significantly higher in tumors of diameter higher than 3 cm compared to smaller ones (<i title="valid: False, node: 420, tag: i, level: 15" node_number="420">p</i> = 0.017). Conclusions: Presented findings confirm the significant role of fibrosis in both PDAC and CP; however, they do not confirm the role of &#945;SMA as a marker of differentiation. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 421, tag: div, level: 13" node_number="421"> (This article belongs to the Special Issue Pancreatic Cancer: Biomarkers, Risk Factors, Early Detection) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 422, tag: div, level: 13" node_number="422"><div class="valid" valid="valid" title="valid: True, node: 423, tag: div, level: 14" node_number="423"><div title="valid: False, node: 424, tag: div, level: 15" node_number="424"><p title="valid: False, node: 425, tag: p, level: 16" node_number="425">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 426, tag: div, level: 10" node_number="426"> <div class="valid" valid="valid" title="valid: True, node: 427, tag: div, level: 11" node_number="427"> <div class="valid" valid="valid" title="valid: True, node: 428, tag: div, level: 12" node_number="428"> <div class="valid" valid="valid" title="valid: True, node: 429, tag: div, level: 13" node_number="429"> <a class="valid" valid="valid" title="valid: True, node: 430, tag: a, level: 14" node_number="430"> <i title="valid: False, node: 431, tag: i, level: 15" node_number="431">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 432, tag: div, level: 13" node_number="432"> <a class="valid" valid="valid" title="valid: True, node: 433, tag: a, level: 14" node_number="433"> <i title="valid: False, node: 434, tag: i, level: 15" node_number="434">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 435, tag: div, level: 14" node_number="435"> View online as: Abstract Page </div> </div> <div class="valid" valid="valid" title="valid: True, node: 436, tag: div, level: 13" node_number="436">Open AccessArticle</div> Is It Possible to Predict Clonal Thrombocytosis in Triple-Negative Patients with Isolated Thrombocytosis Based Only on Clinical or Blood Findings? <div class="valid" valid="valid" title="valid: True, node: 437, tag: div, level: 13" node_number="437"> by <span class="valid" valid="valid" title="valid: True, node: 438, tag: span, level: 14" node_number="438"><div title="valid: False, node: 439, tag: div, level: 15" node_number="439">Tanja Bel&#269;i&#269; Miki&#269;</div>, </span><span class="valid" valid="valid" title="valid: True, node: 440, tag: span, level: 14" node_number="440"><div title="valid: False, node: 441, tag: div, level: 15" node_number="441">Bor Vratanar</div>, </span><span class="valid" valid="valid" title="valid: True, node: 442, tag: span, level: 14" node_number="442"><div title="valid: False, node: 443, tag: div, level: 15" node_number="443">Tadej Paji&#269;</div>, </span><span class="valid" valid="valid" title="valid: True, node: 444, tag: span, level: 14" node_number="444"><div title="valid: False, node: 445, tag: div, level: 15" node_number="445">Sa&#353;a An&#382;ej Doma</div>, </span><span class="valid" valid="valid" title="valid: True, node: 446, tag: span, level: 14" node_number="446"><div title="valid: False, node: 447, tag: div, level: 15" node_number="447">Nata&#353;a Debeljak</div>, </span><span class="valid" valid="valid" title="valid: True, node: 448, tag: span, level: 14" node_number="448"><div title="valid: False, node: 449, tag: div, level: 15" node_number="449">Irena Prelo&#382;nik Zupan</div>, </span><span class="valid" valid="valid" title="valid: True, node: 450, tag: span, level: 14" node_number="450"><div title="valid: False, node: 451, tag: div, level: 15" node_number="451">Matja&#382; Sever</div> and </span><span class="valid" valid="valid" title="valid: True, node: 452, tag: span, level: 14" node_number="452"><div title="valid: False, node: 453, tag: div, level: 15" node_number="453">Samo Zver</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 454, tag: div, level: 13" node_number="454"> J. Clin. Med. <b class="valid" valid="valid" title="valid: True, node: 455, tag: b, level: 14" node_number="455">2021</b>, 10(24), 5803; https://doi.org/10.3390/jcm10245803 (registering&#160;DOI) - 11 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 456, tag: div, level: 13" node_number="456"> Abstract <div class="valid" valid="valid" title="valid: True, node: 457, tag: div, level: 14" node_number="457"> <i title="valid: False, node: 458, tag: i, level: 15" node_number="458">JAK2</i>, <i title="valid: False, node: 459, tag: i, level: 15" node_number="459">MPL,</i> and <i title="valid: False, node: 460, tag: i, level: 15" node_number="460">CALR</i> mutations define clonal thrombocytosis in about 90% of patients with sustained isolated thrombocytosis. In the remainder of patients (triple-negative patients) diagnosing clonal thrombocytosis is especially difficult due to the different underlying conditions and possible inconclusive bone marrow biopsy [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 461, tag: div, level: 14" node_number="461"> <i title="valid: False, node: 462, tag: i, level: 15" node_number="462">JAK2</i>, <i title="valid: False, node: 463, tag: i, level: 15" node_number="463">MPL,</i> and <i title="valid: False, node: 464, tag: i, level: 15" node_number="464">CALR</i> mutations define clonal thrombocytosis in about 90% of patients with sustained isolated thrombocytosis. In the remainder of patients (triple-negative patients) diagnosing clonal thrombocytosis is especially difficult due to the different underlying conditions and possible inconclusive bone marrow biopsy results. The ability to predict patients with sustained isolated thrombocytosis with a potential clonal origin has a prognostic value and warrants further examination. The aim of our study was to define a non-invasive clinical or blood parameter that could help predict clonal thrombocytosis in triple-negative patients. We studied 237 <i title="valid: False, node: 465, tag: i, level: 15" node_number="465">JAK2</i> V617-negative patients who were diagnosed with isolated thrombocytosis and referred to the haematology service. Sixteen routine clinical and blood parameters were included in the logistic regression model which was used to predict the type of thrombocytosis (reactive/clonal). Platelet count and lactate dehydrogenase (LDH) were the only statistically significant predictors of clonal thrombocytosis. The platelet count threshold for the most accurate prediction of clonal or reactive thrombocytosis was 449 &#215; 10<sup title="valid: False, node: 466, tag: sup, level: 15" node_number="466">9</sup>/L. Other tested clinical and blood parameters were not statistically significant predictors of clonal thrombocytosis. The level of LDH was significantly higher in <i title="valid: False, node: 467, tag: i, level: 15" node_number="467">CALR</i>-positive patients compared to <i title="valid: False, node: 468, tag: i, level: 15" node_number="468">CALR</i>-negative patients. We did not identify any new clinical or blood parameters that could distinguish clonal from reactive thrombocytosis. When diagnosing clonal thrombocytosis triple-negative patients are most likely to be misdiagnosed. Treatment in patients with suspected triple negative clonal thrombocytosis should not be delayed if cardiovascular risk factors or pregnancy coexist, even in the absence of firm diagnostic criteria. In those cases the approach &#8220;better treat more than less&#8221; should be followed. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 469, tag: div, level: 13" node_number="469"> (This article belongs to the Special Issue Diagnosis and Management of Blood Diseases) </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 470, tag: div, level: 10" node_number="470"> <div class="valid" valid="valid" title="valid: True, node: 471, tag: div, level: 11" node_number="471"> <div class="valid" valid="valid" title="valid: True, node: 472, tag: div, level: 12" node_number="472"> <div class="valid" valid="valid" title="valid: True, node: 473, tag: div, level: 13" node_number="473"> <a class="valid" valid="valid" title="valid: True, node: 474, tag: a, level: 14" node_number="474"> <i title="valid: False, node: 475, tag: i, level: 15" node_number="475">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 476, tag: div, level: 13" node_number="476"> <a class="valid" valid="valid" title="valid: True, node: 477, tag: a, level: 14" node_number="477"> <i title="valid: False, node: 478, tag: i, level: 15" node_number="478">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 479, tag: div, level: 14" node_number="479"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 480, tag: div, level: 13" node_number="480">Open AccessArticle</div> Measuring and Predicting Maturity to Parenthood: What Has Personality Got to Do with It? <div class="valid" valid="valid" title="valid: True, node: 481, tag: div, level: 13" node_number="481"> by <span class="valid" valid="valid" title="valid: True, node: 482, tag: span, level: 14" node_number="482"><div title="valid: False, node: 483, tag: div, level: 15" node_number="483">Ariadna Beata &#321;ada-Ma&#347;ko</div> and </span><span class="valid" valid="valid" title="valid: True, node: 484, tag: span, level: 14" node_number="484"><div title="valid: False, node: 485, tag: div, level: 15" node_number="485">Maria Ka&#378;mierczak</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 486, tag: div, level: 13" node_number="486"> J. Clin. Med. <b class="valid" valid="valid" title="valid: True, node: 487, tag: b, level: 14" node_number="487">2021</b>, 10(24), 5802; https://doi.org/10.3390/jcm10245802 (registering&#160;DOI) - 11 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 488, tag: div, level: 13" node_number="488"> Abstract <div class="valid" valid="valid" title="valid: True, node: 489, tag: div, level: 14" node_number="489"> Maturity to parenthood is essential for taking on parental roles but remains an understudied issue. Still, close relations between maturity and personality dimensions are commonly emphasized. Thus, conducting research on maturity in context of personality seems a valuable research direction. The present research [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 490, tag: div, level: 14" node_number="490"> Maturity to parenthood is essential for taking on parental roles but remains an understudied issue. Still, close relations between maturity and personality dimensions are commonly emphasized. Thus, conducting research on maturity in context of personality seems a valuable research direction. The present research consists of two studies, focusing on the development and validation of Maturity to Parenthood Scale (MPS), in relation to personality, emotional regulation, coping with challenges, and intimate relationship satisfaction. In both studies, childless adults aged 20&#8211;35 years took part: (1) 718 participants (<i title="valid: False, node: 491, tag: i, level: 15" node_number="491">M</i><sub title="valid: False, node: 492, tag: sub, level: 15" node_number="492">age</sub> = 25.49; <i title="valid: False, node: 493, tag: i, level: 15" node_number="493">SD</i> = 2.89; 479 women), (2) 150 participants (<i title="valid: False, node: 494, tag: i, level: 15" node_number="494">M</i><sub title="valid: False, node: 495, tag: sub, level: 15" node_number="495">age</sub> = 23.69; <i title="valid: False, node: 496, tag: i, level: 15" node_number="496">SD</i> = 3.15; 104 women). All the participants had been in an intimate relationship for at least six months at the time of the study, the majority declared their willingness to have children in the future, had higher education, and were professionally active. The results showed that MPS is a reliable, valid measure comprising the following three subscales: valence, behavioral, and cognitive&#8211;emotional maturity to parenthood. The findings also confirmed the importance of broad- and narrow-band individual differences and contextual factors for maturity. MPS may be used in psychoeducation, supporting the transition to biological or adoptive/foster parenthood, as well as in medical and psychological care. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 497, tag: div, level: 13" node_number="497"> (This article belongs to the Special Issue Personality Psychology: Clinical Application and Future Directions) </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 498, tag: div, level: 10" node_number="498"> <div class="valid" valid="valid" title="valid: True, node: 499, tag: div, level: 11" node_number="499"> <div class="valid" valid="valid" title="valid: True, node: 500, tag: div, level: 12" node_number="500"> <div class="valid" valid="valid" title="valid: True, node: 501, tag: div, level: 13" node_number="501"> <a class="valid" valid="valid" title="valid: True, node: 502, tag: a, level: 14" node_number="502"> <i title="valid: False, node: 503, tag: i, level: 15" node_number="503">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 504, tag: div, level: 13" node_number="504"> <a class="valid" valid="valid" title="valid: True, node: 505, tag: a, level: 14" node_number="505"> <i title="valid: False, node: 506, tag: i, level: 15" node_number="506">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 507, tag: div, level: 14" node_number="507"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 508, tag: div, level: 13" node_number="508">Open AccessArticle</div> Effect of Intra-Articular Injection of Platelet-Rich Plasma on the Serum Levels of Osteoarthritic Biomarkers in Patients with Unilateral Knee Osteoarthritis <div class="valid" valid="valid" title="valid: True, node: 509, tag: div, level: 13" node_number="509"> by <span class="valid" valid="valid" title="valid: True, node: 510, tag: span, level: 14" node_number="510"><div title="valid: False, node: 511, tag: div, level: 15" node_number="511">Marek Lacko</div>, </span><span class="valid" valid="valid" title="valid: True, node: 512, tag: span, level: 14" node_number="512"><div title="valid: False, node: 513, tag: div, level: 15" node_number="513">Denisa Harvanov&#225;</div>, </span><span class="valid" valid="valid" title="valid: True, node: 514, tag: span, level: 14" node_number="514"><div title="valid: False, node: 515, tag: div, level: 15" node_number="515">Lucia Slovinsk&#225;</div>, </span><span class="valid" valid="valid" title="valid: True, node: 516, tag: span, level: 14" node_number="516"><div title="valid: False, node: 517, tag: div, level: 15" node_number="517">Martin Matu&#353;ka</div>, </span><span class="valid" valid="valid" title="valid: True, node: 518, tag: span, level: 14" node_number="518"><div title="valid: False, node: 519, tag: div, level: 15" node_number="519">Marek Balog</div>, </span><span class="valid" valid="valid" title="valid: True, node: 520, tag: span, level: 14" node_number="520"><div title="valid: False, node: 521, tag: div, level: 15" node_number="521">Ant&#243;nia Lackov&#225;</div>, </span><span class="valid" valid="valid" title="valid: True, node: 522, tag: span, level: 14" node_number="522"><div title="valid: False, node: 523, tag: div, level: 15" node_number="523">Timea &#352;pakov&#225;</div> and </span><span class="valid" valid="valid" title="valid: True, node: 524, tag: span, level: 14" node_number="524"><div title="valid: False, node: 525, tag: div, level: 15" node_number="525">J&#225;n Rosocha</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 526, tag: div, level: 13" node_number="526"> J. Clin. Med. <b class="valid" valid="valid" title="valid: True, node: 527, tag: b, level: 14" node_number="527">2021</b>, 10(24), 5801; https://doi.org/10.3390/jcm10245801 (registering&#160;DOI) - 11 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 528, tag: div, level: 13" node_number="528"> Abstract <div class="valid" valid="valid" title="valid: True, node: 529, tag: div, level: 14" node_number="529"> Background: The aim of this study is to determine the effect of three doses of intra-articular injection of platelet-rich plasma (PRP) into the osteoarthritic (OA) knee joint on the functional status and on the changes in the levels of specific OA biomarkers in [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 530, tag: div, level: 14" node_number="530"> Background: The aim of this study is to determine the effect of three doses of intra-articular injection of platelet-rich plasma (PRP) into the osteoarthritic (OA) knee joint on the functional status and on the changes in the levels of specific OA biomarkers in blood serum. Methods: Forty patients with unilateral primary knee osteoarthritis were enrolled in this single center, prospective clinical trial. For each patient, three intra-articular PRP injections were administered one week apart. Clinical and laboratory assessment was performed before the first PRP injection (baseline), and 3 months after the third PRP application (3-month follow up). Pain in the affected knee joint was assessed with the Visual Analog Scale for Pain (VAS). Change in clinical status was evaluated with the Western Ontario and McMaster Universities Arthritis Index Questionnaire (WOMAC). Concentrations of 19 biomarkers (EGF, Eotaxin, FGF-2, GRO, IL-10, IL-1RA, IL-8, IP-10, MCP-1, PDGF-AB/BB, RANTES, MMP-3, MMP-13, Collagen type 2, BMP-2, TIMP-1, TIMP-2, TGF beta 1, and COMP) in the serum of studied patients were quantified. Results: At 3-month follow up, there was a significant decrease in the VAS score and significant improvement in the WOMAC score. There was a significant decrease in the levels of Eotaxin, MCP-1, MMP-1, IL-10, EGF, PDGF-AB/BB, TGF- &#946;1 compared to baseline levels. A significant increase in markers BMP-2, COMP, Collagen type 2 and GRO was found at the same time point. There was no significant change in the concentrations of other biomarkers (FGF-2, IL-1RA, IL-8, IL-10, MMP-3, RANTES, TIMP-1, TIMP-3). Conclusions: We found an increase in specific pro-anabolic and anti-inflammatory biomarkers with a concomitant decrease in pro-inflammatory biomarkers at 3 months after three intra-articular applications of PRP. Significant improvement in VAS and WOMAC scores was observed. Treatment with PRP may be an effective therapeutic option with anti-inflammatory and regenerative potential in patients with primary knee OA. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 531, tag: div, level: 13" node_number="531"> (This article belongs to the Topic Orthopaedic Diseases and Innovative Intervention Strategies) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 532, tag: div, level: 13" node_number="532"><div class="valid" valid="valid" title="valid: True, node: 533, tag: div, level: 14" node_number="533"><div title="valid: False, node: 534, tag: div, level: 15" node_number="534"><p title="valid: False, node: 535, tag: p, level: 16" node_number="535">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 536, tag: div, level: 10" node_number="536"> <div class="valid" valid="valid" title="valid: True, node: 537, tag: div, level: 11" node_number="537"> <div class="valid" valid="valid" title="valid: True, node: 538, tag: div, level: 12" node_number="538"> <div class="valid" valid="valid" title="valid: True, node: 539, tag: div, level: 13" node_number="539"> <a class="valid" valid="valid" title="valid: True, node: 540, tag: a, level: 14" node_number="540"> <i title="valid: False, node: 541, tag: i, level: 15" node_number="541">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 542, tag: div, level: 14" node_number="542"> Supplementary material: Supplementary File 1 (ZIP, 333 KiB) </div> </div> <div class="valid" valid="valid" title="valid: True, node: 543, tag: div, level: 13" node_number="543"> <a class="valid" valid="valid" title="valid: True, node: 544, tag: a, level: 14" node_number="544"> <i title="valid: False, node: 545, tag: i, level: 15" node_number="545">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 546, tag: div, level: 13" node_number="546"> <a class="valid" valid="valid" title="valid: True, node: 547, tag: a, level: 14" node_number="547"> <i title="valid: False, node: 548, tag: i, level: 15" node_number="548">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 549, tag: div, level: 14" node_number="549"> View online as: Abstract Page </div> </div> <div class="valid" valid="valid" title="valid: True, node: 550, tag: div, level: 13" node_number="550">Open AccessArticle</div> Associations between Early Surgery and Postoperative Outcomes in Elderly Patients with Distal Femur Fracture: A Retrospective Cohort Study <div class="valid" valid="valid" title="valid: True, node: 551, tag: div, level: 13" node_number="551"> by <span class="valid" valid="valid" title="valid: True, node: 552, tag: span, level: 14" node_number="552"><div title="valid: False, node: 553, tag: div, level: 15" node_number="553">Norio Yamamoto</div>, </span><span class="valid" valid="valid" title="valid: True, node: 554, tag: span, level: 14" node_number="554"><div title="valid: False, node: 555, tag: div, level: 15" node_number="555">Hiroyuki Ohbe</div>, </span><span class="valid" valid="valid" title="valid: True, node: 556, tag: span, level: 14" node_number="556"><div title="valid: False, node: 557, tag: div, level: 15" node_number="557">Yosuke Tomita</div>, </span><span class="valid" valid="valid" title="valid: True, node: 558, tag: span, level: 14" node_number="558"><div title="valid: False, node: 559, tag: div, level: 15" node_number="559">Takashi Yorifuji</div>, </span><span class="valid" valid="valid" title="valid: True, node: 560, tag: span, level: 14" node_number="560"><div title="valid: False, node: 561, tag: div, level: 15" node_number="561">Mikio Nakajima</div>, </span><span class="valid" valid="valid" title="valid: True, node: 562, tag: span, level: 14" node_number="562"><div title="valid: False, node: 563, tag: div, level: 15" node_number="563">Yusuke Sasabuchi</div>, </span><span class="valid" valid="valid" title="valid: True, node: 564, tag: span, level: 14" node_number="564"><div title="valid: False, node: 565, tag: div, level: 15" node_number="565">Yuki Miyamoto</div>, </span><span class="valid" valid="valid" title="valid: True, node: 566, tag: span, level: 14" node_number="566"><div title="valid: False, node: 567, tag: div, level: 15" node_number="567">Hiroki Matsui</div>, </span><span class="valid" valid="valid" title="valid: True, node: 568, tag: span, level: 14" node_number="568"><div title="valid: False, node: 569, tag: div, level: 15" node_number="569">Tomoyuki Noda</div> and </span><span class="valid" valid="valid" title="valid: True, node: 570, tag: span, level: 14" node_number="570"><div title="valid: False, node: 571, tag: div, level: 15" node_number="571">Hideo Yasunaga</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 572, tag: div, level: 13" node_number="572"> J. Clin. Med. <b class="valid" valid="valid" title="valid: True, node: 573, tag: b, level: 14" node_number="573">2021</b>, 10(24), 5800; https://doi.org/10.3390/jcm10245800 (registering&#160;DOI) - 11 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 574, tag: div, level: 13" node_number="574"> Abstract <div class="valid" valid="valid" title="valid: True, node: 575, tag: div, level: 14" node_number="575"> Previous literature has provided conflicting results regarding the associations between early surgery and postoperative outcomes in elderly patients with distal femur fractures. Using data from the Japanese Diagnosis Procedure Combination inpatient database from April 2014 to March 2019, we identified elderly patients who [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 576, tag: div, level: 14" node_number="576"> Previous literature has provided conflicting results regarding the associations between early surgery and postoperative outcomes in elderly patients with distal femur fractures. Using data from the Japanese Diagnosis Procedure Combination inpatient database from April 2014 to March 2019, we identified elderly patients who underwent surgery for distal femur fracture within two days of hospital admission (early surgery group) or at three or more days after hospital admission (delayed surgery group). Of 9678 eligible patients, 1384 (14.3%) were assigned to the early surgery group. One-to-one propensity score matched analyses showed no significant difference in 30-day mortality between the early and delayed groups (0.5% versus 0.5%; risk difference, 0.0%; 95% confidence interval, &#8722;0.7% to 0.7%). Patients in the early surgery group had significantly lower proportions of the composite outcome (death or postoperative complications), shorter hospital stays, and lower total hospitalization costs than patients in the delayed surgery group. Our results showed that early surgery within two days of hospital admission for geriatric distal femur fracture was not associated with a reduction in 30-day mortality but was associated with reductions in postoperative complications and total hospitalization costs. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 577, tag: div, level: 13" node_number="577"> (This article belongs to the Special Issue Orthopedic Treatment of Diseases and Fractures in Elderly) </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 578, tag: div, level: 10" node_number="578"> <div class="valid" valid="valid" title="valid: True, node: 579, tag: div, level: 11" node_number="579"> <div class="valid" valid="valid" title="valid: True, node: 580, tag: div, level: 12" node_number="580"> <div class="valid" valid="valid" title="valid: True, node: 581, tag: div, level: 13" node_number="581"> <a class="valid" valid="valid" title="valid: True, node: 582, tag: a, level: 14" node_number="582"> <i title="valid: False, node: 583, tag: i, level: 15" node_number="583">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 584, tag: div, level: 13" node_number="584"> <a class="valid" valid="valid" title="valid: True, node: 585, tag: a, level: 14" node_number="585"> <i title="valid: False, node: 586, tag: i, level: 15" node_number="586">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 587, tag: div, level: 14" node_number="587"> View online as: Abstract Page </div> </div> <div class="valid" valid="valid" title="valid: True, node: 588, tag: div, level: 13" node_number="588">Open AccessReview</div> Long COVID a New Derivative in the Chaos of SARS-CoV-2 Infection: The Emergent Pandemic? <div class="valid" valid="valid" title="valid: True, node: 589, tag: div, level: 13" node_number="589"> by <span class="valid" valid="valid" title="valid: True, node: 590, tag: span, level: 14" node_number="590"><div title="valid: False, node: 591, tag: div, level: 15" node_number="591">Diego Fern&#225;ndez-L&#225;zaro</div>, </span><span class="valid" valid="valid" title="valid: True, node: 592, tag: span, level: 14" node_number="592"><div title="valid: False, node: 593, tag: div, level: 15" node_number="593">Nerea S&#225;nchez-Serrano</div>, </span><span class="valid" valid="valid" title="valid: True, node: 594, tag: span, level: 14" node_number="594"><div title="valid: False, node: 595, tag: div, level: 15" node_number="595">Juan Mielgo-Ayuso</div>, </span><span class="valid" valid="valid" title="valid: True, node: 596, tag: span, level: 14" node_number="596"><div title="valid: False, node: 597, tag: div, level: 15" node_number="597">Juan Luis Garc&#237;a-Hern&#225;ndez</div>, </span><span class="valid" valid="valid" title="valid: True, node: 598, tag: span, level: 14" node_number="598"><div title="valid: False, node: 599, tag: div, level: 15" node_number="599">Jer&#243;nimo J. Gonz&#225;lez-Bernal</div> and </span><span class="valid" valid="valid" title="valid: True, node: 600, tag: span, level: 14" node_number="600"><div title="valid: False, node: 601, tag: div, level: 15" node_number="601">Jes&#250;s Seco-Calvo</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 602, tag: div, level: 13" node_number="602"> J. Clin. Med. <b class="valid" valid="valid" title="valid: True, node: 603, tag: b, level: 14" node_number="603">2021</b>, 10(24), 5799; https://doi.org/10.3390/jcm10245799 (registering&#160;DOI) - 11 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 604, tag: div, level: 13" node_number="604"> Abstract <div class="valid" valid="valid" title="valid: True, node: 605, tag: div, level: 14" node_number="605"> Coronavirus disease 2019 (COVID-19) is a multisystem illness caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which can manifest with a multitude of symptoms in the setting of end-organ damage, though it is predominantly respiratory. However, various symptoms may remain after acute [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 606, tag: div, level: 14" node_number="606"> Coronavirus disease 2019 (COVID-19) is a multisystem illness caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which can manifest with a multitude of symptoms in the setting of end-organ damage, though it is predominantly respiratory. However, various symptoms may remain after acute SARS-CoV-2 infection, and this condition is referred to as &#8220;Long COVID&#8221; (LC). Patients with LC may develop multi-organ symptom complex that remains 4&#8211;12 weeks after the acute phase of illness, with symptoms intermittently persisting over time. The main symptoms are fatigue, post-exertional malaise, cognitive dysfunction, and limitation of functional capacity. Pediatric patients developed the main symptoms of LC like those described in adults, although there may be variable presentations of LC in children. The underlying mechanisms of LC are not clearly known, although they may involve pathophysiological changes generated by virus persistence, immunological alterations secondary to virus&#8211;host interaction, tissue damage of inflammatory origin and hyperactivation of coagulation. Risk factors for developing LC would be female sex, more than five early symptoms, early dyspnea, previous psychiatric disorders, and alterations in immunological, inflammatory and coagulation parameters. There is currently no specific treatment for LC, but it could include pharmacological treatments to treat symptoms, supplements to restore nutritional, metabolic, and gut flora balance, and functional treatments for the most disabling symptoms. In summary, this study aims to show the scientific community the current knowledge of LC. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 607, tag: div, level: 13" node_number="607"> (This article belongs to the Special Issue Post-COVID Symptoms in Long-Haulers: Definition, Identification, Mechanisms, and Management) </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 608, tag: div, level: 10" node_number="608"> <div class="valid" valid="valid" title="valid: True, node: 609, tag: div, level: 11" node_number="609"> <div class="valid" valid="valid" title="valid: True, node: 610, tag: div, level: 12" node_number="610"> <div class="valid" valid="valid" title="valid: True, node: 611, tag: div, level: 13" node_number="611"> <a class="valid" valid="valid" title="valid: True, node: 612, tag: a, level: 14" node_number="612"> <i title="valid: False, node: 613, tag: i, level: 15" node_number="613">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 614, tag: div, level: 13" node_number="614"> <a class="valid" valid="valid" title="valid: True, node: 615, tag: a, level: 14" node_number="615"> <i title="valid: False, node: 616, tag: i, level: 15" node_number="616">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 617, tag: div, level: 14" node_number="617"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 618, tag: div, level: 13" node_number="618">Open AccessArticle</div> Radiographs and MRI of the Cervical Spine in Juvenile Idiopathic Arthritis: A Cross-Sectional Retrospective Study <div class="valid" valid="valid" title="valid: True, node: 619, tag: div, level: 13" node_number="619"> by <span class="valid" valid="valid" title="valid: True, node: 620, tag: span, level: 14" node_number="620"><div title="valid: False, node: 621, tag: div, level: 15" node_number="621">Mateusz Kotecki</div>, </span><span class="valid" valid="valid" title="valid: True, node: 622, tag: span, level: 14" node_number="622"><div title="valid: False, node: 623, tag: div, level: 15" node_number="623">Piotr Gietka</div>, </span><span class="valid" valid="valid" title="valid: True, node: 624, tag: span, level: 14" node_number="624"><div title="valid: False, node: 625, tag: div, level: 15" node_number="625">Magdalena Posadzy</div> and </span><span class="valid" valid="valid" title="valid: True, node: 626, tag: span, level: 14" node_number="626"><div title="valid: False, node: 627, tag: div, level: 15" node_number="627">Iwona Sudo&#322;-Szopi&#324;ska</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 628, tag: div, level: 13" node_number="628"> J. Clin. Med. <b class="valid" valid="valid" title="valid: True, node: 629, tag: b, level: 14" node_number="629">2021</b>, 10(24), 5798; https://doi.org/10.3390/jcm10245798 (registering&#160;DOI) - 11 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 630, tag: div, level: 13" node_number="630"> Abstract <div class="valid" valid="valid" title="valid: True, node: 631, tag: div, level: 14" node_number="631"> Background: Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease among children. In some patients, cervical spine arthritis remains a serious and chronic manifestation of JIA. The aim of this study was to assess the frequency of cervical spine lesions on radiographs [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 632, tag: div, level: 14" node_number="632"> Background: Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease among children. In some patients, cervical spine arthritis remains a serious and chronic manifestation of JIA. The aim of this study was to assess the frequency of cervical spine lesions on radiographs and MRI in JIA patients with clinical signs of cervical spine involvement and to verify if with the addition of MRI, the use of radiographs could be abandoned. Methods: This retrospective study evaluated consecutive 34 children (25 girls; aged 6&#8211;18 years, median 15.5 years) with JIA and with clinical involvement of cervical spine. In each patient, both radiographs and MRI of the cervical spine were performed. Imaging findings were correlated with clinical and laboratory data. Results: The cervical spine was affected in 35% of patients. The most frequent lesions were subaxial subluxations (SAS; 24%), apophyseal joint ankylosis (9%), and C1/C2 joint lesions (9%). Anterior atlanto-axial subluxation (AAS) was diagnosed only by radiography, and most of the SAS were seen on radiography, whereas only a few on MRI. Reversely, C1/C2 soft tissue involvement were seen on MRI only. Cervical spine involvement was associated with raised ESR (<i title="valid: False, node: 633, tag: i, level: 15" node_number="633">p</i> = 0.012) and CRP (<i title="valid: False, node: 634, tag: i, level: 15" node_number="634">p</i> = 0.014). Conclusions: The cervical spine lesions are still frequent complication of JIA affecting up to 35% of JIA patients. Most of them develop serious complications, such as AAS and ankylosis. Despite advantages of MRI in terms of the imaging of the atlanto-axial region radiography shows superiority in diagnosis of AAS and SAS. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 635, tag: div, level: 13" node_number="635"> (This article belongs to the Special Issue Diagnostic Imaging of Arthritis) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 636, tag: div, level: 13" node_number="636"><div class="valid" valid="valid" title="valid: True, node: 637, tag: div, level: 14" node_number="637"><div title="valid: False, node: 638, tag: div, level: 15" node_number="638"><p title="valid: False, node: 639, tag: p, level: 16" node_number="639">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 640, tag: div, level: 10" node_number="640"> <div class="valid" valid="valid" title="valid: True, node: 641, tag: div, level: 11" node_number="641"> <div class="valid" valid="valid" title="valid: True, node: 642, tag: div, level: 12" node_number="642"> <div class="valid" valid="valid" title="valid: True, node: 643, tag: div, level: 13" node_number="643"> <a class="valid" valid="valid" title="valid: True, node: 644, tag: a, level: 14" node_number="644"> <i title="valid: False, node: 645, tag: i, level: 15" node_number="645">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 646, tag: div, level: 13" node_number="646"> <a class="valid" valid="valid" title="valid: True, node: 647, tag: a, level: 14" node_number="647"> <i title="valid: False, node: 648, tag: i, level: 15" node_number="648">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 649, tag: div, level: 14" node_number="649"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 650, tag: div, level: 13" node_number="650">Open AccessArticle</div> Omentin Is Independently Associated with Stroke Severity and Ipsilateral Carotid Artery Stenosis in Patients with Acute Cerebral Ischemia <div class="valid" valid="valid" title="valid: True, node: 651, tag: div, level: 13" node_number="651"> by <span class="valid" valid="valid" title="valid: True, node: 652, tag: span, level: 14" node_number="652"><div title="valid: False, node: 653, tag: div, level: 15" node_number="653">Maria Chondrogianni</div>, </span><span class="valid" valid="valid" title="valid: True, node: 654, tag: span, level: 14" node_number="654"><div title="valid: False, node: 655, tag: div, level: 15" node_number="655">Vaia Lambadiari</div>, </span><span class="valid" valid="valid" title="valid: True, node: 656, tag: span, level: 14" node_number="656"><div title="valid: False, node: 657, tag: div, level: 15" node_number="657">Aristeidis H. Katsanos</div>, </span><span class="valid" valid="valid" title="valid: True, node: 658, tag: span, level: 14" node_number="658"><div title="valid: False, node: 659, tag: div, level: 15" node_number="659">Maria Ioanna Stefanou</div>, </span><span class="valid" valid="valid" title="valid: True, node: 660, tag: span, level: 14" node_number="660"><div title="valid: False, node: 661, tag: div, level: 15" node_number="661">Palaiodimou Lina</div>, </span><span class="valid" valid="valid" title="valid: True, node: 662, tag: span, level: 14" node_number="662"><div title="valid: False, node: 663, tag: div, level: 15" node_number="663">Alexandros Stavros Triantafyllou</div>, </span><span class="valid" valid="valid" title="valid: True, node: 664, tag: span, level: 14" node_number="664"><div title="valid: False, node: 665, tag: div, level: 15" node_number="665">Georgios Karagiannis</div>, </span><span class="valid" valid="valid" title="valid: True, node: 666, tag: span, level: 14" node_number="666"><div title="valid: False, node: 667, tag: div, level: 15" node_number="667">Vasileios Konstantakos</div>, </span><span class="valid" valid="valid" title="valid: True, node: 668, tag: span, level: 14" node_number="668"><div title="valid: False, node: 669, tag: div, level: 15" node_number="669">Michael Ioakeimidis</div>, </span><span class="valid" valid="valid" title="valid: True, node: 670, tag: span, level: 14" node_number="670"><div title="valid: False, node: 671, tag: div, level: 15" node_number="671">Sokratis Triantafyllou</div>, </span><span class="valid" valid="valid" title="valid: True, node: 672, tag: span, level: 14" node_number="672"><div title="valid: False, node: 673, tag: div, level: 15" node_number="673">Christina Zompola</div>, </span><span class="valid" valid="valid" title="valid: True, node: 674, tag: span, level: 14" node_number="674"><div title="valid: False, node: 675, tag: div, level: 15" node_number="675">Chryssa Liantinioti</div>, </span><span class="valid" valid="valid" title="valid: True, node: 676, tag: span, level: 14" node_number="676"><div title="valid: False, node: 677, tag: div, level: 15" node_number="677">Alexandra Pappa</div>, </span><span class="valid" valid="valid" title="valid: True, node: 678, tag: span, level: 14" node_number="678"><div title="valid: False, node: 679, tag: div, level: 15" node_number="679">Ioannis Rizos</div>, </span><span class="valid" valid="valid" title="valid: True, node: 680, tag: span, level: 14" node_number="680"><div title="valid: False, node: 681, tag: div, level: 15" node_number="681">Konstantinos Voumvourakis</div>, </span><span class="valid" valid="valid" title="valid: True, node: 682, tag: span, level: 14" node_number="682"><div title="valid: False, node: 683, tag: div, level: 15" node_number="683">Georgios Tsivgoulis</div> and </span><span class="valid" valid="valid" title="valid: True, node: 684, tag: span, level: 14" node_number="684"><div title="valid: False, node: 685, tag: div, level: 15" node_number="685">Eleni Boutati</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 686, tag: div, level: 13" node_number="686"> J. Clin. Med. <b class="valid" valid="valid" title="valid: True, node: 687, tag: b, level: 14" node_number="687">2021</b>, 10(24), 5797; https://doi.org/10.3390/jcm10245797 (registering&#160;DOI) - 11 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 688, tag: div, level: 13" node_number="688"> Abstract <div class="valid" valid="valid" title="valid: True, node: 689, tag: div, level: 14" node_number="689"> Mounting evidence indicates an association between adipokines and inflammation-related atherosclerosis. Here, we sought to investigate the association of vaspin and omentin with clinical characteristics and outcomes of patients with acute cerebral ischemia (ACI). Consecutive ACI patients were evaluated within 24 h from symptom-onset. [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 690, tag: div, level: 14" node_number="690"> Mounting evidence indicates an association between adipokines and inflammation-related atherosclerosis. Here, we sought to investigate the association of vaspin and omentin with clinical characteristics and outcomes of patients with acute cerebral ischemia (ACI). Consecutive ACI patients were evaluated within 24 h from symptom-onset. Stroke aetiology was classified using TOAST criteria. Adipokines were assayed using quantikine enzyme immunoassay commercially available kits. Stroke severity was assessed by NIHSS-score, and ipsilateral carotid stenosis (&#8805;50% by NASCET criteria) by ultrasound and CT/MR angiography. Major cerebrovascular events were assessed at three months. We included 135 ACI patients (05 (78%) and 30 (22%) with acute ischemic stroke and transient ischemic attack, respectively; mean age &#177; SD: 59 &#177; 10 years; 68% men; median NIHSS-score: 3 (IQR:1&#8211;7)). Omentin was strongly correlated to admission stroke severity (Spearman rho coefficient: +0.303; <i title="valid: False, node: 691, tag: i, level: 15" node_number="691">p</i> &lt; 0.001). Patients with ipsilateral carotid stenosis had higher omentin levels compared to patients without stenosis (13.3 &#177; 8.9 ng/mL vs. 9.5 &#177; 5.5 ng/mL, <i title="valid: False, node: 692, tag: i, level: 15" node_number="692">p</i> = 0.014). Increasing omentin levels were independently associated with higher stroke severity (linear regression coefficient = 0.290; 95%CI: 0.063&#8211;0.516; <i title="valid: False, node: 693, tag: i, level: 15" node_number="693">p</i> = 0.002) and ipsilateral carotid stenosis (linear regression coefficient = 3.411; 95%CI: 0.194&#8211;6.628; <i title="valid: False, node: 694, tag: i, level: 15" node_number="694">p</i> = 0.038). No association of vaspin with clinical characteristics and outcomes was found. Circulating omentin may represent a biomarker for the presence of atherosclerotic plaque, associated with higher stroke severity in ACI patients. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 695, tag: div, level: 13" node_number="695"> (This article belongs to the Special Issue New Frontiers in Cerebrovascular Disorders) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 696, tag: div, level: 13" node_number="696"><div class="valid" valid="valid" title="valid: True, node: 697, tag: div, level: 14" node_number="697"><div title="valid: False, node: 698, tag: div, level: 15" node_number="698"><p title="valid: False, node: 699, tag: p, level: 16" node_number="699">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 700, tag: div, level: 10" node_number="700"> <div class="valid" valid="valid" title="valid: True, node: 701, tag: div, level: 11" node_number="701"> <div class="valid" valid="valid" title="valid: True, node: 702, tag: div, level: 12" node_number="702"> <div class="valid" valid="valid" title="valid: True, node: 703, tag: div, level: 13" node_number="703"> <a class="valid" valid="valid" title="valid: True, node: 704, tag: a, level: 14" node_number="704"> <i title="valid: False, node: 705, tag: i, level: 15" node_number="705">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 706, tag: div, level: 13" node_number="706"> <a class="valid" valid="valid" title="valid: True, node: 707, tag: a, level: 14" node_number="707"> <i title="valid: False, node: 708, tag: i, level: 15" node_number="708">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 709, tag: div, level: 14" node_number="709"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 710, tag: div, level: 13" node_number="710">Open AccessReview</div> Autoimmune Diseases of Digestive Organs&#8212;A Multidisciplinary Challenge: A Focus on Hepatopancreatobiliary Manifestation <div class="valid" valid="valid" title="valid: True, node: 711, tag: div, level: 13" node_number="711"> by <span class="valid" valid="valid" title="valid: True, node: 712, tag: span, level: 14" node_number="712"><div title="valid: False, node: 713, tag: div, level: 15" node_number="713">Lumir Kunovsky</div>, </span><span class="valid" valid="valid" title="valid: True, node: 714, tag: span, level: 14" node_number="714"><div title="valid: False, node: 715, tag: div, level: 15" node_number="715">Petr Dite</div>, </span><span class="valid" valid="valid" title="valid: True, node: 716, tag: span, level: 14" node_number="716"><div title="valid: False, node: 717, tag: div, level: 15" node_number="717">Petr Jabandziev</div>, </span><span class="valid" valid="valid" title="valid: True, node: 718, tag: span, level: 14" node_number="718"><div title="valid: False, node: 719, tag: div, level: 15" node_number="719">Zdenek Kala</div>, </span><span class="valid" valid="valid" title="valid: True, node: 720, tag: span, level: 14" node_number="720"><div title="valid: False, node: 721, tag: div, level: 15" node_number="721">Jitka Vaculova</div>, </span><span class="valid" valid="valid" title="valid: True, node: 722, tag: span, level: 14" node_number="722"><div title="valid: False, node: 723, tag: div, level: 15" node_number="723">Tomas Andrasina</div>, </span><span class="valid" valid="valid" title="valid: True, node: 724, tag: span, level: 14" node_number="724"><div title="valid: False, node: 725, tag: div, level: 15" node_number="725">Matej Hrunka</div>, </span><span class="valid" valid="valid" title="valid: True, node: 726, tag: span, level: 14" node_number="726"><div title="valid: False, node: 727, tag: div, level: 15" node_number="727">Martina Bojkova</div> and </span><span class="valid" valid="valid" title="valid: True, node: 728, tag: span, level: 14" node_number="728"><div title="valid: False, node: 729, tag: div, level: 15" node_number="729">Jan Trna</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 730, tag: div, level: 13" node_number="730"> J. Clin. Med. <b class="valid" valid="valid" title="valid: True, node: 731, tag: b, level: 14" node_number="731">2021</b>, 10(24), 5796; https://doi.org/10.3390/jcm10245796 (registering&#160;DOI) - 11 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 732, tag: div, level: 13" node_number="732"> Abstract <div class="valid" valid="valid" title="valid: True, node: 733, tag: div, level: 14" node_number="733"> It is well known that some pathological conditions, especially of autoimmune etiology, are associated with the HLA (human leukocyte antigen) phenotype. Among these diseases, we include celiac disease, inflammatory bowel disease, autoimmune enteropathy, autoimmune hepatitis, primary sclerosing cholangitis and primary biliary cholangitis. Immunoglobulin [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 734, tag: div, level: 14" node_number="734"> It is well known that some pathological conditions, especially of autoimmune etiology, are associated with the HLA (human leukocyte antigen) phenotype. Among these diseases, we include celiac disease, inflammatory bowel disease, autoimmune enteropathy, autoimmune hepatitis, primary sclerosing cholangitis and primary biliary cholangitis. Immunoglobulin G4-related diseases (IgG4-related diseases) constitute a second group of autoimmune gastrointestinal, hepatobiliary and pancreatic illnesses. IgG4-related diseases are systemic and rare autoimmune illnesses. They often are connected with chronic inflammation and fibrotic reaction that can occur in any organ of the body. The most typical feature of these diseases is a mononuclear infiltrate with IgG4-positive plasma cells and self-sustaining inflammatory response. In this review, we focus especially upon the hepatopancreatobiliary system, autoimmune pancreatitis and IgG4-related sclerosing cholangitis. The cooperation of the gastroenterologist, radiologist, surgeon and histopathologist is crucial for establishing correct diagnoses and appropriate treatment, especially in IgG4 hepatopancreatobiliary diseases. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 735, tag: div, level: 13" node_number="735"> (This article belongs to the Special Issue Gastrointestinal Tract Disorders) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 736, tag: div, level: 13" node_number="736"><div class="valid" valid="valid" title="valid: True, node: 737, tag: div, level: 14" node_number="737"><div title="valid: False, node: 738, tag: div, level: 15" node_number="738"><p title="valid: False, node: 739, tag: p, level: 16" node_number="739">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 740, tag: div, level: 10" node_number="740"> <div class="valid" valid="valid" title="valid: True, node: 741, tag: div, level: 11" node_number="741"> <div class="valid" valid="valid" title="valid: True, node: 742, tag: div, level: 12" node_number="742"> <div class="valid" valid="valid" title="valid: True, node: 743, tag: div, level: 13" node_number="743"> <a class="valid" valid="valid" title="valid: True, node: 744, tag: a, level: 14" node_number="744"> <i title="valid: False, node: 745, tag: i, level: 15" node_number="745">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 746, tag: div, level: 13" node_number="746"> <a class="valid" valid="valid" title="valid: True, node: 747, tag: a, level: 14" node_number="747"> <i title="valid: False, node: 748, tag: i, level: 15" node_number="748">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 749, tag: div, level: 14" node_number="749"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 750, tag: div, level: 13" node_number="750">Open AccessArticle</div> Immunohistochemical Expression of Wnt-4 Protein in Clear Cell Renal Carcinoma <div class="valid" valid="valid" title="valid: True, node: 751, tag: div, level: 13" node_number="751"> by <span class="valid" valid="valid" title="valid: True, node: 752, tag: span, level: 14" node_number="752"><div title="valid: False, node: 753, tag: div, level: 15" node_number="753">Oliver Pavlovic</div>, </span><span class="valid" valid="valid" title="valid: True, node: 754, tag: span, level: 14" node_number="754"><div title="valid: False, node: 755, tag: div, level: 15" node_number="755">Tvrtko Hudolin</div>, </span><span class="valid" valid="valid" title="valid: True, node: 756, tag: span, level: 14" node_number="756"><div title="valid: False, node: 757, tag: div, level: 15" node_number="757">Ivan Miskulin</div>, </span><span class="valid" valid="valid" title="valid: True, node: 758, tag: span, level: 14" node_number="758"><div title="valid: False, node: 759, tag: div, level: 15" node_number="759">Stela Bulimbasic</div>, </span><span class="valid" valid="valid" title="valid: True, node: 760, tag: span, level: 14" node_number="760"><div title="valid: False, node: 761, tag: div, level: 15" node_number="761">Marijana Coric</div>, </span><span class="valid" valid="valid" title="valid: True, node: 762, tag: span, level: 14" node_number="762"><div title="valid: False, node: 763, tag: div, level: 15" node_number="763">Josip Perkovic</div> and </span><span class="valid" valid="valid" title="valid: True, node: 764, tag: span, level: 14" node_number="764"><div title="valid: False, node: 765, tag: div, level: 15" node_number="765">Toni Zekulic</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 766, tag: div, level: 13" node_number="766"> J. Clin. Med. <b class="valid" valid="valid" title="valid: True, node: 767, tag: b, level: 14" node_number="767">2021</b>, 10(24), 5795; https://doi.org/10.3390/jcm10245795 (registering&#160;DOI) - 11 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 768, tag: div, level: 13" node_number="768"> Abstract <div class="valid" valid="valid" title="valid: True, node: 769, tag: div, level: 14" node_number="769"> Wingless binding integration site proteins (Wnt) have an important role in normal kidney development and in various kidney diseases. They are required for complete epithelial differentiation and normal nephron formation. Changes in these proteins could also have important role in carcinogenesis. This study [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 770, tag: div, level: 14" node_number="770"> Wingless binding integration site proteins (Wnt) have an important role in normal kidney development and in various kidney diseases. They are required for complete epithelial differentiation and normal nephron formation. Changes in these proteins could also have important role in carcinogenesis. This study included 185 patients with clear cell renal carcinoma (ccRCC) in whom immunohistochemical expression of Wnt-4 protein in healthy and tumorous tissue after surgery was investigated. There was higher expression of Wnt-4 in healthy than in tumor tissue. No difference between Fuhrman&#8217;s grade and Wnt-4 expression was found. A poor negative correlation between tumor size and Wnt-4 expression was found. Patients with suspected metastatic diseases had higher Wnt-4 expression. There was no difference in survival rates between Wnt-4 negative and positive groups. In our study we have shown that high Wnt-4 expression in healthy tissue decreases in low-grade tumors but then increases in high-grade tumors, suggesting that tumor progression requires Wnt-4 activation or reactivation. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 771, tag: div, level: 13" node_number="771"> (This article belongs to the Special Issue Molecular Targets and Chemoprevention (Tumor Growth and Metastasis)) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 772, tag: div, level: 13" node_number="772"><div class="valid" valid="valid" title="valid: True, node: 773, tag: div, level: 14" node_number="773"><div title="valid: False, node: 774, tag: div, level: 15" node_number="774"><p title="valid: False, node: 775, tag: p, level: 16" node_number="775">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 776, tag: div, level: 10" node_number="776"> <div class="valid" valid="valid" title="valid: True, node: 777, tag: div, level: 11" node_number="777"> <div class="valid" valid="valid" title="valid: True, node: 778, tag: div, level: 12" node_number="778"> <div class="valid" valid="valid" title="valid: True, node: 779, tag: div, level: 13" node_number="779"> <a class="valid" valid="valid" title="valid: True, node: 780, tag: a, level: 14" node_number="780"> <i title="valid: False, node: 781, tag: i, level: 15" node_number="781">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 782, tag: div, level: 13" node_number="782"> <a class="valid" valid="valid" title="valid: True, node: 783, tag: a, level: 14" node_number="783"> <i title="valid: False, node: 784, tag: i, level: 15" node_number="784">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 785, tag: div, level: 14" node_number="785"> View online as: Abstract Page </div> </div> <div class="valid" valid="valid" title="valid: True, node: 786, tag: div, level: 13" node_number="786">Open AccessArticle</div> Uterine Adenomyosis Treated by Linzagolix, an Oral Gonadotropin-Releasing Hormone Receptor Antagonist: A Pilot Study with a New &#8217;Hit Hard First and Then Maintain&#8217; Regimen of Administration <div class="valid" valid="valid" title="valid: True, node: 787, tag: div, level: 13" node_number="787"> by <span class="valid" valid="valid" title="valid: True, node: 788, tag: span, level: 14" node_number="788"><div title="valid: False, node: 789, tag: div, level: 15" node_number="789">Jacques Donnez</div>, </span><span class="valid" valid="valid" title="valid: True, node: 790, tag: span, level: 14" node_number="790"><div title="valid: False, node: 791, tag: div, level: 15" node_number="791">Olivier Donnez</div>, </span><span class="valid" valid="valid" title="valid: True, node: 792, tag: span, level: 14" node_number="792"><div title="valid: False, node: 793, tag: div, level: 15" node_number="793">Jean Tourniaire</div>, </span><span class="valid" valid="valid" title="valid: True, node: 794, tag: span, level: 14" node_number="794"><div title="valid: False, node: 795, tag: div, level: 15" node_number="795">Michel Brethous</div>, </span><span class="valid" valid="valid" title="valid: True, node: 796, tag: span, level: 14" node_number="796"><div title="valid: False, node: 797, tag: div, level: 15" node_number="797">Elke Bestel</div>, </span><span class="valid" valid="valid" title="valid: True, node: 798, tag: span, level: 14" node_number="798"><div title="valid: False, node: 799, tag: div, level: 15" node_number="799">Elizabeth Garner</div>, </span><span class="valid" valid="valid" title="valid: True, node: 800, tag: span, level: 14" node_number="800"><div title="valid: False, node: 801, tag: div, level: 15" node_number="801">S&#233;bastien Charpentier</div>, </span><span class="valid" valid="valid" title="valid: True, node: 802, tag: span, level: 14" node_number="802"><div title="valid: False, node: 803, tag: div, level: 15" node_number="803">Andrew Humberstone</div> and </span><span class="valid" valid="valid" title="valid: True, node: 804, tag: span, level: 14" node_number="804"><div title="valid: False, node: 805, tag: div, level: 15" node_number="805">Ernest Loumaye</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 806, tag: div, level: 13" node_number="806"> J. Clin. Med. <b class="valid" valid="valid" title="valid: True, node: 807, tag: b, level: 14" node_number="807">2021</b>, 10(24), 5794; https://doi.org/10.3390/jcm10245794 (registering&#160;DOI) - 10 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 808, tag: div, level: 13" node_number="808"> Abstract <div class="valid" valid="valid" title="valid: True, node: 809, tag: div, level: 14" node_number="809"> (1) Background: The aim of the present pilot study was to study the effect of a new oral gonadotropin-releasing hormone antagonist on adenomyosis. (2) Methods: Eight premenopausal women, aged between 37 and 45 years, presenting with heavy menstrual bleeding, pelvic pain, and dysmenorrhea [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 810, tag: div, level: 14" node_number="810"> (1) Background: The aim of the present pilot study was to study the effect of a new oral gonadotropin-releasing hormone antagonist on adenomyosis. (2) Methods: Eight premenopausal women, aged between 37 and 45 years, presenting with heavy menstrual bleeding, pelvic pain, and dysmenorrhea due to diffuse and disseminated uterine adenomyosis, confirmed by magnetic resonance imaging (MRI), received 200 mg linzagolix once daily for a period of 12 weeks, after which they were switched to 100 mg linzagolix once daily for another 12 weeks. The primary efficacy endpoint was the change in volume of the adenomyotic uterus from baseline to 24 weeks, evaluated by MRI. Secondary efficacy endpoints included the change in uterine volume from baseline to 12 and 36 weeks by MRI, and also weeks 12, 24, and 36 assessed by transvaginal ultrasound (TVUS). Other endpoints were overall pelvic pain, dysmenorrhea, non-menstrual pelvic pain, dyspareunia, amenorrhea, quality of life measures, bone mineral density (BMD), junctional zone thickness, and serum estradiol values. (3) Results: Median serum estradiol was suppressed below 20 pg/mL during the 12 weeks on linzagolix 200 mg, and maintained below 60 pg/mL during the second 12 weeks on linzagolix 100 mg. At baseline, the mean &#177; SD uterine volume was 333 &#177; 250 cm<sup title="valid: False, node: 811, tag: sup, level: 15" node_number="811">3</sup>. After 24 weeks of treatment, it was 204 &#177; 126 cm<sup title="valid: False, node: 812, tag: sup, level: 15" node_number="812">3</sup>, a reduction of 32% (<i title="valid: False, node: 813, tag: i, level: 15" node_number="813">p</i> = 0.0057). After 12 weeks, the mean uterine volume was 159 &#177; 95 cm<sup title="valid: False, node: 814, tag: sup, level: 15" node_number="814">3</sup>, a reduction of 55% from baseline (<i title="valid: False, node: 815, tag: i, level: 15" node_number="815">p</i> = 0.0001). A similar pattern was observed when uterine volume was assessed by TVUS. Improvements in overall pelvic pain, dysmenorrhea, non-menstrual pelvic pain, dyspareunia, and dyschezia, as well as quality of life measured using the EHP-30 were also observed. Mean percentage BMD loss at 24 weeks was, respectively, &#8722;2.4%, &#8722;1.3%, and &#8722;4.1% for the spine, femoral neck, and total hip. The most common adverse events were hot flushes, which occurred in 6/8 women during the first 12 weeks, and 1/8 women between 12 and 24 weeks. (4) Conclusions: Linzagolix at a dose of 200 mg/day reduced uterine volume, and improved clinically relevant symptoms. Treatment with 100 mg thereafter retains the therapeutic benefits of the starting dose while minimizing side effects. This &#8216;hit hard first and then maintain&#8217; approach may be the optimal way to treat women with symptomatic adenomyosis. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 816, tag: div, level: 13" node_number="816"> (This article belongs to the Special Issue Fertility Preservation and Conservative Therapy in Malignant and Benign Gynecological Diseases) </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 817, tag: div, level: 10" node_number="817"> <div class="valid" valid="valid" title="valid: True, node: 818, tag: div, level: 11" node_number="818"> <div class="valid" valid="valid" title="valid: True, node: 819, tag: div, level: 12" node_number="819"> <div class="valid" valid="valid" title="valid: True, node: 820, tag: div, level: 13" node_number="820"> <a class="valid" valid="valid" title="valid: True, node: 821, tag: a, level: 14" node_number="821"> <i title="valid: False, node: 822, tag: i, level: 15" node_number="822">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 823, tag: div, level: 13" node_number="823"> <a class="valid" valid="valid" title="valid: True, node: 824, tag: a, level: 14" node_number="824"> <i title="valid: False, node: 825, tag: i, level: 15" node_number="825">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 826, tag: div, level: 14" node_number="826"> View online as: Abstract Page </div> </div> <div class="valid" valid="valid" title="valid: True, node: 827, tag: div, level: 13" node_number="827">Open AccessArticle</div> The Relationship between Initial Tacrolimus Metabolism Rate and Recipients Body Composition in Kidney Transplantation <div class="valid" valid="valid" title="valid: True, node: 828, tag: div, level: 13" node_number="828"> by <span class="valid" valid="valid" title="valid: True, node: 829, tag: span, level: 14" node_number="829"><div title="valid: False, node: 830, tag: div, level: 15" node_number="830">Aureliusz Kolonko</div>, </span><span class="valid" valid="valid" title="valid: True, node: 831, tag: span, level: 14" node_number="831"><div title="valid: False, node: 832, tag: div, level: 15" node_number="832">Patrycja Pokora</div>, </span><span class="valid" valid="valid" title="valid: True, node: 833, tag: span, level: 14" node_number="833"><div title="valid: False, node: 834, tag: div, level: 15" node_number="834">Natalia S&#322;abiak-B&#322;a&#380;</div>, </span><span class="valid" valid="valid" title="valid: True, node: 835, tag: span, level: 14" node_number="835"><div title="valid: False, node: 836, tag: div, level: 15" node_number="836">Beata Czerwie&#324;ska</div>, </span><span class="valid" valid="valid" title="valid: True, node: 837, tag: span, level: 14" node_number="837"><div title="valid: False, node: 838, tag: div, level: 15" node_number="838">Henryk Karkoszka</div>, </span><span class="valid" valid="valid" title="valid: True, node: 839, tag: span, level: 14" node_number="839"><div title="valid: False, node: 840, tag: div, level: 15" node_number="840">Piotr Kuczera</div>, </span><span class="valid" valid="valid" title="valid: True, node: 841, tag: span, level: 14" node_number="841"><div title="valid: False, node: 842, tag: div, level: 15" node_number="842">Grzegorz Piecha</div> and </span><span class="valid" valid="valid" title="valid: True, node: 843, tag: span, level: 14" node_number="843"><div title="valid: False, node: 844, tag: div, level: 15" node_number="844">Andrzej Wi&#281;cek</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 845, tag: div, level: 13" node_number="845"> J. Clin. Med. <b class="valid" valid="valid" title="valid: True, node: 846, tag: b, level: 14" node_number="846">2021</b>, 10(24), 5793; https://doi.org/10.3390/jcm10245793 (registering&#160;DOI) - 10 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 847, tag: div, level: 13" node_number="847"> Abstract <div class="valid" valid="valid" title="valid: True, node: 848, tag: div, level: 14" node_number="848"> There are several premises that the body composition of kidney transplant recipients may play a role in tacrolimus metabolism early after transplantation. The present study aimed at analyzing the relationship between the body composition parameters assessed by bioimpedance analysis (BIA) and initial tacrolimus [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 849, tag: div, level: 14" node_number="849"> There are several premises that the body composition of kidney transplant recipients may play a role in tacrolimus metabolism early after transplantation. The present study aimed at analyzing the relationship between the body composition parameters assessed by bioimpedance analysis (BIA) and initial tacrolimus metabolism. Immediately prior to transplantation, BIA using InBody 770 device was performed in 122 subjects. Tacrolimus concentration-to-dose (C/D) ratio was calculated based on the first blood trough level measurement. There was no difference in phase angle, visceral fat area, lean body mass index (LBMI) and the proportion of lean mass as a percentage of total body mass between the subgroups of slow and fast metabolizers. However, subjects with LBMI &#8805; median value of 18.7 kg/m<sup title="valid: False, node: 850, tag: sup, level: 15" node_number="850">2</sup>, despite similar initial tacrolimus dose per kg of body weight, were characterized by a significantly lower tacrolimus C/D ratio (median 1.39 vs. 1.67, respectively; <i title="valid: False, node: 851, tag: i, level: 15" node_number="851">p </i>&lt; 0.05) in comparison with the subgroup of lower LBMI. Multivariate regression analysis confirmed that age (r<sub title="valid: False, node: 852, tag: sub, level: 15" node_number="852">partial</sub> = 0.322; <i title="valid: False, node: 853, tag: i, level: 15" node_number="853">p </i>&lt; 0.001) and LBMI (r<sub title="valid: False, node: 854, tag: sub, level: 15" node_number="854">partial</sub> = &#8722;0.254; <i title="valid: False, node: 855, tag: i, level: 15" node_number="855">p </i>&lt; 0.01) independently influenced the tacrolimus C/D ratio. A LBMI assessed by BIA may influence the tacrolimus metabolism in the early post-transplant period and can be a useful in the optimization of initial tacrolimus dosing. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 856, tag: div, level: 13" node_number="856"> (This article belongs to the Special Issue Progress and Recent Advances in Solid Organ Transplantation) </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 857, tag: div, level: 10" node_number="857"> <div class="valid" valid="valid" title="valid: True, node: 858, tag: div, level: 11" node_number="858"> <div class="valid" valid="valid" title="valid: True, node: 859, tag: div, level: 12" node_number="859"> <div class="valid" valid="valid" title="valid: True, node: 860, tag: div, level: 13" node_number="860"> <a class="valid" valid="valid" title="valid: True, node: 861, tag: a, level: 14" node_number="861"> <i title="valid: False, node: 862, tag: i, level: 15" node_number="862">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 863, tag: div, level: 14" node_number="863"> Supplementary material: Supplementary File 1 (ZIP, 133 KiB) </div> </div> <div class="valid" valid="valid" title="valid: True, node: 864, tag: div, level: 13" node_number="864"> <a class="valid" valid="valid" title="valid: True, node: 865, tag: a, level: 14" node_number="865"> <i title="valid: False, node: 866, tag: i, level: 15" node_number="866">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 867, tag: div, level: 13" node_number="867"> <a class="valid" valid="valid" title="valid: True, node: 868, tag: a, level: 14" node_number="868"> <i title="valid: False, node: 869, tag: i, level: 15" node_number="869">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 870, tag: div, level: 14" node_number="870"> View online as: Abstract Page </div> </div> <div class="valid" valid="valid" title="valid: True, node: 871, tag: div, level: 13" node_number="871">Open AccessArticle</div> Relationship between Serum Kallistatin and Afamin and Anthropometric Factors Associated with Obesity and of Being Overweight in Patients after Myocardial Infarction and without Myocardial Infarction <div class="valid" valid="valid" title="valid: True, node: 872, tag: div, level: 13" node_number="872"> by <span class="valid" valid="valid" title="valid: True, node: 873, tag: span, level: 14" node_number="873"><div title="valid: False, node: 874, tag: div, level: 15" node_number="874">Grzegorz J&#243;zef Nowicki</div>, </span><span class="valid" valid="valid" title="valid: True, node: 875, tag: span, level: 14" node_number="875"><div title="valid: False, node: 876, tag: div, level: 15" node_number="876">Barbara &#346;lusarska</div>, </span><span class="valid" valid="valid" title="valid: True, node: 877, tag: span, level: 14" node_number="877"><div title="valid: False, node: 878, tag: div, level: 15" node_number="878">Maciej Polak</div>, </span><span class="valid" valid="valid" title="valid: True, node: 879, tag: span, level: 14" node_number="879"><div title="valid: False, node: 880, tag: div, level: 15" node_number="880">Katarzyna Naylor</div> and </span><span class="valid" valid="valid" title="valid: True, node: 881, tag: span, level: 14" node_number="881"><div title="valid: False, node: 882, tag: div, level: 15" node_number="882">Tomasz Kocki</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 883, tag: div, level: 13" node_number="883"> J. Clin. Med. <b class="valid" valid="valid" title="valid: True, node: 884, tag: b, level: 14" node_number="884">2021</b>, 10(24), 5792; https://doi.org/10.3390/jcm10245792 (registering&#160;DOI) - 10 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 885, tag: div, level: 13" node_number="885"> Abstract <div class="valid" valid="valid" title="valid: True, node: 886, tag: div, level: 14" node_number="886"> Extensive clinical and epidemiological evidence has linked obesity to a broad spectrum of cardiovascular disease (CVD), including coronary disease, heart failure, hypertension, cerebrovascular disease, atrial fibrillation, ventricular arrhythmias, and sudden death. In addition, increasing knowledge of regulatory peptides has allowed an assessment of [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 887, tag: div, level: 14" node_number="887"> Extensive clinical and epidemiological evidence has linked obesity to a broad spectrum of cardiovascular disease (CVD), including coronary disease, heart failure, hypertension, cerebrovascular disease, atrial fibrillation, ventricular arrhythmias, and sudden death. In addition, increasing knowledge of regulatory peptides has allowed an assessment of their role in various non-communicable diseases, including CVD. The study assessed the concentration of kallistatin and afamin in the blood serum of patients after a myocardial infarction and without a cardiovascular event, and determined the relationship between the concentration of kallistatin and afamin and the anthropometric indicators of being overweight and of obesity in these groups. Serum kallistatin and afamin were quantified by ELISA tests in a cross-sectional study of 160 patients who were divided into two groups: study group (SG) (<i title="valid: False, node: 888, tag: i, level: 15" node_number="888">n</i> = 80) and another with no cardiovascular event (CG) (<i title="valid: False, node: 889, tag: i, level: 15" node_number="889">n</i> = 80). Serum kallistatin concentration was significantly higher in the SG (<i title="valid: False, node: 890, tag: i, level: 15" node_number="890">p </i>&lt; 0.001), while the level of afamin was significantly lower in this group (<i title="valid: False, node: 891, tag: i, level: 15" node_number="891">p </i>&lt; 0.001). In addition, a positive correlation was observed in the SG between the afamin concentration and the waist to hip ratio (WHR), lipid accumulation product (LAP) and the triglyceride glucose index (TyG index). In the CG, the concentration of kallistatin positively correlated with the LAP and TyG index, while the concentration of afamin positively correlated with all the examined parameters: body mass index (BMI), waist circumference (WC), hip circumference (HC), waist to hip ratio (WHtR), visceral adiposity index (VAI), LAP and TyG index. Serum kallistatin and afamin concentrations are associated with the anthropometric parameters related to being overweight and to obesity, especially to those describing the visceral distribution of adipose tissue and metabolic disorders related to excessive fatness. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 892, tag: div, level: 13" node_number="892"> (This article belongs to the Special Issue (Cardio-)Vascular System in Health and Disease: Current Update and Perspectives) </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 893, tag: div, level: 10" node_number="893"> <div class="valid" valid="valid" title="valid: True, node: 894, tag: div, level: 11" node_number="894"> <div class="valid" valid="valid" title="valid: True, node: 895, tag: div, level: 12" node_number="895"> <div class="valid" valid="valid" title="valid: True, node: 896, tag: div, level: 13" node_number="896"> <a class="valid" valid="valid" title="valid: True, node: 897, tag: a, level: 14" node_number="897"> <i title="valid: False, node: 898, tag: i, level: 15" node_number="898">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 899, tag: div, level: 13" node_number="899"> <a class="valid" valid="valid" title="valid: True, node: 900, tag: a, level: 14" node_number="900"> <i title="valid: False, node: 901, tag: i, level: 15" node_number="901">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 902, tag: div, level: 14" node_number="902"> View online as: Abstract Page </div> </div> <div class="valid" valid="valid" title="valid: True, node: 903, tag: div, level: 13" node_number="903">Open AccessReview</div> An Overview of Robotic Capsules for Drug Delivery to the Gastrointestinal Tract <div class="valid" valid="valid" title="valid: True, node: 904, tag: div, level: 13" node_number="904"> by <span class="valid" valid="valid" title="valid: True, node: 905, tag: span, level: 14" node_number="905"><div title="valid: False, node: 906, tag: div, level: 15" node_number="906">Pablo Cortegoso Valdivia</div>, </span><span class="valid" valid="valid" title="valid: True, node: 907, tag: span, level: 14" node_number="907"><div title="valid: False, node: 908, tag: div, level: 15" node_number="908">Alexander R. Robertson</div>, </span><span class="valid" valid="valid" title="valid: True, node: 909, tag: span, level: 14" node_number="909"><div title="valid: False, node: 910, tag: div, level: 15" node_number="910">Nanne K. H. De Boer</div>, </span><span class="valid" valid="valid" title="valid: True, node: 911, tag: span, level: 14" node_number="911"><div title="valid: False, node: 912, tag: div, level: 15" node_number="912">Wojciech Marlicz</div> and </span><span class="valid" valid="valid" title="valid: True, node: 913, tag: span, level: 14" node_number="913"><div title="valid: False, node: 914, tag: div, level: 15" node_number="914">Anastasios Koulaouzidis</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 915, tag: div, level: 13" node_number="915"> J. Clin. Med. <b class="valid" valid="valid" title="valid: True, node: 916, tag: b, level: 14" node_number="916">2021</b>, 10(24), 5791; https://doi.org/10.3390/jcm10245791 (registering&#160;DOI) - 10 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 917, tag: div, level: 13" node_number="917"> Abstract <div class="valid" valid="valid" title="valid: True, node: 918, tag: div, level: 14" node_number="918"> The introduction of capsule endoscopy two decades ago marked the beginning of the &#8220;small bowel revolution&#8221;. Since then, the rapid evolution of microtechnology has allowed the development of drug delivery systems (DDS) designed to address some of the needs that are not met [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 919, tag: div, level: 14" node_number="919"> The introduction of capsule endoscopy two decades ago marked the beginning of the &#8220;small bowel revolution&#8221;. Since then, the rapid evolution of microtechnology has allowed the development of drug delivery systems (DDS) designed to address some of the needs that are not met by standard drug delivery. To overcome the complex anatomy and physiology of the gastrointestinal (GI) tract, several DDS have been developed, including many prototypes being designed, built and eventually produced with ingenious drug-release mechanisms and anchoring systems allowing targeted therapy. This review highlights the currently available systems for drug delivery in the GI tract and discusses the needs, limitations, and future considerations of these technologies. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 920, tag: div, level: 13" node_number="920"> (This article belongs to the Special Issue Current and Emerging Technologies Applications of Endoscopy in Clinical Practice) </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 921, tag: div, level: 10" node_number="921"> <div class="valid" valid="valid" title="valid: True, node: 922, tag: div, level: 11" node_number="922"> <div class="valid" valid="valid" title="valid: True, node: 923, tag: div, level: 12" node_number="923"> <div class="valid" valid="valid" title="valid: True, node: 924, tag: div, level: 13" node_number="924"> <a class="valid" valid="valid" title="valid: True, node: 925, tag: a, level: 14" node_number="925"> <i title="valid: False, node: 926, tag: i, level: 15" node_number="926">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 927, tag: div, level: 13" node_number="927"> <a class="valid" valid="valid" title="valid: True, node: 928, tag: a, level: 14" node_number="928"> <i title="valid: False, node: 929, tag: i, level: 15" node_number="929">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 930, tag: div, level: 14" node_number="930"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 931, tag: div, level: 13" node_number="931">Open AccessArticle</div> Oral Mucositis Association with Periodontal Status: A Retrospective Analysis of 496 Patients Undergoing Hematopoietic Stem Cell Transplantation <div class="valid" valid="valid" title="valid: True, node: 932, tag: div, level: 13" node_number="932"> by <span class="valid" valid="valid" title="valid: True, node: 933, tag: span, level: 14" node_number="933"><div title="valid: False, node: 934, tag: div, level: 15" node_number="934">Vladim&#237;ra Radochov&#225;</div>, </span><span class="valid" valid="valid" title="valid: True, node: 935, tag: span, level: 14" node_number="935"><div title="valid: False, node: 936, tag: div, level: 15" node_number="936">Martin &#352;embera</div>, </span><span class="valid" valid="valid" title="valid: True, node: 937, tag: span, level: 14" node_number="937"><div title="valid: False, node: 938, tag: div, level: 15" node_number="938">Radovan Slez&#225;k</div>, </span><span class="valid" valid="valid" title="valid: True, node: 939, tag: span, level: 14" node_number="939"><div title="valid: False, node: 940, tag: div, level: 15" node_number="940">Ond&#345;ej Heneberk</div> and </span><span class="valid" valid="valid" title="valid: True, node: 941, tag: span, level: 14" node_number="941"><div title="valid: False, node: 942, tag: div, level: 15" node_number="942">Jakub Radocha</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 943, tag: div, level: 13" node_number="943"> J. Clin. Med. <b class="valid" valid="valid" title="valid: True, node: 944, tag: b, level: 14" node_number="944">2021</b>, 10(24), 5790; https://doi.org/10.3390/jcm10245790 (registering&#160;DOI) - 10 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 945, tag: div, level: 13" node_number="945"> Abstract <div class="valid" valid="valid" title="valid: True, node: 946, tag: div, level: 14" node_number="946"> Background: Hematopoietic stem cell transplantation (HSCT) can induce serious oral complications, including oral mucositis (OM). The presence of periodontal inflammation before HSCT is believed to be associated with OM. The aim of our study was to determine the prevalence and severity of OM [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 947, tag: div, level: 14" node_number="947"> Background: Hematopoietic stem cell transplantation (HSCT) can induce serious oral complications, including oral mucositis (OM). The presence of periodontal inflammation before HSCT is believed to be associated with OM. The aim of our study was to determine the prevalence and severity of OM in patients undergoing HSCT and its relation to periodontal status. Patients and methods: This is a retrospective study of patients who underwent HSCT and a detailed dental examination between 2007 and 2015. The dental and periodontal status of all patients was evaluated by clinical and radiographic examination prior to HSCT. Oral health was assessed with the gingival index, the the community periodontal index, presence of plaque-related gingivitis, and marginal periodontitis. During the HSCT period, patients were examined daily for the presence of OM, which was graded according to World Health Organization (WHO) classification if present. The patients were assigned to the groups according to type of transplantation: autologous HSCT, myeloablative allogeneic HSCT, and non-myeloablative allogeneic HSCT. Results: A total of 496 patients were included in the study. OM was present in 314 of 496 patients (63.3%): 184/251 (73.3%) in the autologous group, 100/151 (66.2%) in the myeloablative allogeneic group, and 30/94 (31.9%) in the nonmyeloablative allogeneic group. Significantly more patients suffered from OM in the autologous and myeloablative groups versus the nonmyeloablative conditioning group (<i title="valid: False, node: 948, tag: i, level: 15" node_number="948">p</i> &lt; 0.001). The presence of periodontal inflammation did not significantly differ among the groups. There was only a borderline trend for the higher prevalence of OM in the non-myeloablative allogeneic nonmyeloablative group when periodontal inflammation was present (0.073939). Conclusions: Oral mucositis prevalence and severity after stem cell transplantation is not widely affected by the oral hygiene and periodontal disease presence before HSCT. We confirmed the wide-known connection of the conditioning regimen intensity to the prevalence of OM. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 949, tag: div, level: 13" node_number="949"> (This article belongs to the Section Stomatology) </div> </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 950, tag: div, level: 9" node_number="950"> More Articles... </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 951, tag: div, level: 6" node_number="951"> <div class="valid" valid="valid" title="valid: True, node: 952, tag: div, level: 7" node_number="952"> <div class="valid" valid="valid" title="valid: True, node: 953, tag: div, level: 8" node_number="953"> <div class="valid" valid="valid" title="valid: True, node: 954, tag: div, level: 9" node_number="954"> <a class="valid" valid="valid" title="valid: True, node: 955, tag: a, level: 10" node_number="955"> Submit to <i class="valid" valid="valid" title="valid: True, node: 956, tag: i, level: 11" node_number="956">JCM</i> </a> Review for JCM <div class="valid" valid="valid" title="valid: True, node: 957, tag: div, level: 10" node_number="957"> Share </div> </div> <div class="valid" valid="valid" title="valid: True, node: 958, tag: div, level: 9" node_number="958"> <h2 class="valid" valid="valid" title="valid: True, node: 959, tag: h2, level: 10" node_number="959">Journal Menu</h2> &#9658; &#9660; Journal Menu <ul class="valid" valid="valid" title="valid: True, node: 960, tag: ul, level: 10" node_number="960"> <li class="valid" valid="valid" title="valid: True, node: 961, tag: li, level: 11" node_number="961"> <ul class="valid" valid="valid" title="valid: True, node: 962, tag: ul, level: 12" node_number="962"> <li class="valid" valid="valid" title="valid: True, node: 963, tag: li, level: 13" node_number="963"> JCM Home </li> <li class="valid" valid="valid" title="valid: True, node: 964, tag: li, level: 13" node_number="964"> Aims Scope </li> <li class="valid" valid="valid" title="valid: True, node: 965, tag: li, level: 13" node_number="965"> Editorial Board </li> <li class="valid" valid="valid" title="valid: True, node: 966, tag: li, level: 13" node_number="966"> Reviewer Board </li> <li class="valid" valid="valid" title="valid: True, node: 967, tag: li, level: 13" node_number="967"> Topical Advisory Panel </li> <li class="valid" valid="valid" title="valid: True, node: 968, tag: li, level: 13" node_number="968"> Instructions for Authors </li> <li class="valid" valid="valid" title="valid: True, node: 969, tag: li, level: 13" node_number="969"> Special Issues </li> <li class="valid" valid="valid" title="valid: True, node: 970, tag: li, level: 13" node_number="970"> Sections Collections </li> <li class="valid" valid="valid" title="valid: True, node: 971, tag: li, level: 13" node_number="971"> Article Processing Charge </li> <li class="valid" valid="valid" title="valid: True, node: 972, tag: li, level: 13" node_number="972"> Indexing Archiving </li> <li class="valid" valid="valid" title="valid: True, node: 973, tag: li, level: 13" node_number="973"> Editor's Choice Articles </li> <li class="valid" valid="valid" title="valid: True, node: 974, tag: li, level: 13" node_number="974"> Most Cited Viewed </li> <li class="valid" valid="valid" title="valid: True, node: 975, tag: li, level: 13" node_number="975"> Journal Statistics </li> <li class="valid" valid="valid" title="valid: True, node: 976, tag: li, level: 13" node_number="976"> Journal History </li> <li class="valid" valid="valid" title="valid: True, node: 977, tag: li, level: 13" node_number="977"> Journal Awards </li> <li class="valid" valid="valid" title="valid: True, node: 978, tag: li, level: 13" node_number="978"> Society Collaborations </li> <li class="valid" valid="valid" title="valid: True, node: 979, tag: li, level: 13" node_number="979"> Editorial Office </li> </ul> </li> </ul> </div> <h2 class="valid" valid="valid" title="valid: True, node: 980, tag: h2, level: 9" node_number="980">Journal Browser</h2> &#9658; &#9660; Journal Browser <div class="valid" valid="valid" title="valid: True, node: 981, tag: div, level: 9" node_number="981"> <div class="valid" valid="valid" title="valid: True, node: 982, tag: div, level: 10" node_number="982"> <ul class="valid" valid="valid" title="valid: True, node: 983, tag: ul, level: 11" node_number="983"> <li class="valid" valid="valid" title="valid: True, node: 984, tag: li, level: 12" node_number="984"> <a class="valid" valid="valid" title="valid: True, node: 985, tag: a, level: 13" node_number="985"> <i class="valid" valid="valid" title="valid: True, node: 986, tag: i, level: 14" node_number="986"> arrow_forward_ios </i> Forthcoming issue </a> <a class="valid" valid="valid" title="valid: True, node: 987, tag: a, level: 13" node_number="987"> <i class="valid" valid="valid" title="valid: True, node: 988, tag: i, level: 14" node_number="988"> arrow_forward_ios </i> Current issue </a> </li> <div class="valid" valid="valid" title="valid: True, node: 989, tag: div, level: 12" node_number="989"> <div class="valid" valid="valid" title="valid: True, node: 990, tag: div, level: 13" node_number="990"> <div class="valid" valid="valid" title="valid: True, node: 991, tag: div, level: 14" node_number="991"> <li title="valid: False, node: 992, tag: li, level: 15" node_number="992"> Vol.&#160;10&#160;(2021) </li> <li title="valid: False, node: 993, tag: li, level: 15" node_number="993"> Vol.&#160;9&#160;(2020) </li> <li title="valid: False, node: 994, tag: li, level: 15" node_number="994"> Vol.&#160;8&#160;(2019) </li> <li title="valid: False, node: 995, tag: li, level: 15" node_number="995"> Vol.&#160;7&#160;(2018) </li> <li title="valid: False, node: 996, tag: li, level: 15" node_number="996"> Vol.&#160;6&#160;(2017) </li> <li title="valid: False, node: 997, tag: li, level: 15" node_number="997"> Vol.&#160;5&#160;(2016) </li> <li title="valid: False, node: 998, tag: li, level: 15" node_number="998"> Vol.&#160;4&#160;(2015) </li> <li title="valid: False, node: 999, tag: li, level: 15" node_number="999"> Vol.&#160;3&#160;(2014) </li> <li title="valid: False, node: 1000, tag: li, level: 15" node_number="1000"> Vol.&#160;2&#160;(2013) </li> <li title="valid: False, node: 1001, tag: li, level: 15" node_number="1001"> Vol.&#160;1&#160;(2012) </li> </div> </div> </div> </ul> </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1002, tag: div, level: 7" node_number="1002"> <div class="valid" valid="valid" title="valid: True, node: 1003, tag: div, level: 8" node_number="1003"> <h2 class="valid" valid="valid" title="valid: True, node: 1004, tag: h2, level: 9" node_number="1004">Highly Accessed Articles</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1005, tag: div, level: 8" node_number="1005"> <div class="valid" valid="valid" title="valid: True, node: 1006, tag: div, level: 9" node_number="1006"> View More... </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1007, tag: div, level: 7" node_number="1007"> <div class="valid" valid="valid" title="valid: True, node: 1008, tag: div, level: 8" node_number="1008"> <h2 class="valid" valid="valid" title="valid: True, node: 1009, tag: h2, level: 9" node_number="1009">Latest Books</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1010, tag: div, level: 8" node_number="1010"> <div class="valid" valid="valid" title="valid: True, node: 1011, tag: div, level: 9" node_number="1011"> More Open Access Books... </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1012, tag: div, level: 6" node_number="1012"> <div class="valid" valid="valid" title="valid: True, node: 1013, tag: div, level: 7" node_number="1013"> <div class="valid" valid="valid" title="valid: True, node: 1014, tag: div, level: 8" node_number="1014"> <h2 class="valid" valid="valid" title="valid: True, node: 1015, tag: h2, level: 9" node_number="1015">E-Mail Alert</h2> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1016, tag: div, level: 7" node_number="1016"> <div class="valid" valid="valid" title="valid: True, node: 1017, tag: div, level: 8" node_number="1017"> <h2 class="valid" valid="valid" title="valid: True, node: 1018, tag: h2, level: 9" node_number="1018">News</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1019, tag: div, level: 8" node_number="1019"> <div class="valid" valid="valid" title="valid: True, node: 1020, tag: div, level: 9" node_number="1020"> 22 November 2021 720 MDPI Editorial Board Members Receiving "2021 Highly Cited Researchers" Distinction </div> <div class="valid" valid="valid" title="valid: True, node: 1021, tag: div, level: 9" node_number="1021"> 16 November 2021 Topical Advisory Panel Established to Support Editorial Board </div> <div class="valid" valid="valid" title="valid: True, node: 1022, tag: div, level: 9" node_number="1022"> 25 October 2021 Open Access Week 2021 | It Matters How We Open Knowledge: Building Structural Equity, 25&#8211;31 October </div> <div class="valid" valid="valid" title="valid: True, node: 1023, tag: div, level: 9" node_number="1023"> More News Announcements... </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1024, tag: div, level: 7" node_number="1024"> <div class="valid" valid="valid" title="valid: True, node: 1025, tag: div, level: 8" node_number="1025"> <h2 class="valid" valid="valid" title="valid: True, node: 1026, tag: h2, level: 9" node_number="1026">Topics</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1027, tag: div, level: 8" node_number="1027"> <div class="valid" valid="valid" title="valid: True, node: 1028, tag: div, level: 9" node_number="1028"><div class="valid" valid="valid" title="valid: True, node: 1029, tag: div, level: 10" node_number="1029"> Topic in IJMS, Biomedicines, Antioxidants, CIMB, JCM</div> Sterile Inflammation in Solid Organ Transplantation Editors-in-Chief: Jerzy W. Kupiec-Weglinski, Joan Rosell&#243;-Catafau, Ren&#233; Adam, Teresa Carbonell Cam&#243;s, Arnau Panisello-Rosell&#243;Deadline: 10 February 2022</div> <div class="valid" valid="valid" title="valid: True, node: 1030, tag: div, level: 9" node_number="1030"><div class="valid" valid="valid" title="valid: True, node: 1031, tag: div, level: 10" node_number="1031"> Topic in Applied Sciences, JCM, Dentistry Journal, IJMS, MPs</div> Advances in Dental Biomaterials and Oral Tissues Engineering Editors-in-Chief: Gianrico Spagnuolo, Marco TatulloDeadline: 31 March 2022</div> <div class="valid" valid="valid" title="valid: True, node: 1032, tag: div, level: 9" node_number="1032"><div class="valid" valid="valid" title="valid: True, node: 1033, tag: div, level: 10" node_number="1033"> Topic in Biomedicines, Viruses, JoF, Microorganisms, JCM</div> Infectious Diseases Editor-in-Chief: C&#233;lia F. RodriguesDeadline: 31 May 2022</div> <div class="valid" valid="valid" title="valid: True, node: 1034, tag: div, level: 9" node_number="1034"><div class="valid" valid="valid" title="valid: True, node: 1035, tag: div, level: 10" node_number="1035"> Topic in Materials, Dentistry Journal, JCM, JFB</div> New Frontiers and Boundaries in the Use of Biomaterials in Dentistry Editors-in-Chief: Daniele Botticelli, Adriano Piattelli, Gabi ChaushuDeadline: 10 June 2022</div> <div class="valid" valid="valid" title="valid: True, node: 1036, tag: div, level: 9" node_number="1036"> More Topics </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1037, tag: div, level: 7" node_number="1037"> <div class="valid" valid="valid" title="valid: True, node: 1038, tag: div, level: 8" node_number="1038"> <h2 class="valid" valid="valid" title="valid: True, node: 1039, tag: h2, level: 9" node_number="1039">Conferences</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1040, tag: div, level: 8" node_number="1040"> <div class="valid" valid="valid" title="valid: True, node: 1041, tag: div, level: 9" node_number="1041"> Announce Your Conference </div> <div class="valid" valid="valid" title="valid: True, node: 1042, tag: div, level: 9" node_number="1042"> 9 January 2021&#8211;9 January 2022 New Ultrasonographic Techniques for the Study of the Inferior Vena Cava to Guide Patient Management in Different Clinical Contexts</div> <div class="valid" valid="valid" title="valid: True, node: 1043, tag: div, level: 9" node_number="1043"> 18&#8211;19 February 2022 6th International 4 Corners of Cardiology Meeting</div> <div class="valid" valid="valid" title="valid: True, node: 1044, tag: div, level: 9" node_number="1044"> 17&#8211;20 July 2022 15th International Neurotrauma Symposium</div> <div class="valid" valid="valid" title="valid: True, node: 1045, tag: div, level: 9" node_number="1045"> More Conferences... </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1046, tag: div, level: 7" node_number="1046"> <div class="valid" valid="valid" title="valid: True, node: 1047, tag: div, level: 8" node_number="1047"> <h2 class="valid" valid="valid" title="valid: True, node: 1048, tag: h2, level: 9" node_number="1048">Special Issues</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1049, tag: div, level: 8" node_number="1049"> <div class="valid" valid="valid" title="valid: True, node: 1050, tag: div, level: 9" node_number="1050"> Edit a Special Issue </div> <div class="valid" valid="valid" title="valid: True, node: 1051, tag: div, level: 9" node_number="1051"><div class="valid" valid="valid" title="valid: True, node: 1052, tag: div, level: 10" node_number="1052"> Special Issue in JCM</div> Update on Diagnostic, Antibiotic Treatment, and Prevention of Infections in Critically Ill Patients Guest Editor: Erlangga YusufDeadline: 15 December 2021</div> <div class="valid" valid="valid" title="valid: True, node: 1053, tag: div, level: 9" node_number="1053"><div class="valid" valid="valid" title="valid: True, node: 1054, tag: div, level: 10" node_number="1054"> Special Issue in JCM</div> Molecular Epidemiology in Hepatitis C Virus (HCV) Infection: Studies of Viral and Human Genomes Guest Editors: Salvador Resino, Isidoro Mart&#237;nezDeadline: 31 December 2021</div> <div class="valid" valid="valid" title="valid: True, node: 1055, tag: div, level: 9" node_number="1055"><div class="valid" valid="valid" title="valid: True, node: 1056, tag: div, level: 10" node_number="1056"> Special Issue in JCM</div> Natural History and Clinical Consequences of Hepatitis B Virus (HBV) Infection Guest Editor: Cristina StasiDeadline: 1 January 2022</div> <div class="valid" valid="valid" title="valid: True, node: 1057, tag: div, level: 9" node_number="1057"><div class="valid" valid="valid" title="valid: True, node: 1058, tag: div, level: 10" node_number="1058"> Special Issue in JCM</div> Peripheral Artery Disease: From Diagnosis to Treatment Guest Editor: Guillaume MaheDeadline: 10 January 2022</div> <div class="valid" valid="valid" title="valid: True, node: 1059, tag: div, level: 9" node_number="1059"> More Special Issues </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1060, tag: div, level: 7" node_number="1060"> <div class="valid" valid="valid" title="valid: True, node: 1061, tag: div, level: 8" node_number="1061"> <h2 class="valid" valid="valid" title="valid: True, node: 1062, tag: h2, level: 9" node_number="1062">Topical Collections</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1063, tag: div, level: 8" node_number="1063"> <div class="valid" valid="valid" title="valid: True, node: 1064, tag: div, level: 9" node_number="1064"><div class="valid" valid="valid" title="valid: True, node: 1065, tag: div, level: 10" node_number="1065"> Topical Collection in JCM</div> State-of-the-Art in Inflammatory Bowel Disease Collection Editors: Stefanos Bonovas, Daniele Piovani</div> <div class="valid" valid="valid" title="valid: True, node: 1066, tag: div, level: 9" node_number="1066"><div class="valid" valid="valid" title="valid: True, node: 1067, tag: div, level: 10" node_number="1067"> Topical Collection in JCM</div> Novel Coronavirus Pandemic: Public Health, Epidemiological, and Multi-Disciplinary Research Collection Editors: Paulo Jorge Nogueira, Miguel de Ara&#250;jo Nobre</div> <div class="valid" valid="valid" title="valid: True, node: 1068, tag: div, level: 9" node_number="1068"><div class="valid" valid="valid" title="valid: True, node: 1069, tag: div, level: 10" node_number="1069"> Topical Collection in JCM</div> Bariatric Surgery: Latest Advances and Prospects Collection Editor: David Benaiges Boix</div> <div class="valid" valid="valid" title="valid: True, node: 1070, tag: div, level: 9" node_number="1070"><div class="valid" valid="valid" title="valid: True, node: 1071, tag: div, level: 10" node_number="1071"> Topical Collection in JCM</div> Implant Dentistry&#8212;Trends, Challenges and Innovations Collection Editor: Miguel de Ara&#250;jo Nobre</div> <div class="valid" valid="valid" title="valid: True, node: 1072, tag: div, level: 9" node_number="1072"> More Topical Collections </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1073, tag: div, level: 7" node_number="1073"> <div class="valid" valid="valid" title="valid: True, node: 1074, tag: div, level: 8" node_number="1074"> <h2 class="valid" valid="valid" title="valid: True, node: 1075, tag: h2, level: 9" node_number="1075">Jobs in Research</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1076, tag: div, level: 8" node_number="1076"> <div class="valid" valid="valid" title="valid: True, node: 1077, tag: div, level: 9" node_number="1077"> Post New Job Opening </div> </div> </div> </div> </div> </div> </section> <div class="valid" valid="valid" title="valid: True, node: 1078, tag: div, level: 3" node_number="1078"> <div class="valid" valid="valid" title="valid: True, node: 1079, tag: div, level: 4" node_number="1079"> J. Clin. Med., EISSN 2077-0383, Published by MDPI <span class="valid" valid="valid" title="valid: True, node: 1080, tag: span, level: 5" node_number="1080"> Disclaimer <div class="valid" valid="valid" title="valid: True, node: 1081, tag: div, level: 6" node_number="1081"> The statements, opinions and data contained in the journal Journal of Clinical Medicine are solely those of the individual authors and contributors and not of the publisher and the editor(s). MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. </div> </span> <div class="valid" valid="valid" title="valid: True, node: 1082, tag: div, level: 5" node_number="1082"> RSS Content Alert </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1083, tag: div, level: 4" node_number="1083"> <div class="valid" valid="valid" title="valid: True, node: 1084, tag: div, level: 5" node_number="1084"> <h3 class="valid" valid="valid" title="valid: True, node: 1085, tag: h3, level: 6" node_number="1085"> Further Information </h3> Article Processing Charges <a class="valid" valid="valid" title="valid: True, node: 1086, tag: a, level: 6" node_number="1086"> Pay an Invoice </a> <a class="valid" valid="valid" title="valid: True, node: 1087, tag: a, level: 6" node_number="1087"> Open Access Policy </a> <a class="valid" valid="valid" title="valid: True, node: 1088, tag: a, level: 6" node_number="1088"> Contact MDPI </a> <a class="valid" valid="valid" title="valid: True, node: 1089, tag: a, level: 6" node_number="1089"> Jobs at MDPI </a> </div> <div class="valid" valid="valid" title="valid: True, node: 1090, tag: div, level: 5" node_number="1090"> <h3 class="valid" valid="valid" title="valid: True, node: 1091, tag: h3, level: 6" node_number="1091"> Guidelines </h3> <a class="valid" valid="valid" title="valid: True, node: 1092, tag: a, level: 6" node_number="1092"> For Authors </a> <a class="valid" valid="valid" title="valid: True, node: 1093, tag: a, level: 6" node_number="1093"> For Reviewers </a> <a class="valid" valid="valid" title="valid: True, node: 1094, tag: a, level: 6" node_number="1094"> For Editors </a> <a class="valid" valid="valid" title="valid: True, node: 1095, tag: a, level: 6" node_number="1095"> For Librarians </a> <a class="valid" valid="valid" title="valid: True, node: 1096, tag: a, level: 6" node_number="1096"> For Publishers </a> <a class="valid" valid="valid" title="valid: True, node: 1097, tag: a, level: 6" node_number="1097"> For Societies </a> </div> <div class="valid" valid="valid" title="valid: True, node: 1098, tag: div, level: 5" node_number="1098"> <h3 class="valid" valid="valid" title="valid: True, node: 1099, tag: h3, level: 6" node_number="1099"> MDPI Initiatives </h3> <a class="valid" valid="valid" title="valid: True, node: 1100, tag: a, level: 6" node_number="1100"> Sciforum </a> <a class="valid" valid="valid" title="valid: True, node: 1101, tag: a, level: 6" node_number="1101"> MDPI Books </a> <a class="valid" valid="valid" title="valid: True, node: 1102, tag: a, level: 6" node_number="1102"> Preprints </a> <a class="valid" valid="valid" title="valid: True, node: 1103, tag: a, level: 6" node_number="1103"> Scilit </a> <a class="valid" valid="valid" title="valid: True, node: 1104, tag: a, level: 6" node_number="1104"> SciProfiles </a> <a class="valid" valid="valid" title="valid: True, node: 1105, tag: a, level: 6" node_number="1105"> Encyclopedia </a> <a class="valid" valid="valid" title="valid: True, node: 1106, tag: a, level: 6" node_number="1106"> JAMS </a> <a class="valid" valid="valid" title="valid: True, node: 1107, tag: a, level: 6" node_number="1107"> Proceedings Series </a> </div> <div class="valid" valid="valid" title="valid: True, node: 1108, tag: div, level: 5" node_number="1108"> <h3 class="valid" valid="valid" title="valid: True, node: 1109, tag: h3, level: 6" node_number="1109"> Follow MDPI </h3> <a class="valid" valid="valid" title="valid: True, node: 1110, tag: a, level: 6" node_number="1110"> LinkedIn </a> <a class="valid" valid="valid" title="valid: True, node: 1111, tag: a, level: 6" node_number="1111"> Facebook </a> <a class="valid" valid="valid" title="valid: True, node: 1112, tag: a, level: 6" node_number="1112"> Twitter </a> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1113, tag: div, level: 4" node_number="1113"> <div class="valid" valid="valid" title="valid: True, node: 1114, tag: div, level: 5" node_number="1114"> <div class="valid" valid="valid" title="valid: True, node: 1115, tag: div, level: 6" node_number="1115"> &#169; 1996-2021 MDPI (Basel, Switzerland) unless otherwise stated </div> <div class="valid" valid="valid" title="valid: True, node: 1116, tag: div, level: 6" node_number="1116"> <a class="valid" valid="valid" title="valid: True, node: 1117, tag: a, level: 7" node_number="1117"> Disclaimer </a> <div class="valid" valid="valid" title="valid: True, node: 1118, tag: div, level: 7" node_number="1118"> The statements, opinions and data contained in the journals are solely those of the individual authors and contributors and not of the publisher and the editor(s). MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. </div> <a class="valid" valid="valid" title="valid: True, node: 1119, tag: a, level: 7" node_number="1119"> Terms and Conditions </a> <a class="valid" valid="valid" title="valid: True, node: 1120, tag: a, level: 7" node_number="1120"> Privacy Policy </a> </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1121, tag: div, level: 3" node_number="1121"> <div class="valid" valid="valid" title="valid: True, node: 1122, tag: div, level: 4" node_number="1122"> We use cookies on our website to ensure you get the best experience. Read more about our cookies <a class="valid" valid="valid" title="valid: True, node: 1123, tag: a, level: 5" node_number="1123">here</a>. </div> <div class="valid" valid="valid" title="valid: True, node: 1124, tag: div, level: 4" node_number="1124"> <a class="valid" valid="valid" title="valid: True, node: 1125, tag: a, level: 5" node_number="1125">Accept</a> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1126, tag: div, level: 3" node_number="1126"> <div class="valid" valid="valid" title="valid: True, node: 1127, tag: div, level: 4" node_number="1127"> We have just recently launched a new version of our website. Help us to further improve by taking part in this short 5 minute survey here. here. </div> <div class="valid" valid="valid" title="valid: True, node: 1128, tag: div, level: 4" node_number="1128"> <a class="valid" valid="valid" title="valid: True, node: 1129, tag: a, level: 5" node_number="1129">Never show this again</a> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1130, tag: div, level: 2" node_number="1130"> <div class="valid" valid="valid" title="valid: True, node: 1131, tag: div, level: 3" node_number="1131"> <div class="valid" valid="valid" title="valid: True, node: 1132, tag: div, level: 4" node_number="1132"> <h2 class="valid" valid="valid" title="valid: True, node: 1133, tag: h2, level: 5" node_number="1133">Share Link</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1134, tag: div, level: 4" node_number="1134"> <a class="valid" valid="valid" title="valid: True, node: 1135, tag: a, level: 5" node_number="1135">Copy</a> </div> </div> <a class="valid" valid="valid" title="valid: True, node: 1136, tag: a, level: 3" node_number="1136"> <i class="valid" valid="valid" title="valid: True, node: 1137, tag: i, level: 4" node_number="1137">clear</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 1138, tag: div, level: 2" node_number="1138"> <div class="valid" valid="valid" title="valid: True, node: 1139, tag: div, level: 3" node_number="1139"> <div class="valid" valid="valid" title="valid: True, node: 1140, tag: div, level: 4" node_number="1140"> <h2 class="valid" valid="valid" title="valid: True, node: 1141, tag: h2, level: 5" node_number="1141">Share</h2> </div> </div> <a class="valid" valid="valid" title="valid: True, node: 1142, tag: a, level: 3" node_number="1142"> <i class="valid" valid="valid" title="valid: True, node: 1143, tag: i, level: 4" node_number="1143">clear</i> </a> </div> <a class="valid" valid="valid" title="valid: True, node: 1144, tag: a, level: 2" node_number="1144">Back to TopTop</a> </body>
        <style tyle='text/css'>
body{
    position: relative;
    padding-left: 30px;
    top: 60px;
}
* {
    border: 1px solid #eee;
    padding: 5px 12px;
    margin: 3px 0;
    box-sizing: content-box;
    background-color: #fff;
    cursor: no-drop;
}
main:hover > *, section:hover > *, header:hover > *, nav:hover > *, a:hover > *, div:hover > *, p:hover > *, ul:hover > *, h1:hover > *, h2:hover > *, h3:hover > *, li:hover > *, span:hover > *{
    border: 2px solid green;
    background-color: #fffeee;
    padding: 5px 23px !important;
    margin: 1px 0;
    color: green;
}
main:hover, section:hover, header:hover, nav:hover, a:hover, div:hover, p:hover, ul:hover, h1:hover, h2:hover, h3:hover, li:hover, span:hover{
    border: 1px solid #fff;
    background-color: #eee;
}
a, span {
    display: block;
}
.selected {
    border: 2px solid orchid !important;
    opacity: 0.8;
    color: orchid !important;
}
.selected * {
    padding: 2px !important;
    color: orchid !important;
}
.valid {
  cursor: pointer;
}
.btn{
  cursor: pointer;
  font-weight: bolder;
  padding: 8px;
}
</style> 
        <script>function OpenOriginalLink($event){
    $event.stopPropagation();
    console.log(url);
}

function removeItem($event){
    $event.stopPropagation();
    console.log('Remove item: ', url)
    localStorage.removeItem(url)
}

function exportData($event){
    $event.stopPropagation();

    result = []
    for(let i=0; i<localStorage.length; i++) {
        let key = localStorage.key(i);
        result.push(localStorage.getItem(key))
    }
    const _url = URL.createObjectURL(new Blob([result.join("\n")], {type: 'text/plain'}))
    $event.target.href = _url;
    localStorage.clear()
}

var removeItemBtn = document.createElement("BUTTON");   // Create a <button> element
removeItemBtn.innerHTML = "Remove Item";
removeItemBtn.classList.add('btn');
removeItemBtn.style.position = "fixed";
removeItemBtn.style.left = '5px';
removeItemBtn.style.top = 0;
removeItemBtn.style.border = "1px solid";
removeItemBtn.style.boxShadow = "3px 3px #888";
removeItemBtn.onclick = removeItem;
document.body.appendChild(removeItemBtn);

var goToOriginLink = document.createElement("A");   // Create a <button> element
goToOriginLink.innerHTML = "GoToOrigin";
goToOriginLink.classList.add('btn');
goToOriginLink.style.position = "fixed"
goToOriginLink.style.left = '115px'
goToOriginLink.style.top = 0;
goToOriginLink.onclick = OpenOriginalLink;
goToOriginLink.setAttribute('href', decodeURIComponent(url));
goToOriginLink.target = '_blank';
document.body.appendChild(goToOriginLink);

var current = new Date
var exportDataLink = document.createElement("A");   // Create a <button> element
exportDataLink.innerHTML = "Export data";
exportDataLink.classList.add('btn');
exportDataLink.download = current.toISOString() + '.exported.txt';
exportDataLink.style.position = "fixed";
exportDataLink.style.right = '5px';
exportDataLink.style.top = 0;
exportDataLink.style.border = "1px solid #888";
exportDataLink.style.boxShadow = "3px 3px #888";
exportDataLink.onclick = exportData;
document.body.appendChild(exportDataLink);

data = {
    'title': null ,
    'article': null
}

var body = document.getElementsByTagName("body")[0];

body.onclick = function($e){
    var num = $e.target.getAttribute('node_number')
    var valid = $e.target.getAttribute('valid')

    if(!valid){
        console.log("Element is invalid")
        return
    }

    if(data.length > 2){
        data = data.splice(0, 2)
    }

    console.log("node:", $e.target)

    if(!data.title && !data.article){
        data.title = num;
        console.log("data:", data)
        $e.target.classList.add('selected')
    }else if (data.title && !data.article){
        data.article = num;
        console.log("data:", data)
        $e.target.classList.add('selected')
    }else{
        selected = Array.from(document.getElementsByClassName("selected"))
        selected.forEach(function(el){
            el.classList.remove('selected')
        })

        data.title = num;
        data.article = null;
        $e.target.classList.add('selected')

    }

    if(data.title && data.article){
        var obj = {
            url: url,
            text: body_html,
            title: data.title,
            article: data.article,
        }

        var datasetItem = JSON.stringify(obj)
        localStorage.setItem(url, datasetItem)
    }
}
</script> 
      </html>